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1 Introduction 
 
1.1 The mammalian selenoproteome 
 
Selenium (Se) is an important trace element for some eubacteria, archaea and 
eukaryotes that exerts its biological functions mainly through its direct incorporation 
into selenoproteins as a component of the 21st amino acid selenocysteine (Sec). Sec 
is part of the reactive centre in most selenoproteins and comprises a higher reactivity 
compared with its sulphur containing analogue cysteine (Cys). This has been shown 
by targeted mutagenesis of Sec to Cys and other amino acids in various 
selenoproteins, such as glutathione peroxidases (Maiorino et al., 1995) and 
thioredoxin reductases (Lee et al., 2000; Zhong et al., 2000), which leads to a 
dramatic decrease in enzyme activity. Yet, the reasons for the incorporation of Sec 
instead of Cys are not fully understood. Unlike the 20 amino acids of the universal 
genetic code, Sec is encoded by the opal codon UGA in a process that requires 
translational recoding, as UGA is normally translated as a stop codon (Chambers et 
al., 1986; Zinoni et al., 1986). Consequently, many selenoproteins have been 
originally misannotated due to wrong interpretations of the UGA codon as 
translational terminator. As a result of the rapid progression of genome sequencing 
and improved bioinformatic tools, the number of identified selenoproteins has 
increased dramatically over the last few years. Recent computational approaches 
revealed 310 prokaryotic selenoproteins in the largest microbial sequence dataset, 
the Sargasso Sea environmental genome project (Zhang et al., 2005). The functional 
analysis of the recently discovered selenoproteins, however, could not keep pace 
with the velocity of newly designated selenoproteins. 
 
The first mammalian selenoenzyme, glutathione peroxidase 1 (GPx1), has been 
discovered by two independent groups in 1973 (Flohe et al., 1973; Rotruck et al., 
1973). Initial in vivo labelling experiments with 75Se-selenite in rat suggested 30-50 
different mammalian Se-containing proteins (Behne et al., 1996a). Recent 
computational approaches, however, revealed not more than 25 mammalian 
selenoenzymes (table 1). This discrepancy may arise from splice variants or the use 
of alternative start codons on a single gene. In 2003, Kryukov et al. characterized the 
mammalian selenoproteome in silico by an algorithm, based on the identification of 
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predicted secondary structures of the selenocysteine insertion sequence (SECIS) 
and the presence of catalytically conserved Cys-containing homologues. This 
approach revealed 24 selenoproteins in mouse and rat, and a 25th human 
selenoprotein, designated GPx6 (Kryukov et al., 2003). Interestingly, GPx6 is a Cys-
containing orthologue in mouse and rat. The mammalian selenoproteins investigated 
so far share little sequence homology and exert quite diverse enzymatic functions. 
Yet, some of the characterized selenoproteins can be subdivided into the families of 
glutathione peroxidases (GPxs), thioredoxin reductases (TrxRs) and deiodinases. All 
known human selenoproteins are summarized in table 1 (Kryukov et al., 2003). 
 
Table 1: The human selenoproteome consists of 25 enzymes (GPx6 is a Cys-containing homologue in 
rodents). All known human selenoproteins are listed in alphabetical order. Deiodinases (DIs), 
glutathione peroxidases (GPxs), and thioredoxin reductases (TrxRs) are classified into protein 
families. Due to its relevance for this work GPx4 (PHGPx) is highlighted in grey (Kryukov et al., 2003).  
 
Selenoprotein Chromosomal location (number of exons) 
Sec location in protein 
(length of protein) 
15kDa 1p22.3 (5) 93 (162) 
DI1 1p32.3 (4) 126 (249) 
DI2 14q31.1 (2) 133 (265) 
DI3 14q32 144 (278) 
GPx1 3p21.31 (2) 47 (201) 
GPx2 14q23.3 (2) 40 (190) 
GPx3 5q33.1 (5) 73 (226) 
GPx4 (PHGPx) 19p13.3 (7) 73 (197) 
GPx6 6p22.1 (5) 73 (221) 
H 11q12.1 (4) 44 (122) 
I 2p23.3 (10) 387 (397) 
K 3p21.31 (5) 92 (94) 
M 22q12.2 (5) 48 (145) 
N 1p36.11 (12) 428 (556) 
O 22q13.33 (9) 667 (669) 
P 5p12 (4) 
59, 300, 318, 330, 345, 
352, 367, 369, 376, 378 
(381) 
R 16p13.3 (4) 95 (116) 
S 15q26.3 (6) 188 (189) 
SPS2   60 (448) 
T 3q24 (6) 36 (182) 
TrxR1 12q23.3 (15) 498 (499) 
TrxR2 3q21.2 (16) 655 (656) 
TrxR3 22q11.21 (18) 522 (523) 
V 19q13.13 (6) 273 (346) 
W 19q13.32 (6) 13 (87) 
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Care must be taken by the interpretation of experimental results involving the 
overexpression of individual selenoproteins and in particular by Se 
depletion/repletion and supplementation studies. Alterations in cellular Se availability 
have significant influence on the expression of selenoproteins, which may cause a 
profound effect on the redox metabolism of the cell. Individual selenoproteins 
respond in a different manner to selenium deprivation/repletion, which has been 
described as the “hierarchy” of selenoprotein expression. This phenomenon has 
especially been investigated for members of the GPx family, revealing a specific 
kinetic in the loss of expression during selenium depletion as well as differences in 
the rate of the de novo synthesis of GPxs during selenium repletion (Bermano et al., 
1995; Fujieda et al., 2007; Lei et al., 1995; Wingler et al., 1999). GPx1 and GPx3 
expression decreased rapidly even under moderate Se-deficiency, whereas GPx2 
and GPx4 expression is maintained. The relative position within the deduced 
hierarchy (GPx2>GPx4>GPx3=GPx1) was considered to reflect the biological 
significance of the respective GPx (Brigelius-Flohe, 1999). Yet, findings from 
knockout mice indicate that GPx4 is of major importance within the family of GPxs, 
GPx4 deficiency in mice causes early embryonic lethality, whereas all other GPx 
knockout mice are fully viable. The complexity of selenoprotein expression and 
especially the partial redundancy of family members demand a profound knowledge 
of the molecular functions of all selenoproteins, when investigated in cellular or 
animal model systems. 
 
1.1.1 Deiodinases (DI) 
Three mammalian deiodinase enzymes have been cloned so far, which differ mainly 
in their biochemical activity, tissue distribution and developmental expression pattern. 
Deiodinases cleave specific iodine carbon bonds in thyroid hormones, thereby 
regulating hormonal activity. Thyroid hormones are involved in proliferation, 
development, differentiation and regulate most metabolic functions in vertebrates. 
The synthesis of thyroid hormones occurs exclusively in the thyroid gland, whose 
main secretory product is L-thyroxine (T4). T4 is activated in the extrathyroidal tissue 
by type I 5’-deiodinase (5’-DI1) and type II 5’-deiodinase (5’-DI2), which catalyze the 
deiodination to T3 (3,5,3’-triiodo-L-thyronine). Type III 5’-deiodinase (5’-DI3) 
inactivates the thyroid hormones T4 and T3 by removing iodine atoms from the inner 
tyrosyl ring (Kohrle, 2000).  
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1.1.2 Thioredoxin reductases (TrxR) 
Thioredoxins (Trx) are small redox-active enzymes that regulate a variety of cellular 
processes, including cell-cell communication, redox metabolism, proliferation and 
apoptosis (Arner and Holmgren, 2000). Trx activity is regulated by TrxRs and NADPH 
as a cofactor. Three distinct genes for mammalian TrxR are known, including the 
cytosolic (TrxR1), the mitochondrial (TrxR2), and the testis-specific TrxR (TrxR3). 
TrxRs are homodimeric flavoproteins with two interacting N- and C-terminal catalytic 
centers. Electrons from NADPH are transferred via the FAD prosthetic group to the 
N-terminal Cys-containing catalytic site from where they are passed on to the Sec- 
and Cys-containing C-terminal catalytic site of the second TrxR molecule. The major 
function of TrxRs is the NADPH-dependent reduction of thioredoxin, but several other 
substrates have been reported (Arner and Holmgren, 2000). Due to the flexible 
structure of the C-terminal tail, the reduced Sec at the penultimate position of the C-
terminus provides electrons to a wide range of low molecular weight compounds as 
well as large substrates. Targeted inactivation of either TrxR1 or TrxR2 in genetically 
modified mice leads to embryonic death at gestational days 10.5 and 13.5, 
respectively (Conrad et al., 2004; Jakupoglu et al., 2005). 
 
1.1.3 Glutathione peroxidases (GPxs) 
The family of mammalian GPxs includes seven isoenzymes (GPx1-7). Mammalian 
GPx1, GPx2, GPx3 and PHGPx (GPx4) are selenoproteins, whereas GPx6 is a 
selenoprotein in humans but a Cys-containing homologue in rodents. GPxs reduce 
H2O2 and alkyl hydroperoxides to H2O and their corresponding alcohols, respectively. 
GSH serves as electron donor, which in turn is recycled by GSH reductase and 
NADPH/H+ (figure 1). Yet, GSH should not be considered as the sole physiological 
reducing substrate for all GPxs, since GPx3 has been shown to use also thioredoxin 
or glutaredoxin as reductant (Bjornstedt et al., 1994). 
 
 
Figure 1: Reaction mechanism of glutathione peroxidases (GPxs). GPxs reduce hydrogen peroxide 
and alkyl hydroperoxides to H2O and alcohols, respectively. Two moles of GSH are required to fully 
reduce one mole of GPx. Oxidized GSH (GSSG) is recycled by GSH reductase at the expense of 
NADPH/H+. 
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The specificity for various hydroperoxide substrates differs markedly among the GPx 
isoforms. Whereas GPx1 reduces only soluble hydroperoxides, such as H2O2 and 
some organic hydroperoxides, PHGPx and to some extent GPx3 also reduce 
phospholipid-associated hydroperoxides like phosphatidylcholine hydroperoxide. 
However, PHGPx is the only GPx that efficiently acts on hydroperoxides integrated in 
cellular membranes. GPx1, GPx2 and GPx3 are homotetramers in contrast to the 
smaller monomeric structure of PHGPx. 
 
All Sec containing GPxs share the same enzymatic mechanism involving a 
conserved catalytic triad, consisting of Sec, Gln and Trp (figure 2). The substitution of 
Sec by Cys severely impairs peroxidase activity as shown for GPx1 (Rocher et al., 
1992) and PHGPx (Maiorino et al., 1995) in vitro. Thus the relevance of Cys-
containing GPx isoforms for the detoxification of peroxides is still unclear. The 
reduced enzyme activity of Cys-containing isoforms may account for an involvement 
in the regulation of enzymes with redox-sensitive motifs, such as Cys and metal co-
factors.  
 
Gene:   Sequence: 
 
GPx1      ---------MCAARLSAAAQST-----------------VYAFSARPLTGGEPVSLGSLR 034 
GPx2      --------------MAYIAKS------------------FYDLSAIGLDG-EKIDFNTFR 027 
GPx3      MARILRASCLLSLLLAGFVPPGRGQEKSKTDCHGGMSGTIYEYGALTIDGEEYIPFKQYA 060 
GPx4      ---------MCASRDDWRCARS-----------------MHEFSAKDIDG-HMVCLDKYR 033 
                                                 .:  .*  : * . : :     
 
GPx1      GKVLLIENVASLUGTTIRDYTEMNDLQKRLGPRGLVVLGFPCNQFGHQENGKNEEILNSL 094 
GPx2      GRAVLIENVASLUGTTTRDYNQLNELQCRF-PRRLVVLGFPCNQFGHQENCQNEEILNSL 086 
GPx3      GKYILFVNVASYUGLTD-QYLELNALQEELGPFGLVILGFPSNQFGKQEPGENSEILPSL 119 
GPx4      GFVCIVTNVASQUGKTDVNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSNQEIK--- 090 
          *   :. **** ** *  :* ::  *: .     * :*.**.****:**  .*.**     
 
GPx1      KYVRPGGGFEPNFTLFEKCEVNGEKAHPLFTFLRNALPTPSDDPTALMTDPKYIIWSPVC 154 
GPx2      KYVRPGGGYQPTFSLTQKCDVNGQNEHPVFAYLKDKLPYPYDDPFSLMTDPKLIIWSPVR 146 
GPx3      KYVRPGGGFVPNFQLFEKGDVNGEKEQKFYTFLKNSCPP----TAELLGSPGRLFWEPMK 175 
GPx4      ---EFAAGYNVKFDMYSKICVNGDDAHPLWKWMK--------------VQPK---GRGML 130 
             . ..*:  .* : .*  ***:. : .: :::               .*       :  
 
GPx1      RNDIAWNFEKFLVGPDGVPVRRYSRRFRTIDIEPDIETLLSQQSGNS---- 201 
GPx2      RSDVSWNFEKFLIGPEGEPFRRYSRSFQTINIEPDIKRLLKVAI------- 190 
GPx3      IHDIRWNFEKFLVGPDGIPVMRWYHRTTVSNVKMDILSYMRRQAALSARGK 226 
GPx4      GNAIKWNFTKFLIDKNGCVVKRYGPMEEPQVIEKDLPCYL----------- 170 
             : *** ***:. :*  . *:        :: *:   :            
 
Figure 2: Amino acid sequence alignment of murine Sec-containing GPxs, using ClustalW V1.82 (“*” 
= identical amino acid; “:” = conserved substitution; “.” = semi-conserved substitution). The 
conserved catalytic triad of Sec (U), Gln (Q), and Trp (W) is highlighted in red. The sequence 
homology of the 4 GPxs ranges between 33-60 %. PHGPx shares the least sequence homology to the 
other glutathione peroxidases (33–39 %). 
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Hydroperoxides have long been considered as mere toxic compounds, generated by 
electron leakage from the respiratory chain or exogenous sources like ultraviolet light, 
ionizing radiation, chemotherapeutic drugs, and environmental toxins (Finkel and 
Holbrook, 2000). Over the last couple of years, it has become apparent that 
hydroperoxides are not only detrimental but are also involved in the regulation of 
various cellular processes by changing the redox state of the cell. The cellular redox 
state has been reported to affect cell signalling, cell-cycle progression (Menon and 
Goswami, 2007), proliferation, apoptosis, and differentiation (Steinbeck et al., 1998). 
A well established model for redox-mediated signalling is the reversible inactivation of 
protein tyrosine phosphatases by oxidation, which in turn causes an activation of 
protein tyrosine kinase signalling (Chiarugi and Buricchi, 2007). Hydroperoxides have 
been implicated in the activation of NF-κB by TNF (Kretz-Remy et al., 1996) and IL-1 
(Brigelius-Flohe et al., 1997). While apoptosis can be easily triggered by excess 
hydroperoxides (Hampton and Orrenius, 1998; Sandstrom et al., 1994), 
hydroperoxides have also been reported to enhance the rate of proliferation (Dypbukt 
et al., 1994). These findings have drastically changed the perspective of 
hydroperoxides from mere toxic metabolic by-products to important molecules which 
have a substantial and physiological impact on various cellular processes. GPxs 
have distinct roles in the defense against oxidative stress, yet redox sensing and 
redox regulation are interesting paradigms, which may highlight still enigmatic 
functions of GPxs. 
 
1.1.3.1 Glutathione peroxidase 1 (GPx1) 
GPx1 was originally discovered in 1957 (Mills, 1957) and was the first mammalian 
selenoenzyme described independently by two groups in 1973 (Flohe et al., 1973; 
Rotruck et al., 1973). It is a ubiquitously expressed, homotetrameric cytosolic enzyme 
(therefore also referred as cGPx), reducing H2O2 and a range of organic peroxides, 
including cholesterol and long chain fatty acid hydroperoxides to their respective 
alcohols. GPx1 can only reduce free fatty acid peroxides released from phospholipids 
by phospholipase A2 (PLA2). GPx1 knockout mice do not show any overt phenotype 
under normal conditions (Ho et al., 1997), unless when challenged with electrophilic 
agents such as the herbicides paraquat and diquat (Cheng et al., 1998; Fu et al., 
1999). GPx1-deficient mice are also more susceptible to myocardial ischemia 
reperfusion injury (Yoshida et al., 1997) and stroke (Crack et al., 2001). Noteworthy, 
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the loss of GPx1 does not influence the expression levels of GPx2 (Chu et al., 1997), 
GPx3 and PHGPx (Cheng et al., 1997), candidates which were considered to 
substitute GPx1 deficiency, at least to some extent. Hence, GPx1 appears to be 
dispensable under physiological conditions in mice, but essential for the protection 
from oxidative stress induced detriment. 
 
Interestingly, GPx1 knockout mice infected with a benign coxsackie virus develop 
myocarditis. The transfer of viruses isolated from cardiomyopathic GPx1 knockout 
mice to normal littermates caused an identical pathology, indicating a rapid genetic 
mutation from an avirulent to a virulent pathogen. This may be caused by increased 
oxidative mutations of viral DNA in the absence of GPx1 (Beck et al., 1998; Beck et 
al., 1995; Diamond et al., 2001). 
 
1.1.3.2 Glutathione peroxidase 2 (GPx2) 
Only limited information is available regarding the physiological function of GPx2. 
GPx1 and GPx2 comprise similar substrate specificity in that they efficiently reduce 
H2O2 or fatty acid hydroperoxides, but do not reduce phospholipid hydroperoxides. 
GPx2 is a homotetrameric enzyme found in liver and the epithelium of the 
gastrointestinal tract (therefore also referred as giGPx), suggesting an important 
function in the defense against ingested hydroperoxides in food. GPx2 is one of the 
few enzymes whose expression is well preserved under Se-deficiency, however, 
targeted inactivation of GPx2 in the mouse did not cause any pathological phenotype 
(Esworthy et al., 2000). 
 
1.1.3.3 Glutathione peroxidase 3 (GPx3) 
The extracellular GPx3 is mainly present in plasma (therefore also referred as pGPx) 
and intestine. GPx3 shows enzymatic activity towards phospholipid hydroperoxides, 
and thus may be implicated in protecting outer cell membranes from lipid 
peroxidation (Yamamoto et al., 1993). In humans, GPx3 is mainly expressed in 
kidney, and to a minor extent in heart, lung and other tissues (Ursini et al., 1985). 
High expression and secretion of GPx3 into renal tissue led to the hypothesis that the 
kidney is the main site of GPx3 function (Avissar et al., 1994), albeit its physiological 
function has not yet been resolved. Whether GPx3 is a mere antioxidant enzyme is 
not clear, since no efficient reductant for GPx3 in the plasma has been identified 
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(Bjornstedt et al., 1994). GPx3 has been considered as a regulator of the host’s 
defense reaction by counteracting the oxidative burst of stimulated phagocytes, 
which in turn may activate lipoxygenases (LOXs) and cyclooxygenases (COXs) that 
produce inflammatory mediators (Brigelius-Flohe, 1999).  
 
1.1.3.4 Phospholipid hydroperoxide glutathione peroxidase (PHGPx) 
Due to its relevance for this work, PHGPx will be discussed in detail below (see 
chapter 1.4). 
 
1.1.3.5 Other glutathione peroxidases 
GPx5 is a non-Sec containing isoform which is exclusively found in the epididymis 
(Schwaab et al., 1998; Vernet et al., 1996). In general, Cys-containing isoforms 
generally comprise a relatively low peroxidase activity compared to their Sec-
containing counterparts, thus its function as a putative GPx is still debated. GPx6 has 
been discovered only recently as a human selenoprotein with Cys homologues in 
rodents. GPx6 transcripts were only detected in embryos and in the olfactory 
epithelium (Kryukov et al., 2003). GPx7 is an additional non-Sec-containing 
cytoplasmic isoform with barely detectable GPx activity in vitro (Utomo et al., 2004). 
 
1.1.4 Other selenoproteins 
The plasma glycoprotein selenoprotein P (SelP) contains up to 10 Sec residues per 
polypeptide chain, depending on intracellular Sec availability (Hill et al., 1991). It is 
the only known selenoprotein containing more than one Sec residue. Efficient Sec 
incorporation (figure 3) in SelP is achieved by two different types of SECIS elements 
in the 3’-untranslated region of SelP mRNA. The vast majority of SelP is secreted by 
the liver, providing more than 50 % of total plasma selenium. This rendered SelP a 
transport and storage protein for selenium in mammals; but antioxidant and heavy 
metal chelating functions are discussed as well. Interestingly, SelP gene disruption in 
transgenic mice leads to 80-90% decrease in Se-plasma levels and the activities of 
various selenoproteins drop significantly in brain, kidney and testis (Hill et al., 2003; 
Schweizer et al., 2004a). While Se-deficiency does not impair embryonic 
development, approximately three weeks post partum, knockout mice showed 
reduced weight gain, sporadic fatalities, and symptoms like ataxia (Schomburg et al., 
2003). Yet, most symptoms could be overcome by feeding mice with a Se-enriched 
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diet (Hill et al., 2003). These findings render SelP dispensable for survival under 
conditions when sufficient inorganic Se is provided by food, e.g. breast feeding from 
mother to offspring (Schweizer et al., 2004b). 
 
The Selenoprotein R (SelR) is a methionine-R-sulfoxide reductase that exists only in 
vertebrates, but Cys-containing homologues in other eukaryotes and prokaryotes 
exist (Kryukov et al., 2002). Thioredoxin provides reducing equivalents for SelR. 
 
Selenophospate synthetase 2 (SPS2) catalyzes the formation of mono-
selenophosphate from inorganic selenium sources, required for tRNA[Ser]Sec 
synthesis. The tRNA[Ser]Sec is essential for co-translational Sec incorporation into 
nascent polypeptide chains (refer to chapter 1.2). 
 
Functional and structural data is still very limited for many selenoproteins, including 
selenoprotein 15 kDa, GPx6, H, I, K, M, N, O, S, T, V and W. Reasons are either 
their very recent discovery and also general technical difficulties in the analysis of 
selenoprotein function due to their relatively low abundance in cells and tissues. 
 
 
1.2 The biosynthesis of selenoproteins 
 
Sec incorporation into the nascent polypeptide chain occurs during ribosomal 
translation; however, it is far more complex as compared to the classical 
incorporation of the other 20 amino acids. Sec is encoded by the UGA codon in a 
process that requires translational recoding, since UGA is usually translated as a 
Stop codon. Sec incorporation requires a specific cis-acting mRNA secondary 
structure, the SECIS element, and at least 5 different gene products (SelC, SelA, 
SPS, SBP2, EFsec) in eukaryotes. 
 
1.2.1 Sec-tRNA biosynthesis (SelA, SelC, SPS) 
The biosynthesis of the Sec-specific tRNA is distinctive from the other 20 amino 
acids, in that its synthesis always occurs on its tRNA. The Sec biosynthesis pathway 
and its incorporation into the nascent polypeptide chain have been elucidated in 
great detail in E. coli in the early nineties mainly by Böck´s group (LMU Munich), but 
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the exact mechanism in mammals still awaits final completeness. The SelC gene 
(Trsp in mammals) encodes a unique tRNA[Ser]Sec that becomes initially 
aminoacylated with Ser by serine synthetase in both prokaryotes and eukaryotes 
(Park et al., 1997). Disruption of SelC in transgenic mice causes early embryonic 
death (E6.5), highlighting the importance of at least one selenoprotein during early 
mammalian development (Bosl et al., 1997). The Ser-loaded tRNA[Ser]Sec serves as 
scaffold for Sec synthesis. In E. coli, the SelA gene product, selenocysteine 
synthase, converts Ser-tRNA[Ser]Sec to Sec-tRNA[Ser]Sec in a two-step reaction, 
involving removal of the hydroxyl-group from Ser and the addition of mono-
selenophosphate. Bacterial selenocysteine synthase has been identified several 
years ago but its eukaryotic counterpart is still unknown. Mono-selenophosphate, the 
activated form of selenium, is synthesized from selenide and ATP by 
selenophosphate synthetase (SPS) (Glass et al., 1993). Two mammalian SPS 
isoforms, designated as SPS1 and SPS2, have been cloned (see also chapter 1.1.4). 
Interestingly, SPS2 is a selenoprotein which may auto-regulate selenoprotein 
synthesis in a negative feedback mechanism (Guimaraes et al., 1996).  
 
1.2.2 Co-translational Sec incorporation (SECIS, EFsec, SBP2, SelB) 
Since the UGA codon comprises a dual role in cell biology, several cis- and trans-
acting factors are required to discriminate between Stop and Sec codon. Those 
factors include (i) the cis-acting stem-loop structure in the mRNA sequence of 
selenoproteins, designated the SECIS element and two trans-acting factors, (ii) the 
SECIS Binding Protein (SBP2) (Copeland et al., 2000), and (iii) the Sec-specific 
elongation factor (EFsec or SelB) (Fletcher et al., 2001). The efficiency of Sec 
insertion has been determined for the bacterial formiat dehydrogenase and is rather 
low, ranging around 4 % compared to the incorporation of other amino acids. This 
has been nicely shown by mutating the Sec codon to a Ser codon, which increased 
the amino acid insertion efficiency to 95 % (Suppmann et al., 1999). 
 
Eukaryotic and archaeal SECIS elements are located in the 3’ untranslated region of 
the selenoprotein mRNA (figure 3). The distance of the UGA codon and the SECIS 
element can be as far as 4000 bp (Buettner et al., 1998), whereas in prokaryotic 
mRNAs the SECIS element is located just downstream of the UGA codon as part of 
the coding region of the selenoprotein. Eukaryotic SECIS elements are composed of 
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two helices, an internal and apical loop, and a conserved non-Watson-Crick 
interacting nucleotide quartet, located at the base of helix 2. Some large apical loops 
contain an additional ministem that presumably stabilizes the SECIS element. 
 
SBP2 is recruited in eukaryotic cells by the SECIS element to form a stable SECIS-
SBP2 complex (Copeland et al., 2000; Low et al., 2000). SBP2 binds the elongation 
factor EFsec, which in turn recruits Sec-loaded tRNA[Ser]Sec (Fagegaltier et al., 2000; 
Tujebajeva et al., 2000). This complex translocates to the ribosome, where 
tRNA[Ser]Sec is released to the ribosomal A-site by GTP hydrolysis. Recently, the 
eukaryotic ribosomal protein L30 has been implicated in Sec incorporation (Chavatte 
et al., 2005). L30 is considered to replace SBP2 upon binding of the complex to the 
ribosome, triggering the release of tRNA[Ser]Sec. Eventually, the polypeptide chain at 
the P-site is transferred to the tRNA[Ser]Sec, forming a peptide bond with Sec. The 
elongation factor EFsec is specific for Sec incorporation and differs from EF-Tu, 
which is involved in the aminoacyl-tRNA delivery of the other 20 amino acids. SBP2 
along with EFsec constitute the functional equivalent of a single elongation factor in 
prokaryotic selenoprotein synthesis, designated SelB (Forchhammer et al., 1989). 
 
 
 
Figure 3: Mechanism of mammalian Sec incorporation. The tRNA[Ser]Sec (black shamrock shape), 
carrying Sec, is depicted in a complex with EFsec (green), SBP2 (blue) and the SECIS element (black 
hairpin loop). This complex translocates tRNA[Ser]Sec to the ribosomal A-site, encoded by an in-frame 
UGA codon in the mRNA sequence. Released tRNA[Ser]Sec provides Sec for the ribosomal elongation 
reaction in which Sec is incorporated into the nascent polypeptide chain (red) by peptide bond 
formation. Translational start and stop codons of the translated mRNA are indicated by black arrows. 
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Recently two additional eukaryotic proteins, SECp43 and soluble liver antigen (SLA), 
have been implicated in selenoprotein biosynthesis. SECp43 and SLA form a 
complex with tRNA[Ser]Sec. Targeted knockdown of both factors reduced overall 
selenoprotein biosynthesis (Xu et al., 2005), but detailed characterization of both 
factors requires further studies. 
 
 
1.3 GSH biosynthesis and the Cys/(Cys)2-cycle 
 
1.3.1 Cellular functions of GSH 
GPxs belong to a class of GSH-dependent redox enzymes, mainly using electrons 
from the reducing equivalent GSH. The tripeptide GSH (L-gammaglutamyl-L-
cysteinylglycine) is the predominant non-protein sulfhydryl compound in the cell. It is 
present in millimolar concentrations (up to 10 mM) and exists predominantly in its 
reduced form. The oxidised form of GSH consists of two GSH molecules (GSSG), 
connected by a disulfide bond and represents about 1 % of the overall GSH pool 
under normal conditions. GSH is the major endogenous scavenger of reactive 
oxygen species (ROS) in the cell, by acting as a reducing equivalent for GPxs and 
other GSH-dependent detoxifying enzymes (figure 1). 
 
Beyond its antioxidant activity, GSH exerts several other cellular functions. 
Glutaredoxins are relatively small GSH-dependent thiol-disulfide oxidoreductases 
that can reduce protein disulfides or mixed disulfides between proteins and GSH 
(Holmgren, 1979a, b). Glutathionylation of proteins has emerged as a novel 
regulatory mechanism of signalling cascades by reversible protein thiol modification. 
This modification is believed to act as a redox-sensing mechanism under conditions 
of oxidative stress (Fernandes and Holmgren, 2004). Glutaredoxins are also involved 
in DNA synthesis by reducing ribonucleotide reductase. Glutathione-S-transferases 
represent a family of GSH-dependent enzymes that mainly detoxify xenobiotics by 
GSH conjugation (Hayes and Pulford, 1995; Mannervik and Danielson, 1988). These 
enzymes have also been implicated in the protection against lipid peroxidation as a 
second line of defense behind catalases, superoxide dismutases, and GPxs (Sharma 
et al., 2004). GSH also acts as a reservoir for intracellular Cys, as the free form of 
Cys is considered to be toxic. 
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1.3.2 The γ-glutamyl and the Cys/(Cys)2 cycle of GSH biosynthesis 
GSH is synthesized intracellularly in a two step mechanism by the rate-limiting 
enzyme γ-glutamylcysteine synthetase (γ-GCS) and glutathione synthase (GSH-S) 
from cysteine (Cys), glutamate (Glu) and glycine (Gly). The importance of GSH for 
mammalian life has been demonstrated by targeted deletion of γ-GCS in mice. γ-
GCS-deficient mice lack GSH biosynthesis and fail to develop beyond embryonic day 
7.5. (Shi et al., 2000). The enzymatic activity of γ-GCS can efficiently be blocked by 
the chemical inhibitor L-buthionine sulfoximine (BSO). The rate-limiting substrate for 
GSH biosynthesis is Cys. Reduced Cys can be transported into the cell by the 
unspecific amino acid transport system ASC (a shared amino acid transporter for Ala, 
Ser, and Cys), whereas oxidised cystine (Cys)2 (figure 4) can only be transported by 
the Glu/(Cys)2 exchange system, system xc-. 
 
Figure 4: The reversible oxidation of cysteine (Cys) to cystine ((Cys)2). (Cys)2 is formed by the 
oxidation of two molecules Cys. 
 
The Glu/(Cys)2 antiporter, system xc-, consists of two protein components, xCT light 
chain and 4F2 heavy chain, whereas xCT mediates transport specificity (Sato et al., 
1999). System xc- transports one mole (Cys)2 into the cell in exchange of one mole 
Glu (figure 5), which can be inhibited by high concentrations of extracellular Glu 
(Bannai, 1986). The reducing environment inside the cell rapidly reduces (Cys)2 to 
Cys, which is used for GSH or protein biosynthesis. A part of intracellular Cys is 
released back into the medium via neutral amino acid transport systems, where it is 
rapidly oxidized to (Cys)2 by oxygen in the medium. Thus, system xc- is regarded as a 
major part of the Cys/(Cys)2 cycle, essential for the maintenance of the Cys/(Cys)2 
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redox balance (Bannai et al., 1989) as well as cellular GSH levels (Bannai and 
Tateishi, 1986). xCT knockout mice are healthy in appearance and fertile, but 
isolated fibroblasts die in cell culture, if not supplemented with thiol-containing 
compounds (Sato et al., 2005). Thus, system xc- seems to be dispensable for 
mammalian development although it is vitally important for cells cultivated in vitro. Of 
note, certain cell types (e.g. B and T cells) have a very limited (Cys)2 uptake capacity 
due to low expression levels of xCT. This renders B cells and Burkitt lymphoma cells 
dependent on reduced Cys, which must be provided by feeder cells or thiol-
containing supplements (Falk et al., 1993). Recently, Sakakura et al., showed that 
xCT is expressed in activated neutrophils, indicating that system xc- protects 
neutrophils from generated ROS during host defense (Sakakura et al., 2007). 
 
 
 
Figure 5: The γ-glutamyl and the Cys/(Cys)2 cycle of glutathione (GSH) biosynthesis. De novo GSH 
biosynthesis is catalysed from Cys, Glu and Gly by the rate-limiting enzyme γ-GCS and GSH-S. The 
rate limiting substrate of the de novo GSH biosynthesis is Cys. Cys is transported into the cell by the 
transport system ASC and in its oxidized form (Cys)2 by system xc-, respectively. Intracellular Cys is 
partially secreted by neutral amino acid transport systems. The salvage pathway of GSH biosynthesis 
is mediated by GGT and the γ-Glu-AA transport system, bypassing the rate limiting step of γ-
glutamylcysteine synthesis. For further details please refer to text. 
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Extracellular GSH levels are rather low, yet the export of GSH provides a salvage 
pathway of GSH biosynthesis, bypassing the rate-limiting step of γ-glutamylcysteine 
synthesis. This pathway recycles secreted GSH, by recovering Cys-containing 
cleavage products and is independent from system xc-. Synthesized GSH 
translocates to the membrane bound γ-glutamyl transpeptidase (GGT), which 
catalyses the transfer of the γ-glutamyl moiety to reduced Cys or its oxidised form 
(Cys)2, forming γ-glutamyl-cysteine/cystine (γ-Glu-Cys/(Cys)2) and cysteinylglycine 
(Cys-Gly). GGT can be blocked by the chemical inhibitor acivicin.  γ-Glu-Cys/(Cys)2 is 
taken up by a γ-glutamyl amino acid transporter (γ-Glu-AA), whereas Cys-Gly can be 
cleaved by dipeptidases, releasing Cys.  
 
 
1.4 Phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) 
 
1.4.1 The genetic and molecular structure of PHGPx 
PHGPx was first purified from pig liver in 1982 by Ursini et al. and characterized as a 
protein efficiently protecting liposomes and biomembranes from peroxidative 
degradation in the presence of GSH (Ursini et al., 1982). PHGPx shares the least 
sequence homology with the other GPxs and significantly differs from its family 
members in terms of its monomeric structure, relatively low substrate specificity, and 
its necessity for mouse development (Imai and Nakagawa, 2003; Yant et al., 2003). 
 
Three distinct forms of mammalian PHGPx exist, revealing different subcellular 
localization and distinct tissue-specific expression. Any of these forms is expressed 
from its own promoter (figure 6). Alternative transcription initiation leads to formation 
of either the short cytosolic form (20 kDa), the mitochondrial form (23 kDa) with an N-
terminal mitochondrial leader sequence, and the 34 kDa nuclear form of PHGPx 
(nPHGPx), previously referred to as sperm nuclei-specific GPx (SnGPx) (Pfeifer et 
al., 2001). The alternative exon (Ea) encodes a nuclear targeting sequence. The 
cytosolic form of PHGPx is ubiquitously expressed, whereas the mitochondrial and 
the nuclear form are predominantly expressed in testis (Pfeifer et al., 2001; Pushpa-
Rekha et al., 1995; Schneider et al., 2006). 
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Figure 6: Genomic DNA structure of mammalian PHGPx. PHGPx consists of 7 regular exons (E) and 
one additional exon, located between exon 1 and exon 2. The mitochondrial and cytosolic start codons 
are encoded by E1. The sperm nuclei specific form of PHGPx is transcribed from the alternative exon 
(Ea). The Ea encodes a nuclear targeting signal and clusters of basic amino acids, which most 
probably allow binding of PHGPx to DNA. The Sec codon (red asterisk) is encoded by exon 3. The 
SECIS element (yellow asterisk) is located on exon 7. 
 
 
In mice, the amino acid sequence homology of PHGPx compared with the other Sec-
containing GPxs is less than 40 %, yet they share conserved motifs that include the 
catalytic triad of Sec, Gln and Trp. This conserved triad has been shown to form a 
catalytic centre in which the selenol group of Sec is stabilized and activated by 
hydrogen bonds, provided by the Gln and Trp residues (Maiorino et al., 1995). An 
initial mutational and biochemical approach by Maiorino et al. revealed that the 
conversion of Sec to Cys causes a decrease of PHGPx activity by about three orders 
of magnitude in the recombinant protein (Maiorino et al., 1995). 
 
1.4.2 The catalytic mechanism of PHGPx 
The catalytic mechanism is similar in all GPxs, involving redox shuttling of the Sec 
residue within the active site (figure 7). The dissociated selenol (-SeH) from Sec is 
oxidized by hydroperoxides to yield a selenenic acid (-SeOH). The selenenic acid 
reacts with a free thiol (-SH), typically GSH, to form an intermediate selenodisulfide, 
which in turn is resolved by a second GSH molecule. In contrast to the other GPxs, 
PHGPx activity does not solely rely on GSH as a reducing equivalent but also reacts 
with thiols from proteins, in particular when GSH is limiting as evident in mature 
spermatozoa (see chapter 1.4.3.2) (Conrad et al., 2005). Whether PHGPx specifically 
regulates thiol-containing compounds by oxidation is still a matter of debate. 
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Figure 7: The catalytic cycle of PHGPx. The PHGPx selenol (PHGPx-SeH) is oxidized by 
hydroperoxides to selenenic acid (PHGPx-SeOH), following reduction to an intermediate 
selenodisulfide with GSH (A) or other thiol containing molecules (B). PHGPx is reconstituted to its 
active state by a second reducing equivalent, yielding an oxidized GSH dimer (GSSG) or other 
disulfides. 
 
In view of reducing and oxidising substrates, PHGPx is the least specific GPxs. 
Hydrogen peroxide and lipid hydroperoxides are both common substrates for all 
GPxs. In addition, PHGPx can efficiently reduce phospholipid hydroperoxides within 
biological membranes. Hence, PHGPx has been implicated in the protection of 
cellular membranes against oxidative damage. Two features may account for the low 
substrate specificity of PHGPx. Firstly, PHGPx acts as a monomer and the active site 
selenol is displayed on a hydrophobic surface of the enzyme. Secondly, arginine 
residues that direct GSH to the active site are present in GPx1, GPx2 and GPx3, but 
are missing in PHGPx. Instead, two lysine residues (Lys-48, Lys-125), supposedly 
less specific for GSH, guide the sulphur atom of various thiol-containing molecules to 
the active site of PHGPx (Mauri et al., 2003; Roveri et al., 2001; Ursini et al., 1999; 
Ursini et al., 1997). 
 
 
1.4.3 The cellular functions of PHGPx 
 
1.4.3.1 PHGPx as an anti-apoptotic factor 
PHGPx was originally described as a protein which protects liposomes and 
biomembranes from peroxidation and was thus implicated in the protection of 
biomembranes against oxidative stress (Ursini et al., 1982). Over the last couple of 
years it became evident that PHGPx protects cells against various apoptotic stimuli, 
such as prooxidants, DNA damaging agents, glucose depletion, and UV-irradiation 
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(Arai et al., 1999; Imai et al., 1996; Nomura et al., 1999; Shidoji et al., 2006; Yagi et 
al., 1996). PHGPx has been cloned by our group in an expression cloning approach 
as an enzyme protecting Burkitt’s lymphoma cells from cell death imposed by 
seeding cells at low cell density (Brielmeier et al., 2001). Specific inactivation of 
PHGPx in mice causes early embryonic lethality at E7.5 (Imai et al., 2003; Imai and 
Nakagawa, 2003; Yant et al., 2003), but the biological reasons are unclear. Studies 
with primary mouse embryonic fibroblasts (MEFs) isolated from PHGPx knockout 
mice revealed that heterozygous PHGPx knockout cells (PHGPX(wt/-)) are more 
susceptible to oxidative stress induced cell death, compared to their wild-type 
counterparts (Yant et al., 2003). However, PHGPx has not only antioxidant functions 
but plays an important role in other cellular processes, such as sperm maturation and 
redox regulation. 
 
1.4.3.2 PHGPx and spermatogenesis 
Early studies with Se-depleted rodents demonstrated the importance of Se for male 
fertility. Severe Se deficiency causes structural abnormalities of sperm, such as 
broken midpiece of sperm tails, giant heads and reversible testicular atrophy (Behne 
et al., 1996b; Watanabe and Endo, 1991). Due to its particularly high expression 
level in testis, PHGPx has been considered to account for most of the structural and 
morphological defects in the midpiece and head region of mature spermatozoa, as 
well as reversible testicular atrophy observed under severe Se deficiency. 
 
In fact, PHGPx has been shown to comprise several functions during sperm 
maturation. Besides its GSH-dependent peroxidase activity during the early phase of 
spermatogenesis, PHGPx acts as a major structural component (approximately 50% 
of total protein) of the mitochondrial capsule of the midpiece in mature spermatozoa  
(Ursini et al., 1999). PHGPx initiates polymerisation of the mitochondrial capsule by 
oxidising sperm mitochondrion-associated cysteine-rich protein (SMCP) (Maiorino et 
al., 2005). Due to the lack of remaining reducing equivalents, PHGPx eventually 
polymerizes by cross-linking between the Sec46 and Cys148 on the surface of the 
protein, but also heteropolymers with SMCP have been reported (Roveri et al., 2001; 
Ursini et al., 1999). The polymerisation process leads to the loss of PHGPx activity, 
converting it into a structural protein. PHGPx has also been implicated in chromatin 
condensation of maturing spermatozoa. The deduced amino acid composition of the 
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alternative exon (Ea) shows a striking similarity with protamines. This finding 
suggests a similar binding mechanism of nPHGPx to DNA like protamines and a role 
in chromatin condensation by thiol oxidation (Pfeifer et al., 2001). Recent 
experiments with transgenic mice, specifically lacking the nuclear form of PHGPx, 
revealed that nPHGPx contributes to the structural stability of sperm chromatin. 
Thereby nPHGPx acts as a protein thiol peroxidase, but this function appeared not to 
be essential for male fertility (Conrad et al., 2005). Despite its remarkably high 
expression in testis, final evidence that PHGPx plays an essential role in 
spermatogenesis, has still been lacking. Final proof will be provided by ongoing 
studies in our laboratory, in which targeted disruption of the mitochondrial form of 
PHGPx causes sterility in male mice (Schneider et al., submitted). 
 
1.4.3.3 A regulatory role for glutathione peroxidases in arachidonic acid 
metabolism 
GPxs and PHGPx have been considered to control the activities of lipoxygenases 
(LOXs) and cyclooxygenases (COXs), key enzymes of arachidonic acid metabolism 
(figure 8). Arachidonic acid, mainly released from biomembranes by phospholipase 
A2 (PLA2), is a common substrate of both types of enzymes. COXs convert 
arachidonic acid into an unstable hydroperoxide intermediate, prostaglandin G2, 
(PGG2) and subsequently to PGH2, the precursor of various prostanoids (Funk, 
2001). LOXs oxygenate arachidonic acid at different positions and the resulting 
hydroperoxyeicosatetraenoic acids (HPETE) are subsequently reduced either to 
hydroxyeicosatetraenoic acid (HETE) or transformed into leukotrienes, hepoxilins and 
lipoxins (Funk and Cyrus, 2001).  
 
Both types of enzymes require peroxides and/or hydroperoxyl-intermediate 
metabolites for initial activation and full activity (Ivanov et al., 2005). Inactive LOXs 
contain a single iron in the ferrous oxidation state (Fe2+), whereas active LOXs 
contain an iron in the ferric oxidation state (Fe3+). The conversion of the ferrous to the 
ferric state may be triggered by small amounts of peroxides, including HPETEs 
(Zhang et al., 1994). Since PHGPx controls the cellular peroxide tone and efficiently 
reduces alkylhydroperoxides, including HPETEs, PHGPx has been regarded as a 
key enzyme, antagonizing LOX and COX activities. 
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Figure 8: Arachidonic acid metabolism. Arachidonic acid is a substrate for COXs and LOXs , which is 
released from membranes by PLA2. LOX catalyze the production of HPETEs, peroxyl intermediates 
which are either isomerised to leukotriens, hepoxilins or lipoxins. HPETEs can also be converted to 
HETEs by the peroxidase activity of GPxs. LOXs and COXs need a certain peroxide tone for initial and 
full activation, and thus PHGPx has been considered as a counteracting enzyme of eicosanoid 
production. 
 
Initial evidence for an antagonistic role for PHGPx in arachidonic acid metabolism 
was provided by Se depletion and repletion studies in vitro as well as in vivo. Down-
regulation of PHGPx by selenium depletion inversely correlated with 5-LOX activity in 
RBL-1 cells (Weitzel and Wendel, 1993). A similar effect has been reported for 
human B lymphocytes after GSH depletion (Jakobsson et al., 1992). A reverse effect 
was observed by PHGPx overexpression in RBL-2H3 cells, causing decreased 
leukotriene production upon treatment with the Ca2+-ionophore A23187 (Imai et al., 
1998). Likewise, PHGPx knockdown was associated with up-regulation of 12-LOX 
and COX1 activity in human epidermoid carcinoma A431 cells (Chen et al., 2003). 
Moreover, the inactivation of PHGPx by iodoacetate in human platelets inhibited 12-
HETE production by 80% (Sutherland et al., 2001). COX1 and COX2 are inhibited in 
PHGPx overexpressing RBL-2H3 cells, whereas COX activity could be restored by 
either BSO-mediated inhibition of PHGPx (COX2) or upon the addition of 15-HPETE 
(COX1) (Sakamoto et al., 2000). A systematic in vitro assay with purified LOXs, 
COXs and PHGPx showed that PHGPx inhibits the activity of any tested arachidonic 
acid oxidases (5-/12-/15-LOX, COX1/2) to a certain extent. 15-LOX, however, proved 
to be most sensitive to PHGPx-mediated inactivation (Huang et al., 1999). 
Interestingly, 12-LOX activity could be restored by the addition of lipid hydroperoxides 
13-HPODE, supporting the idea that PHGPx antagonizes the product activation of 
LOXs and COXs by reducing hydroperoxide products that are produced by the 
arachidonic acid metabolism itself. Nevertheless, LOX and COX activation may also 
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be triggered by peroxides from other cellular sources, such as electron leakage from 
the respiratory chain, or even ROS produced by exogenous stimuli, such as UV-
irradiation and oxidising chemicals. 
 
 
1.5 Objectives 
 
Glutathione is the major scavenger of ROS, by acting as the reducing equivalent for 
GPxs and other antioxidant enzymes. It is well known that GSH is rapidly consumed 
under conditions of oxidative stress, leading to severe damage of cells and tissue. 
However, it has still been a matter of debate, whether oxidative stress-induced cell 
death is caused by a pleiotropic effect of accumulated ROS or by a distinct signalling 
cascade. Since PHGPx is considered as one of the most significant GSH-dependent 
enzymes, targeted PHGPx disruption in cells promised to be an ideal tool to address 
this question. To bypass early embryonic lethality of PHGPx-deficient mice, the main 
objective of this work was the production and analysis of an inducible knockout model 
for PHGPx, including transgenic MEFs and an inducible Cre/loxP system. The 
physiological functions of PHGPx should then be analysed after targeted PHGPx 
disruption in cells, with special emphasis on the accumulation of ROS, the impact on 
arachidonic acid metabolism, as well as the mechanism of oxidative stress-induced 
cell death. 
 
To gain further insights into the complex system of GSH-dependent enzymes, γ-GCS 
knockout cells deficient in GSH biosynthesis, should be included in these studies. 
GSH has long been considered being indispensable for cell survival. Thus it should 
be addressed, whether cells survive in the absence of GSH, provided that sufficient 
cysteine is available as an alternative reducing equivalent by overexpressing 
antiporter system xc-. This experiment should proof the existence of a putative back-
up system under conditions of oxidative stress and concomitant GSH depletion. 
Thus, these studies should reveal the mechanism of oxidative stress-induced cell 
death, which is a common signature of many degenerative disorders, such as 
atherosclerosis, Alzheimer’s disease, Parkinson’s disease, and accounts for ischemia 
and reperfusion-induced detriment during myocardial infarction and stroke.
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2 Materials 
 
Chemicals    Company     Catalog-No. 
AA-861     Sigma-Aldrich GmbH, Taufkirchen, Germany A3711 
Acivicin     Sigma-Aldrich GmbH, Taufkirchen, Germany A2295 
Acrylamide    Bio-Rad, Munich, Germany   161-0158 
Agarose, electrophoresis grade  Invitrogen, Karlsruhe, Germany   15510-027 
Agarose, low melting point  Fermentas GmbH, St. Leon-Rot, Germany  R0801 
α-Lipoic acid    Sigma-Aldrich GmbH, Taufkirchen, Germany T1395 
Ammonium persulfate   Sigma-Aldrich GmbH, Taufkirchen, Germany A3678 
Ampicillin    Sigma-Aldrich GmbH, Taufkirchen, Germany A9518 
Arachidonic acid    Sigma-Aldrich GmbH, Taufkirchen, Germany A9673 
α-Tocopherol (Toc)   Sigma-Aldrich GmbH, Taufkirchen, Germany T3251 
Baicalein    Sigma-Aldrich GmbH, Taufkirchen, Germany 465119 
β-Mercaptoethanol (2-ME)   Roth Carl GmbH & Co., Karlsruhe, Germany 4227.1 
BODIPY 581/591 C11   Invitrogen, Karsruhe, Germany   D-3861 
Bovine Albumin    MP Biomedicals, Eschwege, Germany  840043 
Bromophenol Blue Sodium Salt  Merck KGaA, Darmstadt, Germany   111746 
Buthionine Sulfoximine (BSO)  Sigma-Aldrich GmbH, Taufkirchen, Germany B2640 
Caffeic acid    Sigma-Aldrich GmbH, Taufkirchen, Germany C0625 
4´,6-diamidino-2-phenylindole (DAPI) Invitrogen, Karsruhe, Germany   D1306 
DCF (CM-H2DCFDA)   Invitrogen, Karsruhe, Germany   C-6827 
dNTP Mix    Fermentas GmbH, St. Leon-Rot, Germany  R0241 
DMSO (Dimethylsulfoxide)  Sigma-Aldrich GmbH, Taufkirchen, Germany D2650 
DTNB     Sigma-Aldrich GmbH, Taufkirchen, Germany D8130 
DTT (Dithiothreitol)   Sigma-Aldrich GmbH, Taufkirchen, Germany D8161 
ECL     GE Healthcare, Freiburg, Germany   RPN2106 
EDTA     Sigma-Aldrich GmbH, Taufkirchen, Germany E9884 
Ethanol p.a.    Merck, Darmstadt, Germany   1.00983.2500 
Ethidiumbromide    Merck, Darmstadt, Germany   70257083 
ETYA (Eicosatetraynoic Acid)  Sigma-Aldrich GmbH, Taufkirchen, Germany E1768 
Foetal Bovine Serum   PAA, Pasching, Austria    A15-043 
Glutathione (GSH)   Sigma-Aldrich GmbH, Taufkirchen, Germany G6013 
Glutathione reduced ethyl ester (GSH-EE) Sigma-Aldrich GmbH, Taufkirchen, Germany G1404 
Glycine     MP Biomedicals, Eschwege, Germany  808831 
Gelatin from porcine skin   Sigma-Aldrich GmbH, Taufkirchen, Germany G2500 
5(S)-HpETE    Cayman Chemical, ANN Arbor, MI, USA  44230 
12(S)-HpETE    Cayman Chemical, ANN Arbor, MI, USA  44570 
15(S)-HpETE    Biomol GmbH, Hamburg, Germany   HP-015 
Hydroperoxide    Sigma-Aldrich GmbH, Taufkirchen, Germany H1009 
4-Hydroxytamoxifen (Tam)  Sigma-Aldrich GmbH, Taufkirchen, Germany H7904 
Indomethacin    Sigma-Aldrich GmbH, Taufkirchen, Germany I7378 
Iodoacetamide    Sigma-Aldrich GmbH, Taufkirchen, Germany I6125 
Isopropanol p.a.    Merck, Darmstadt, Germany   1.09634.2511 
L-Glutamine    Invitrogen, Karsruhe, Germany   25030 
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Chemicals    Company     Catalog-No. 
LIF (ESGRO)    Millipore, Billerica, MA, USA   ESG1107 
Luria Broth Base    Invitrogen, Karsruhe, Germany   12795-019 
MK-886     Biomol GmbH, Hamburg, Germany   EL266 
MOPS     Sigma-Aldrich GmbH, Taufkirchen, Germany M1254 
Mounting medium   Dako Cytomation, Hamburg, Germany  S3023 
N-Acetyl-L-Cysteine   Sigma-Aldrich GmbH, Taufkirchen, Germany A9165 
NDGA     Sigma-Aldrich GmbH, Taufkirchen, Germany N2036 
Oligonucleotides    Metabion international AD, Martinsried, Germany 
Pareformaldehyde (PFA)   Roth Carl GmbH & Co., Karlsruhe, Germany 0335.3 
PD146176    Park-Davis, Pfizer, USA    PD146176 
Penicillin-Streptomycin   Invitrogen, Karsruhe, Germany   15140-122 
Phenol : Chloroform   MP Biomedicals, Eschwege, Germany  802520 
Propidium Iodide (PI)   Sigma-Aldrich GmbH, Taufkirchen, Germany P4170 
Protease Inhibitor Cocktail Tablets  Roche Diagnostics, Mannheim, Germany  1 697 498 
Puromycin    Sigma-Aldrich GmbH, Taufkirchen, Germany P7255 
RO 107 905 1    Keith Walker, Roche, Palo Alto, CA, USA 
Select Agar    Invitrogen, Karsruhe, Germany   30391-023 
Skim Milk Powder   Fluka Chemie GmbH, Buchs, Switzerland  70166 
Sodium Chloride    MP Biomedicals, Eschwege, Germany  194848 
Sodium Deoxocholate   Sigma-Aldrich GmbH, Taufkirchen, Germany D6750 
Sodium Dodecyl Sulfate (SDS)  Fluka Chemie GmbH, Buchs, Switzerland  71729 
Sodium Pyrophosphate Tetrabasic 
   Decahydrate    Sigma-Aldrich GmbH, Taufkirchen, Germany S6422 
TEMED     Fluka Chemie GmbH, Buchs, Switzerland  87689 
Tris-Base    Merck, Darmstadt, Germany   1.08382 
Triton X-100    GE Healthcare, Freiburg, Germany   17-1315-01 
Trypan Blue (0.4%)   Sigma-Aldrich GmbH, Taufkirchen, Germany T8154 
Trypsin-EDTA    Invitrogen, Karsruhe, Germany   25300 
Tween 20    Sigma-Aldrich GmbH, Taufkirchen, Germany P5927 
 
 
 
Radioactive Isotopes  Company     Catalog-No. 
[α-32P]-dCTP    GE Healthcare, Freiburg, Germany   PT10165 
L-[14C (U)] Cystine   Perkin Elmer Life Sciences Inc., Boston, USA NEC465050UC 
 
 
Bacteria    Company      ____ 
DH5α E.coli cells    Invitrogen, Karlsruhe, Germany 
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Enzymes    Company     Catalog-No. 
DNA Polymerase I (Klenow)  New England Biolabs GmbH, Frankfurt, Germany M0210S 
Pfu DNA Polymerase   Promega GmbH, Mannheim, Germany  M774A 
Phosphatase, alkaline   Roche Diagnostics, Mannheim, Germany  713 023 
Proteinase K    Roth Carl GmbH & Co., Karlsruhe, Germany 7528.1 
Restriction Endonucleases  New England Biolabs GmbH, Frankfurt, Germany 
     MBI Fermentas GmbH, St. Leon-Rot, Germany 
T4 DNA Ligase    Promega GmbH, Mannheim, Germany  M180A 
Taq DNA Polymerase   Invitrogen, Karsruhe, Germany   18038-026 
 
 
Antibodies (source)   Company     Catalog-No. 
α-AIF D20 (goat)    Santa Cruz, Heidelberg, Germany   SC-9416 
α-Bcl2 (mouse)    Roche Diagnostics, Mannheim, Germany  1 624 989 
α-HA High Affinity, clone 3F10 (rat)  Roche Diagnostics, Mannheim, Germany  11 867 423 001 
α-Mouse-HRP conjugate (goat)  Promega GmbH, Mannheim, Germany  W4021 
α-PHGPx mGPx4 1B4 (rat)  Elisabeth Kremmer, GSF, Munich, Germany 
α-Rat-HRP conjugate (goat)  Dianova GmbH, Hamburg, Germany  112-035-062 
α-Rat-Cy3 conjugate (mouse)  Jackson Immonoresearch Europe Ltd., UK  212-165-168 
α-Tubulin (mouse)   Dianova GmbH, Hamburg, Germany  DLN-09992 
 
 
Disposables and Kits  Company     Catalog-No. 
DC Protein Assay   Bio-Rad, Munich, Germany   500-0112 
DMEM     Invitrogen, Karsruhe, Germany   41966 
DMEM* (lacking L-cystine)  Invitrogen, Karsruhe, Germany   21013 
Gel Extraction Kit    QIAGEN GmbH, Hilden, Germany   28704 
Hybond-C super membrane  GE Healthcare, Freiburg, Germany   RPN203G 
Hybond-N+ membrane   GE Healthcare, Freiburg, Germany   RPN303B 
Hyperfilm    GE Healthcare, Freiburg, Germany   RPN3103K 
X-ray film    GE Healthcare, Freiburg, Germany   RPN16778K 
JETstar Plasmid purification system Genomed GmbH, Löhne, Germany   220020 
LightCycler Capillaries   Roche Diagnostics, Mannheim, Germany  11 909 339 001 
LightCycler FastStart DNA MasterPLUS 
   SYBR Green I    Roche Diagnostics, Mannheim, Germany  03 515 869 001 
Lipofectamine 2000   Invitrogen, Karsruhe, Germany   11668-027 
OPTI-MEM    Invitrogen, Karsruhe, Germany   31985 
Plasmid Maxi Kit    QIAGEN GmbH, Hilden, Germany   12163 
PCR Cloning Kit    QIAGEN GmbH, Hilden, Germany   231122 
Rediprime II random prime labelling system GE Healthcare, Freiburg, Germany   RPN1633 
Reverse Transcription System  Promega GmbH, Mannheim, Germany  A3500 
RNase-Free DNase Set   QIAGEN GmbH, Hilden, Germany   79254 
RNeasy Mini Kit    QIAGEN GmbH, Hilden, Germany   74104 
Sephadex G-50 columns   GE Healthcare, Freiburg, Germany   27-5330-01 
Supelclean LC-18 columns  Sigma-Aldrich, Stockholm, Sweden   57012 
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Equipment      Company   ____ ____ 
Bench-top radioisotope counter    Bioscan, Washington D.C., USA 
FACS Calibur      BD GmbH, Heidelberg, Germany 
GenAmp PCR system 2700    Applied Biosystems, Darmstadt, Germany 
Gene Pulser II System     Bio-Rad, Munich, Germany 
Gene Pulser Electroporation Cuvettes, 0.4 cm gap  Bio-Rad, Munich, Germany 
Heraeus Incubator, Modell B 5060    Heraeus Holding GmbH, Hanau, Germany 
Leica DM IRBE confocal microscope   Leica Microsystems GmbH, Wetzlar, Germany 
Leica TCS SP2 scanner     Leica Microsystems GmbH, Wetzlar, Germany 
Light-Cycler 1.5      Roche Diagnostics, Mannheim, Germany 
LS 5000 TA Scintillation Counter    Beckman Coulter GmbH, Krefeld, Germany 
Microscope Axiovert 135     Carl Zeiss Jena GmbH, Göttingen, Germany 
Microscope Axiovert 200M    Carl Zeiss Jena GmbH, Göttingen, Germany 
Mini-PROTEAN 3 Electrophoresis Cell   Bio-Rad, Munich, Germany 
Mini-Sub Cell GT Electrophoresis Cell   Bio-Rad, Munich, Germany 
OTD Combi Ultracentrifuge    Sorvall, Langenselbold, Germany 
Photometer Bio      Eppendorf, Hamburg, Germany 
PowerPac 200 Power Supply    Bio-Rad, Munich, Germany 
Spectrophotometer DU-64     Beckman Coulter GmbH, Krefeld, Germany 
Speed Vac Concentrator SVC100H   Savant Instruments NC, Farmingdale, N.Y. USA 
Trans-Blot Semi-Dry     Bio-Rad, Munich, Germany 
RF-10A XL Fluorescence Spectrophotometer  Shimadzu, Duisburg, Germany 
UZ-PA-38,5-1 Ultracentrifuge Tubes   Kisker GbR, Steinfurt, Germany 
 
 
Oligonucleotides   Sequence      ____ 
 
Genotyping 
PF for1     5’ ACTCCCCGTGGAACTGTGAGCTTTGTGC 3’ 
PF rev1     5’ GGATCTAAGGATCACAGAGCTGAGGCTGC3' 
 
Cloning 
HA-PHGPx for1    5’ AATTAGCTAGCTACCCATACGATGTTCCAGATTACG 3’ 
HA-PHGPx rev2    5’ AATTACTCGAGTTTACACAGATCTTGCTGTACATG 3’ 
PHGPx complete for1   5’ CTGGCAGGCACCATGTGTGCATCC 3’ 
PHGPx complete rev1   5’ AGGCAGCCAGGGTGAAGCTCGAGC 3’ 
PHGPx HAtag for1   5’ AATGGATCCGTCGCCACCATGTACCCATACGATGTTCC 
     AGATTACGCTTGTGCATCCCGCGATGATTGGC 3’ 
PHGPx E4 rev1    5’ CATGTCAAACTTGACGTTGTAGC 3’ 
PHGPx UC for1    5’ GTGGCCTCGCAATGCGGCAAAACTGACGTAAAC 3’ 
PHGPx UC rev1    5’ TTTACGTCAGTTTTGCCGCATTGCGAGGCCACG 3’ 
PHGPx US for1    5’ GTGGCCTCGCAAAGCGGCAAAACTGACGTAAAC 3’ 
PHGPx US rev1    5’ GTTTACGTCAGTTTTGCCGCTTTGCGAGGCCAC 3’ 
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Oligonucleotides   Sequence      ____ 
 
RT-PCR 
Aldolase A    5’ GGTCACAGCACTTCGTCGCACAG 3’ 
Aldolase B    5’ TCCTTGACAAGCGAGGCTGTTGGC 3’ 
Alox5 A     5’ AGAACCTGGAGGCCATCGTCAGC 3’ 
Alox5 B     5’ GCACCAGCTGCAGGAAGATCGAC 3’ 
Alox12 A    5’ TCCAACTGCAGGAGCTCCAATTCC 3’ 
Alox12 B    5’ CGCCTCCACCTGTGCTCACTACC 3’ 
Alox12e A    5’ CCGCGAGGTCACTGAGGTTGGAC 3’ 
Alox12e B    5’ GGCAAGGCAACGAGTCCACAATG 3’ 
Alox15 A    5’ CACTGCGCAGCACTCTTCCATCC 3’ 
Alox15 B    5’ CACCATAACAGCCTGGCGTCTGC 3’ 
Alox15b A2    5’ TCCGTTCTGATGCCTGGTTCTGC 3’ 
Alox15b B2    5’ GTCAAGGCAGCGAGGCCAACC 3’ 
Cox1 A     5’ GCACTGGTGGATGCCTTCTCTCG 3’ 
Cox1 B     5’ CTGGCACTTCTCCAGCAGCAACC 3’ 
Cox2 A     5’ TGGAGCCCGTGCTGCTCTGTC 3’ 
Cox2 B     5’ GCCTGGCAAGTCTTTAACCTCACAGC 3’ 
PHGPx A    5’ GCAACCAGTTTGGGAGGCAGGAG 3’ 
PHGPx B    5’ CCTCCATGGGACCATAGCGCTTC 3’ 
xCT for1     5’ GGCACCGTCATCGGATCAGGCATC 3’ 
xCT rev1    5’ CACGAGCTTGATTGCAAGTTCAGG 3’ 
 
Sequencing 
T7 promoter    5’ TAATACGACTCACTATAGGG 3’ 
Sp6 promoter    5’ ATTTAGGTGACACTATAGAA 3’ 
LTR 3’-for1    5’ GCTCACAACCCCTCACTC 3’ 
IRES rev1    5’ CTTCGGCCAGTAACGTTAGG 3’ 
 
siRNA knockdown 
control siRNA:    5’ AAGAGAAAAAGCGAAGAGCCA 3’ 
AIF-12:      5’ ACAGAGAAGAGCCAUUGCC-dTdT 3’ 
AIF-20:     5’ GAGAAACAGAGAAGAGCCA-dTdT 3’ 
AIF-22:     5’ AUGUCACAAAGACACUGCA-dTdT 3’ 
 
All DNA-oligonucleotides were obtained from Metabion GmbH, Martinsried, 
Germany. siRNA-oligonucleotides were obtained from Dharmacon, Inc. (part of 
Fisher Scientific GmbH, Schwerte, Germany). 
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Expression Vectors         ____ ____  
 
Depicted are the expression vector pCAG-3SIP (figure 9) and the lentiviral vector 
p442-PL1 (figure 10). All cloned plasmids are based on these two vectors. Cloning 
steps and packaging plasmids used for lentivirus production are described in chapter 
3.4 and 3.1.6.3, respectively. 
 
 
pCAG-3SIP 
 
pCAG-3SIP
6451 bps
EcoRI
hCMVieE
chicken beta-actin
3xstop
EMC IRESPuroR
globin pA
SV40 ori
colE1
ampR
 
 
 
Figure 9: Map of expression vector pCAG-3SIP. hCMVieE (human cytomegalovirus immediate early-
enhancer), modified chicken beta-actin promoter, EcoRI (restriction site used for cloning), 3 x Stop (3 
Stop codons in all three open reading frames), EMC IRES (encephalomyocarditis IRES), PuroR 
(puromycin N-acetyltransferase gene), globin pA (globin poly A signal), SV40 ori (simian virus 40 
origin), colE1 (colE1 origin), ampR (ampicillin resistance gene). 
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p442-PL1 
442-PL1
8196 bps
BamHI
XbaI
RU5 PBS
RRE
PPT
SFFV
IRES
VENUSnucmem
PRE
SIN
Amp
 
 
Figure 10: Map of lentiviral vector p442-PL1. ampR (ampicillin resistance gene), RU5 (RU5 LTR), 
PBS (primer binding site), RRE (Rev responsive element), PPT (poly-purine tract), SFFVp (spleen 
focus forming virus promoter), BamHI/XbaI (restriction sites used for cloning), IRES (internal ribosome 
entry site), VENUSnucmem (fluorescent protein with nuclear membrane anchor), PRE (post regulatory 
element), SIN (self-inactivating 3’ LTR). 
 
 
Cell lines         ____ _________ 
 
γ-GCS(-/-) ES cell like cells were a kind gift from Michael Lieberman, Houston, Texas, USA [1]. Cells 
were transfected with pCAG-3SIP, pCAG-3SIP-eGFP, and pCAG-3SIP-xCT, yielding single cell clone 
mock, eGFP, and xCT-5/7, respectively. 
 
HEK293 T cells were used as packaging cell line for the production of lentiviral particles, based on the 
third generation lentiviral vector p442-PL1. 
 
Primary MEFs were isolated from PF transgenic mice, yielding PFa1(flox/flox), PFa24(flox/flox), 
PFa37(flox/flox), and PFa43(flox/flox) cells, which contain either one or two floxed PHGPx alleles. MEFs 
were transfected with pCAG-3SIP-MCM, yielding cell line PFa1(flox/flox)-MCM, PFa24(flox/flox)-MCM, 
PFa37(flox/flox)-MCM, and PFa43(flox/flox)-MCM, respectively. 
  Methods 
 - 29 - 
3 Methods 
 
3.1 Cell culture and related techniques 
 
3.1.1 Murine embryonic fibroblasts (MEFs) 
Male and female PHGPx (wt/flox or flox/flox) mice were mated, yielding homozygous 
and heterozygous offspring. Females were checked daily for vaginal plugs. A vaginal 
plug was considered as embryonic day 0.5. Pregnant mice were sacrificed at E12.5 
by cerebral dislocation. Uteri were dissected under sterile conditions and stored in 
PBS. Embryos were removed from the uterus and washed three times in PBS to 
remove maternal blood cells. Subsequently, the embryos were dissected off the 
uterus, organs and the head were removed and the body trunk was minced in a 6 cm 
cell culture dish with two forceps. Tissue pieces were suspended in 1 ml trypsin and 
incubated at 37°C for 15 min. The suspension was homogenized by vigorous 
pipetting and washed in Standard DMEM to remove trypsin. Cell pellets were 
resuspended in 4 ml Standard DMEM and plated on a 6 cm cell culture dish. Cells 
were cultivated at 37°C in a 7% CO2 water-saturated atmosphere. When cell lines 
reached confluency, they were split at a ratio of 1:3 onto larger cell culture dishes. 
Cells from early passage numbers were harvested by trypsinization and aliquots 
were stored by cryo conservation in liquid nitrogen (see chapter 3.1.4). Primary cells 
grow relatively slow during first passage numbers (P2-P5) until they undergo a 
senescence-like crisis after approximately 20 passage numbers. This is eventually 
overcome by outgrowing immortalized cells. Immortalized cells grew faster and were 
easier to manipulate by electroporation and lentiviral infection (see chapter 3.1.6). 
Immortalized MEFs were cultivated in Standard DMEM and were routinely split by 
trypsinization at a ratio of 1:5 every 2nd to 3rd day. 
 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
 
 
3.1.2 ES cell like γ-GCS knockout cells 
ES cell like γ-GCS knockout cells were obtained from Michael Lieberman, Houston, 
Texas, USA (Shi et al., 2000). The cells were cultivated in Standard DMEM 
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containing 15 % FCS and 5 mM NAC, and were routinely split at a ratio of 1:3 every 
2nd or 3rd day. γ-GCS knock out ES cell like cells only adhere weakly to the cell 
culture dish and are rather sensitive to trypsinization. Thus, cells were detached from 
the cell culture dish by rinsing the dish with a pipette. 
 
Standard DMEM: DMEM, 15 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
 
 
3.1.3 Determination of cell number 
Cells were harvested from cell culture dishes by trypsinization and suspended by 
adding 5 volumes of Standard DMEM. 30 µl of the cell suspension was mixed with an 
equal volume of 0.4 % trypan blue solution and cells were counted using a Fuchs-
Rosenthal haemocytometer. Trypan blue is excluded from viable cells, whereas dead 
cells stain blue due to plasma membrane disruption. 
 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
 
 
3.1.4 Cryo conservation and thawing of cells 
Stocks of all cell lines were stored in liquid nitrogen. Cells were grown in 10 cm cell 
culture dishes until they reached approximately 80 % confluency, trypsinized, and 
collected by centrifugation. The cell pellets were resuspended in FCS containing 10% 
DMSO, transferred to cryo vials in 1 ml aliquots and frozen in propanol containers at -
80°C over night. Subsequently, vials were transferred to a liquid nitrogen tank. If 
needed, frozen cells were defrosted in a water bath at 37°C, immediately transferred 
to 5 ml Standard DMEM and collected by centrifugation. Cell pellets were 
resuspended in 10 ml Standard DMEM and seeded onto a 10 cm cell culture dish. 
 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
 
 
3.1.5 Microscopy pictures and time-lapse videos 
Pictures and time-lapse videos of cells were taken with Axiovert Microscopes and 
Improvision Openlab 3.0.8 software. 
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3.1.6 Genetic transfer methods 
 
3.1.6.1 Transfection of siRNA 
3x105 primary MEFs were transfected with siRNA in a 3.5 cm cell culture dish with 
Lipofectamine 2000. Cells were pre-incubated with 600 µl OPTI-MEM for 60 min. 150 
µl OPTI-MEM were mixed with 10 µl Lipofectamine 2000 and 10 µl siRNA solution 
(20 µM), respectively. Both solutions were incubated for 3 min at room temperature. 
The solutions were mixed, vortexed for 10 sec, and incubated for additional 15 min to 
allow formation of siRNA-Lipofectamine 2000 complexes. The complex solution was 
added to the cell culture dish and cells were incubated for 5 h at 37°C. Subsequently, 
cells were washed with PBS and cultivated over night in standard DMEM containing 
15 % FCS. The same lipofection procedure was repeated the next day in order to 
increase transfection efficiency. 
 
 
3.1.6.2 Electroporation 
Cells were harvested by trypsinization, washed twice in PBS and resuspended in 250 
µl FCS-free DMEM. Primary MEFs (1x106 cells) were electroporated with a Gene 
Pulser II (Bio Rad, Munich, Germany) in cuvettes with 0.4 cm gap width. For each 
transfection, 20 µg plasmid DNA were transfected into cells with an electric pulse of 
230 V and a capacitance of 1,000 µF. FCS (500 µl) was applied to the cells 
immediately after the pulse. The cell suspension was gently mixed by pipetting and 
cells were seeded on a 10 cm cell culture dish in Standard DMEM. Selection for 
antibiotic resistance was initiated 48 h after electroporation with 0.5 µg/ml puromycin, 
gradually increasing to 2 µg/ml over a period of 1 to 3 weeks. 
 
 
3.1.6.3 Lentiviral infection 
Lentiviral vectors mediate an efficient gene transfer into primary cells. The lentiviral 
infection method proved to be the most efficient technique to introduce DNA/RNA into 
primary MEFs due to integration and stable expression of transgenes in dividing as 
well as resting cells. Lentiviral particles were produced in HEK293 T packaging cells 
with a third generation lentiviral packaging system, which provides maximal biosafety 
but is more laborious, involving the transfection of four different plasmids into the 
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producer cell line. Three plasmids encode all necessary structural proteins for 
lentivirus production, including pEcoEnv-IRES-puro (contains glycoprotein Env), 
plasmid pMDLg_pRRE (contains the main structural protein Gag and the enzyme 
cluster Pol) and pRSV_Rev (contains the post-transcriptional regulator Rev). Third 
generation packaging systems are Tat independent, as the transfer vector 
pRRL.PPT.SF.IRES-VENUSnucmem (p442) contains an additional SFFV promoter. 
 
5x106 HEK293 T packaging cells were seeded in Standard DMEM on 10 cm cell 
culture dishes and incubated for 24 h. Plasmids (2 µg pEcoEnv-IRES-puro, 5 µg 
pMDLg_pRRE, 10 µg pRSV_Rev, 5 µg p442-PL1-based vectors) were diluted in 500 
µl 12.5 mM CaCl2 solution and mixed with 500 ml HBS by air bubbling. Cell culture 
medium was replaced with TF medium, and chloroquine was added to a final 
concentration of 25 µM. For calcium phosphate transfection, the plasmid mix was 
vortexed, applied to the cell culture dish, and cells were incubated for 8-12 h. The 
transfection medium was replaced with fresh TF medium and the transfected 
packaging cells were incubated for further 36 h. Virus-enriched TF medium was 
recovered from the cell culture dish, filtrated through a 0.22 mm sterile filter and 
centrifuged in a swing rotor ultracentrifuge for at least 16 h at 10,000 x g. The virus 
containing pellet was resuspended in 200 µl Standard DMEM and stored at -80°C. 
 
3x105 MEFs were infected in a 3.5 cm cell culture dish by adding 50 µl of the virus 
concentrate and a subsequent incubation for 48 h. Infection efficiency was monitored 
by fluorescence microscopy, screening for VENUSnucmem expression and 
quantification was performed by FACS analysis. 
 
Chloroquine (1000x): 25 mM chloroquine in PBS  
HBS (2x): 50 mM HEPES, 280 mM NaCl, 1.5 mM Na2HPO4, pH 7.05 adjusted with NaOH 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
TF medium: Standard DMEM, 20 mM HEPES 
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3.2 Genotyping 
The genotyping of isolated MEFs was performed by PCR with purified DNA samples. 
Cells were harvested from 10 cm cell culture dishes with a cell scraper, washed in 
PBS and lysed in 300 µl Lysis Buffer. Cells were incubated at 55°C for 12 h with 
shaking. To remove proteins and lipids, equal volumes of phenol-chloroform were 
added to the lysate, vortexed and centrifuged for 6 min at 10,000 x g. The upper, 
DNA-containing phase was recovered and DNA was precipitated by adding 2.5 x 
volumes of ethanol with 50 mM NaCl. The DNA was recovered by centrifugation at 
4°C with 10,000 x g, subsequently washed with 70 % ethanol and centrifuged again 
at 10,000 x g. The DNA pellet was air dried for 30 min and dissolved in 100 µl TE. 
Genomic DNA samples were stored at 4°C. 
 
For each PCR, a 25 µl reaction mix was prepared as described in the manufacturers’ 
instructions. The PHGPx (flox/wt) PCR was performed with oligonucleotides PFfor1 
and PFrev1 with an annealing temperature of 68°C, elongation time of 40 sec, and 
35 cycles. The PCR products were resolved in a 2 % agarose gel in TAE buffer at 
120 V. 
  
Lysis Buffer: 10 mM Tris pH 7.6; 10 mM EDTA; 0.5 % SDS; 10 mM NaCl, 300 µg/ml Proteinase K 
50x TAE: 2 M Tris-acetate (2 M Tris-base and 5.71 % v/v acetic acid); 50 mM EDTA/NaOH pH 8.0 
TE: 10 mM Tris pH 7,5; 1 mM EDTA 
 
 
3.3 Cloning techniques 
 
3.3.1 Preparation of plasmid DNA 
After transformation, single colonies were picked from LB plates and used to 
inoculate 2 ml LB medium, containing 50 µg/ml ampicillin. The inoculum was 
incubated at 37°C for 12-20 h with shaking. Cells were harvested by centrifugation at 
10,000 x g for 20 sec and resuspended in 200 µl buffer E1 by vortexing. 200 µl of 
denaturing buffer E2 was added to the cell suspension, mixed by inverting the tube 
and incubated for 5 min at room temperature. To stop the denaturation reaction, 200 
µl of buffer E3 was added, mixed by inverting and centrifuged for 6 min at 10,000 x g. 
To extract proteins and lipids, 400 µl of phenol-chloroform was added, vortexed and 
centrifuged for 3 min at 10,000 x g. Plasmid DNA dissolves in the aqueous upper 
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phase, which was recovered and added to 500 ml isopropanol for DNA precipitation. 
The precipitated DNA was harvested by centrifugation for 12 min at 4°C at 10,000 x 
g. The DNA pellet was washed with 70 % ethanol, air dried for 30 min at room 
temperature and resuspended in 50 µl TE. 
 
The purified plasmids were subjected to analytic restriction digestions to identify the 
correct construct and orientation of the insert. After evaluation of the individual clones 
and their respective plasmid DNA, selected single cell clones were used to augment 
plasmid DNA, according to Qiagen Plasmid Maxi Kit instructions. Plasmid 
concentrations were quantified by measuring the absorbance at 260 nm in a 
spectrophotometer. 
 
E1: 50 mM Tris, 10 mM EDTA, pH 8,0 
E2: 200 mM NaOH, 1,0 % w/v SDS  
E3: 3.1 M potassium acetate, adjust to pH 5.5 with acetic acid 
TE: 10 mM Tris pH 7,5; 1 mM EDTA 
 
 
3.3.2 Restriction digestion 
DNA restriction digestion was performed with respective endonucleases according to 
manufacturers’ instructions (New England Biolabs GmbH or MBI Fermentas GmbH).  
DNA fragments were separated by electrophoresis in a 0.8 % low melting point 
(LMP) agarose gel at 60 V in 1x TAE buffer. The desired fragment was isolated from 
the gel with a scalpel and processed with a Qiagen Gel Extraction Kit, according to 
the manufacturers’ instructions. 
 
50x TAE: 2 M Tris-acetate (2 M Tris-base and 5.71 % v/v acetic acid); 50 mM EDTA/NaOH pH 8.0 
 
 
3.3.3 Phenol-chloroform extraction and ethanol precipitation of DNA 
Linearized fragments, obtained from single cutter digestions, were purified by phenol-
chloroform treatment and subsequent ethanol precipitation. Therefore, an equal 
volume of phenol-chloroform was added to the digestion reaction, briefly mixed and 
centrifuged for 6 min at 10,000 x g. The upper aqueous phase was recovered and 
DNA was precipitated by adding 2.5 x volumes of ethanol and 50 mM NaCl, followed 
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by centrifugation at 4°C with 10,000 x g. The DNA precipitate was washed with 70 % 
ethanol, centrifuged as above and air dried for 30 min. The dried DNA pellet was 
dissolved in 30 µl TE and stored at -20°C. 
 
 
3.3.4 DNA ligation 
Ligation reactions were prepared with T4 DNA ligase according to standard 
procedures, described in the manufacturers’ instructions (Promega GmbH). The 
solutions contained 2 µl vector and 2 µl insert DNA and were incubated at 16°C for 
12-24 hours. To quantify the specificity of the ligation reaction, respective backbone 
and insert DNA were subjected to separate control ligations. The ligation reactions 
were used for subsequent heat shock transformation of competent bacteria. 
 
50x TAE: 2 M Tris-acetate (2 M Tris-base and 5.71 % v/v acetic acid); 50 mM EDTA/NaOH pH 8.0 
TE: 10 mM Tris pH 7,5; 1 mM EDTA 
 
 
3.3.5 Klenow fragment fill-in reaction 
For blunt end clonings, DNA fragments were treated with DNA Polymerase I (Klenow 
fragment) according to the manufacturers’ instructions (New England Biolabs GmbH). 
The Klenow fragment retains polymerization fidelity and 3’-5’ exonuclease activity but 
is devoid of 5’-3’ exonuclease activity. Hence, the Klenow fragment forms blunt ends 
by either filling-in 5’-overhangs or by removing 3’-overhangs. DNA fragments were 
purified by phenol-chloroform extraction as described above. 
 
 
3.3.6 Dephosphorylation of linearized plasmid DNA 
Vector DNA was dephosphorylated with alkaline phosphatase according to 
manufacturers’ instructions (Roche Diagnostics). Dephosphorylation of backbone 
DNA favours the integration of DNA inserts since religation of the backbone is 
prevented. After dephosphorylation, DNA fragments were purified by phenol-
chloroform extraction as described above. 
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3.3.7 Preparation of competent cells 
Competent cells were prepared by the rubidium chloride procedure with DH5α E. coli 
cells. 250 ml LB medium, containing 20 mM MgSO4 was inoculated with a single 
colony from an LB plate and incubated over night at 37°C with shaking until the 
OD600 reached 0.4-0.6. Cells were pelleted at 4,500 x g for 5 min at 4°C. All 
subsequent steps were performed in a 4°C cold room with pre-chilled pipettes, tubes 
and flasks. Cells were resuspended in 100 ml of ice cold TFB1, incubated on ice for 5 
min and pelleted at 4,500 x g for 5 min at 4°C. Cells were resuspended gently in 10 
ml TFB2, incubated on ice for 30 min and 200 µl aliquots were snap-frozen in liquid 
nitrogen. Aliquots of competent cells were stored at -80°C. Cells were used no longer 
than 4 months after preparation. 
 
 
3.3.7 Heat shock transformation 
For transformation, 200 µl aliquots were defrosted on ice and 10 µl of the ligation mix 
or 10 ng purified plasmid DNA were added to the cell suspension. Cells were 
incubated for 15 min on ice, heated to 42°C for 90 sec and replaced on ice for 2 min. 
800 µl LB medium were added to the cell suspension and incubated for 45 min at 
37°C with vigorous shaking. All plasmids used in this work contained an ampicillin 
resistance cassette for selection. 100 µl of the transformation mixture was plated on 
a LB plate containing 50 µg/ml ampicillin. Remaining cells were harvested by brief 
centrifugation at 10,000 x g for 20 sec to remove excess LB. The pellet was 
resuspended in 100 µl LB and plated onto a second LB plate with ampicillin. Agar 
plates were incubated for 12-20 h at 37°C until single cell colonies became visible. 
 
TFB1: 30 mM potassium acetate; 10 mM CaCl2; 50 mM MnCl2; 100 mM RbCl; 15 % glycerol; pH 5.8 
TFB2: 10 mM 3-(N-morpholino) propansulfonic acid (MOPS); 75 mM CaCl2; 10 mM RbCl; 15 % 
glycerol; pH 6.5 
 
 
3.4 Cloning of expression vectors 
 
3.4.1 pCAG-3SIP-based vectors (MCM, eGFP, xCT) 
Plasmid pCAG-3SIP drives gene expression from a highly efficient CAG promoter 
and encodes an IRES-linked bicistronic sequence, including the puromycin N-
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acetyltransferase gene (purR) for stable selection. pCAG-3SIP was used for stable 
expression of the fusion protein MerCreMer, consisting of Cre recombinase (Cre) 
flanked by two mutated oestrogen receptors (Mer) (Verrou et al., 1999). The 
MerCreMer cassette was recovered from pBluescript-MerCreMer by EcoRI digestion 
and cloned into EcoRI digested and dephosphorylated pCAG-3SIP, yielding pCAG-
3SIP-MerCreMer (figure 11). The insert orientation was controlled by analytic 
digestion with SalI and NheI/XhoI, respectively. 
 
eGFP was isolated from pEGFP-N1 (Clontech, Saint-Germain-en-Laye, France) by 
BamHI/XbaI digestion. The 751 bp fragment was blunted by Klenow fill-in reaction 
and cloned into EcoRI digested, blunted and dephosphorylated pCAG-3SIP, yielding 
pCAG-3SIP-eGFP (figure 11). The correct orientation of the insert was verified by 
EcoRI/EcoRV and XmnI digestion, respectively. 
 
pCAG-3SIP-xCT (figure 11) was provided by Ana Banjac, encoding the murine DNA 
sequence of xCT light chain (Banjac Ana, PhD thesis, 2005).  
 
 
3.4.2 p442-PL1-based PHGPx expression vectors 
The 3rd generation lentiviral vector p442-PL1 (kind gift from Tim Schröder, GSF, 
Munich, Germany) was used for efficient gene transfer and expression in MEFs by 
viral infection. Gene expression in p442-PL1 is regulated by an SFFV promoter, 
synthesizing a bicistronic mRNA sequence that is linked by an internal ribosome 
entry site (IRES). The fluorescence marker VENUSnucmem including a nuclear 
membrane anchor (nucmem) is encoded at the 3’ position of the bicistronic 
expression cassette. As described below, various genes were cloned into the 5’ 
position of the expression cassette, upstream of the IRES. 
 
 
3.4.4 Cloning of tagged PHGPx 
The PHGPx gene was amplified from murine testis cDNA by RT-PCR with primers 
“PHGPx complete for1” and “PHGPx complete rev1”. The purified 721 nucleotide 
product was cloned into pDrive according to manufacturers’ instructions (Qiagen 
PCR Cloning Kit). pDrive-PHGPx was used as template for a PCR with primers 
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“PHGPx HAtag for1” and “PHGPx E4 rev1”, synthesizing an N-terminal HA-tagged 
fusion of PHGPx. The 351 bp PCR product was digested with BamHI and BssHII and 
the 72 bp fragment was used to replace the N-terminal part of PHGPx in pDrive-
PHGPx, yielding pDrive-HA-PHGPx. The pDrive-HA-PHGPx clones were tested by 
analytic restriction digestion with EcoRI and sequenced with primers ”T7 promoter” 
and “SP6 promoter”. The HA-tagged PHGPx sequence was transferred from pDrive-
HA-PHGPx to the lentiviral expression vector p442-PL1 by restriction digestion with 
BamHI and XbaI. p442-HA-PHGPx clones (figure 11) were analyzed by restriction 
digestion (EcoRI and BamHI/XbaI) and sequenced with primers ”5’-LTR for1” and 
“IRES rev1”. 
 
 
Figure 11: Schematic representation of all cloned expression vectors. Depicted are the pCAG-3SIP-
based vectors, containing an efficient CAG promoter and a PuroR cassette (puromycin N-
acetyltransferase). The p442-PL1-based lentiviral vectors contain a SFFVp (spleen focus forming virus 
promoter) and a VENUSnucmem fluorescence marker. The cloned PHGPx contains an N-terminal 
HA-tag and FSH-tag (Flag-, Strep-, HA-tag), respectively. The two mutant forms of HA-PHGPx have a 
Cys (red asterisk) and Ser (green asterisk) instead of Sec.  
 
For future studies, HA-PHGPx was additionally tagged with an optimised TAPe- 
(enhanced tandem affinity purification) tag, which has been developed and 
functionally tested for B-raf and C-Raf (Raf1) in Marius Ueffing´s laboratory at the 
GSF (kind gift from Dr. Johannes Gloeckner, GSF, Munich, Germany). This tag was 
specifically designed for the purification of native protein complexes from mammalian 
cells. The TAPe-tag facilitates rapid and native purification of protein complexes for 
subsequent identification of PHGPx binding partners by LC-MS/MS as well as 
functional assays. The combination of two medium-affinity binding epitopes (tandem 
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Strep-tag II and a FLAG-tag) reduces the tag size to approximately 5 kDa. Hence, the 
N-terminal TAP-tag/PHGPx fusion protein is only marginally larger than wild type 
PHGPx. The N-terminal part of HA-PHGPx (lacking the start codon) was amplified 
with primers “HA-PHGPx for1” and “HA-PHGPx rev2”, introducing a 5’ NheI and a 3’ 
XhoI restriction site. The 349 bp PCR product was purified and cloned into pcDNA3-
NTAPe with NheI/XhoI. The N-terminal part of PHGPx, now including the TAPe-tag, 
was replaced in pDrive-HA-PHGPx by BamHI/BssHII, yielding a Flag, Strep (2x), and 
HA-tagged PHGPx gene, designated pDrive-FSH-PHGPx (figure 11). The constructs 
were analysed by restriction digestion with BamHI/BglII and sequenced with primers 
”T7 promoter” and “SP6 promoter”. The FSH-PHGPx sequence was transferred to 
p442-PL1 with BamHI/XbaI as described above, yielding p442-FSH-PHGPx. 
 
 
3.4.5 PHGPx Mutagenesis 
Mutations of single amino acids within PHGPx were performed by PCR mutagenesis 
with pDrive-HA-PHGPx in a volume of 50 µl. Primers of 33 nucleotides were 
designed, such that the primer sequence consists of a mutated codon, flanked by 
wild type sequences of at least 10 nucleotides. Mutated codons were chosen 
according to the highest murine codon usage of the respective amino acid. The Sec 
codon (UGA) at position 46 of murine PHGPx was mutated to Cys (UGC) and Ser 
(AGC) with primers “PHGPx UC for1/rev1” and “PHGPx US for1/rev1”, respectively. 
The PCR-reactions were performed with reduced primer annealing temperature (- 
6°C), due to the mismatch of primer and wild type PHGPx sequence. Prior to the 
transformation of competent cells, PCR reactions were digested with DpnI for 60 min 
to remove methylated template DNA. Mutations were verified by sequencing in 
pDrive with primers ”T7 promoter” and “SP6 promoter”. The mutated sequences were 
transferred to the lentiviral expression vector p442-PL1 as described above, yielding 
p442-HA-PHGPx-UC and p442-HA-PHGPx-US, respectively (figure11). 
 
 
3.4.5 Bcl-2 expression vectors 
The sequence for wild type Bcl-2 was recovered from pBabe-Bcl-2-puro (kind gift 
from Gerard Evan, London, UK; (Fanidi et al., 1992)) by restriction digestion with 
EcoRI. The purified 948 bp fragment was cloned into EcoRI-digested and 
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dephosphorylated vector p442-PL1, yielding p442-Bcl-2 (figure 11). Single clones 
were checked for correct orientation of the insert by restriction digestion with BamHI 
and XmaI, respectively. 
 
Plasmid pIRES-neo3-Bcl-2-ActA is based on the CMV promoter-driven expression 
vector pIRESneo3 (Clontech), containing an IRES and a neomycin resistance 
cassette (NeoR) for stable selection of expressing cell clones with G418. The plasmid 
encodes a mutated Bcl-2 in which the membrane anchor was replaced by the 
mitochondrial insertion sequence of ActA (Bcl-2-ActA) (Zhu et al., 1996), targeting 
Bcl-2 localisation to the outer mitochondrial membrane. Plasmid pIRES-neo3-Bcl-2-
ActA was a kind gift from Prof. Peter Daniel (University Medical Centre Charité, 
Berlin-Buch, Germany). 
 
 
3.5 Immunoblotting and Immunocytochemistry 
 
3.5.1 Western blot 
For whole cell lysate preparation, cells were lysed in LCW Lysis Buffer, containing 
Protease Inhibitor Cocktail (Roche Diagnostics), and incubated for 15 min on ice. The 
cell debris was removed by centrifugation for 15 min at 4°C at 10,000 x g. The 
protein concentration of the supernatant was determined by the DC Protein Assay 
(Bio-Rad), according to manufacturers’ instructions. Equal amounts of protein lysates 
were mixed with Sample Loading Buffer, boiled for 5 min at 95°C, and proteins were 
separated by 12 % SDS-PAGE at 160 V in a Mini-PROTEAN 3 Electrophoresis Cell. 
Proteins were transferred from the gel onto a Hybond-C super nitrocellulose 
membrane in Blotting Buffer with a Trans-Blot Semi-Dry Blotter at 20 V for 30 min. 
Membranes were blocked with 5 % skim milk powder in TBST for 60 min and 
hybridized with a primary antibody at 4°C for at least 12 h. Membranes were washed 
three times in TBST for 5 min, following HRP-conjugated secondary antibody 
incubation for 90 min. The nitrocellulose membranes were repeatedly washed in 
TBST (3x 5 min) and proteins were visualized by ECL detection on Hyperfilm. 
Efficient stripping of Hybond-C super membranes was performed with 0.4 M NaOH 
for 10 min. Prior to second hybridisation (usually with primary antibody α-Tubulin), 
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membranes were blocked with 5 % skim milk powder in TBST for 60 min. All 
following steps were performed as described above. 
 
Blotting Buffer: 10 % Running Buffer (10x), 20 % Methanol 
Sample Loading Buffer (2x): 100 mM Tris, 4 % SDS, 20 % Glycerol, 0.1% Bromophenol Blue, 100 
mM DTT, pH 6.8 
LCW Lysis Buffer: 0.5 % TritonX-100, 0.5 % Sodium Deoxocholate Salt, 150 mM NaCl, 20 mM TRIS, 
10 mM EDTA, 30 mM Na-Pyrophosphate, pH 7.5 
Running Buffer (10x): 250 mM TRIS-Base, 1 % SDS, 2.5 M Glycine 
TBST: 25 mM TRIS, 125 mM NaCl, 0.1 % Tween-20, pH 8.0 
 
 
3.5.2 The production of antibodies for murine PHGPx 
The production of antibodies, specific for murine PHGPx, was performed by Elisabeth 
Kremmer, GSF, Munich, Germany. Antibodies were raised in rat against a PHGPx-
specific peptide sequence, homologue to the C-terminal part of PHGPx 
(PQVIEKDLPCYL). The Cys of the PHGPx sequence was replaced by butyric acid 
(Ba) and an additional Cys was added at the C-terminal end. The peptide sequence 
was coupled to ovalbumin (OVA) or keyhole limpet hemocyanin (KLH) at the C-
terminus (PQVIEKDLPBaYLC-OVA/KLH). The peptides were obtained from Peptide 
Specialty Laboratories, Heidelberg, Germany. Five positive clones of hybridoma cells 
were identified (mGPx 1B4, 7E2, 6G8, 7E8, 8A5). The antibody-containing 
supernatant of clone mGPx4 1B4 (IgG1) was used in this work. 
 
 
3.5.3 Immunocytochemistry and confocal microscopy 
MEFs were seeded onto UV-sterilized cover slips in 6-well cell culture dishes. Cells 
were cultivated to semi-confluency in standard DMEM. For fixation of adherent cells, 
medium was aspirated from the cell culture dish, and cover slips were rinsed with 
PBS. Cells were fixed for 10 min in a 4% PFA solution. Cover slips were washed 3x 
with PBS and permeabilized for 15 min with 0.1% Triton X-100 in PBS. 
Subsequently, cells were blocked for 2 h with 10% FCS in PBS. For detection of HA-
tagged PHGPx, cover slips were incubated over night with primary antibody α-HA 
High Affinity (clone 3F10) at 4°C in a humidified chamber. Glasses were washed 3x 
with PBS/Tween and subsequently incubated with secondary antibody α-rat-Cy3 
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conjugate protected from light (45 min). Cover slips were washed 3 x with 
PBS/Tween and then incubated for 2 min in DAPI solution. Glasses were briefly 
rinsed in PBS and mounted onto microscope slides, using mounting medium. Slides 
were dried over night at 4°C, protected from light and eventually sealed with nail 
polish. Pictures were taken by confocal microscopy with Leica DM IRBE microscope, 
Leica TCS SP2 scanner and Leica Confocal software.  
 
α-HA (clone 3F10) antibody solution: 1/10 dilution of 3F10 hybridoma supernatant in PBS/10% FCS 
α-rat-Cy3 solution: 1/1000 dilution in PBS/10% FCS 
DAPI-solution:  1 µg/ml DAPI diluted in PBS (5mg/ml stock solution in H2O) 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
PBS/Tween: 0.1% (v/v) Tween 20 in PBS 
PFA solution: 4% (w/v) PFA in PBS, pH 7.4 adjusted with HCl 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
Triton X-100 solution: 0.1% (v/v) Triton X-100 in PBS 
 
 
3.6 Determination of mRNA levels 
 
3.6.1 RNA isolation and cDNA synthesis 
Total RNA from cells was isolated with RNeasy Mini Kit (Qiagen) according to 
manufacturers’ instructions. MEFs were harvested from 10 cm cell culture dishes with 
a cell scraper. Cells were disrupted by the addition of 600 µl Buffer RLT, containing 
10 µl/ml 2-ME. To process samples simultaneously during time course experiments, 
cell extracts were temporarily stored at -80°C, which did not affect the quality and 
yield of total RNA. To avoid DNA contamination, on-column DNase digestion with the 
accessory RNase-Free DNase Set (Qiagen) was performed. RNA was eluted from 
the column with 30 µl elution buffer. Final RNA concentrations were determined by 
measuring the absorbance at 260 nm in a spectrophotometer. Single-stranded cDNA 
was synthesized from 1 µg of isolated mRNA by Reverse Transcription System 
(Promega) according to manufacturers’ instructions. The incubation time, however, 
was extended to 45 min to obtain more abundant transcripts. The cDNA amplification 
was performed with random primers at 42°C. The 20 µl first-strand cDNA synthesis 
reaction mix was finally diluted to 100 µl with nuclease-free water and subjected to 
RT-PCR. 
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3.6.2 Quantitative RT-PCR 
The synthesized cDNA was amplified and detected with LightCycler FastStart DNA 
MasterPLUS SYBR Green I Kit in combination with LightCycler 1.5 System (Roche). 
For each RT-PCR reaction, 6 µl H2O, 1 µl primer mix, 1 µl Master Mix and 2 µl cDNA 
were mixed in a LightCycler Capillary, pre-cooled in a centrifuge adapter. RT-PCR 
primers were designed with software Primer3 (Rozen and Skaletsky, 2000), 
standardizing optimal TM of approximately 70°C and a product size of 200-300 
nucleotides. If possible, primer pairs hybridizing on different exons were used to 
prevent unspecific amplification of possible genomic DNA contaminations. Gene 
expression levels were normalized to aldolase expression levels. To control the 
specificity of the RT-PCR reaction, the synthesized PCR product was correlated to a 
specific melting point, which was assessed by running a melting curve program.  
 
Primer mix: 5 µl of 100 µM primer A, 5 µl of 100 µM primer B, 90 µl H2O (5 µM each primer) 
TE: 10 mM Tris pH 7,5; 1 mM EDTA 
 
 
3.7 Northern blot 
The specific DNA-probe for murine xCT was a kind gift from Ana Banjac (Banjac Ana, 
PhD thesis, 2005). The DNA fragments were labelled using Rediprime II random 
prime labelling system and 50 µCi [a-32P]-dCTP (3000 Ci/mmol, 10 mCi/ml) 
according to manufacturers’ instructions. Non-incorporated nucleotides were 
separated from the labelled probe by using Sephadex G-50 columns. Labelling 
efficiency was detected by using a bench-top radioisotope counter. Just before 
hybridisation, the probe was heat-denatured at 95°C for 5 min. 
 
Total RNA was isolated with RNeasy Mini Kit (Qiagen) according to manufacturers’ 
instructions. MEFs were harvested from 10 cm cell culture dishes with a cell scraper 
Total RNA was dissolved in 100 µl RNAse-free water and samples were stored at -
80°C. 10 µg of total RNA was lyophilised in a speed vac, dissolved in 15 µl RNA 
loading buffer and incubated at 70°C for 10 min to minimize RNA secondary 
structures. RNA was separated in a 1 % formaldehyde agarose gel in the presence of 
2.2 M formaldehyde in MOPS buffer overnight at 40 V. RNA was transferred to a 
Hybond-N+ membrane by capillary forces using 10 x SSC solution. The gel was 
placed on a glass plate covered with two Whatman filter papers (dipped in reservoirs 
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with 10 x SSC solution) and overlaid with a Hybond-N+ membrane and several layers 
of blotting paper. The transfer of RNA was controlled by UV light. Subsequently, RNA 
was covalently cross-linked to the membrane by baking at 80°C for 1 hour. The 
membrane was pre-hybridised at 65°C for 2 hours in Church buffer. Hybridisation 
was performed at 68°C overnight in 15-20 ml of fresh Church buffer, containing 
approximately 1x107 dpm of radioactively labelled probe. Membranes were washed 
twice for 15 min at 68°C with 2 x SSC, 1 % SDS and then twice for 10 min at 68°C 
with 0.1 x SSC, 0.5 % SDS. Membranes were dried and exposed to an X-ray film 
overnight at -80°C. 
 
Church buffer: 200 mM NaH2PO4, 400 mM Na2HPO4, 7 % (w/v) SDS, 1 mM EDTA, pH 7.1-7.2 
Formaldehyde agarose gel: 2.2 M formaldehyde, 1x MOPS buffer, 1 % (w/v) agarose 
MOPS buffer: 0.4 M MOPS (free acid), 100 mM Na-acetate, 10 mM EDTA/NaOH pH 8.0, pH 7.0 
adjusted with 10 N NaOH 
RNA loading buffer: 50 % (v/v) formamide, 2.2 M formaldehyde, 1 x MOPS buffer, 50 µg/ml ethidium 
bromide, 0.2 % (w/v) bromophenol blue 
SSC (20 x): 3 M NaCl, 300 mM Tris-sodium citrate/NaOH pH 7.0 
 
 
3.8 Flow cytometry (FACS analysis) 
 
3.8.1 Intracellular peroxide detection 
Intracellular peroxide levels were detected by DCF staining. The acetylated forms of 
DCF, such as CM-H2DCFDA, are non-fluorescent until the acetyl groups are 
removed by intracellular esterases and oxidation occurs inside the cell. Cells (1 x 106 
cells) were loaded with 1 µM CM-H2DCFDA for 60 min at 37°C in Standard DMEM. 
Cells were washed with PBS and detached from the cell culture dish by 
trypsinization. Subsequently, cells were harvested by centrifugation (600 x g, 5 min), 
washed in PBS (3x) and resuspended in 200 µl PBS. Samples were applied to a flow 
cytometer (BD FACSCalibur) in which cells were excited with 488 nm UV line argon 
ion laser. The DCF emission was recorded on channel FL1 at 530 nm. Data were 
collected from at least 20,000 cells. 
 
DCF solution: 1 µM CM-H2DCFDA in ethanol 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
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3.8.2 Detection of lipid peroxidation 
Cellular lipid peroxidation was detected by BODIPY staining. The fluorophore 
BODIPY intercalates in biomembranes where its fluorescence shifts from red to 
green upon oxidation. Cells (1 x 106 cells) were loaded with 2 µM BODIPY 581/591 
C11 for 60 min at 37°C in Standard DMEM. Cells were washed with PBS and 
detached from the cell culture dish by trypsinization. Subsequently, cells were 
harvested by centrifugation (600 x g, 5 min), washed in PBS (3x) and resuspended in 
200 µl PBS. Samples were applied to a flow cytometer (BD FACSCalibur), in which 
cells were excited with 488 nm UV line argon ion laser and BODIPY emission was 
recorded on channels FL1 at 530 nm (green) and FL2 at 585 nm (red). Data were 
collected from at least 20,000 cells. 
 
BODIPY solution: 2 mM BODIPY 581/591 C11 in DMSO 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
 
 
3.8.3 Cell viability detection by flow cytometry 
Cell viability was determined by propidium iodide (PI) staining. Adherent cells were 
washed with PBS and detached by trypsinization. Subsequently, cells were 
harvested by centrifugation (600 x g, 5 min), washed in PBS (3x) and resuspended in 
200 µl PBS. PI was added to a final concentration of 1 µg/ml. The fluorogenic dye PI 
enters only dead cells and intercalates into double stranded DNA. PI can not cross 
the intact membrane of viable cells, thus its fluorescence of above 630 nm can be 
used for cell viability screening. Cell suspensions were excited with 488 nm UV line 
argon ion laser and PI emission was recorded on channel FL3 at 661 nm.  
 
PI solution: 1 mg/ml PI in PBS 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
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3.9 Detection of HETE/HPETE and LTB4 detection by HPLC 
Cells were harvested by trypsinization and cell number was determined in a 
haemocytometer by trypan blue exclusion. 2.5x106 cells were washed and 
resuspended in 500 µl prewarmed PBS containing 1 mM CaCl2 and 1 mg/ml glucose. 
To activate arachidonic acid metabolism and enrich its metabolites, cells were 
incubated for 10 min with 40 µM arachidonic acid and 2.5 µM A23187 Ca2+-
ionophore. The incubation was stopped by addition of 1 ml of -20°C methanol to the 
cell suspension, concurrently extracting lipids from the cell extract. Solid phase 
extraction was performed on Supelclean LC-18 columns (Sigma) according to 
manufacturers’ instructions. 
 
Lipid extracts were applied to an HPLC machine equipped with C18 reverse-phase 
NovaPak HPLC column and connected to a UV-detector. Protocol A resolved 5-
HETE/HPETE, 12-HETE/HPETE and 15-HETE/HPETE in a mobile phase containing 
60% acetonitrile, 40% H2O and 0.01% acetic acid at a wavelength of 235 nm. 
Protocol B resolved LTB4 in a mobile phase containing 35 % methanol, 35% H2O, 
30% acetonitrile and 0,0001% acetic acid at 270 nm. 
 
 
3.10 Detection of Cys/(Cys)2 and GSH 
 
3.10.1 Cys and GSH detection by HPLC 
The HPLC system consisted of a System Gold 126 pump, connected to a System 
Gold 508 autosampler (both Beckman Coulther GmbH, Krefeld, Germany) and a RF-
10A XL fluorescence spectrophotometer (Shimadzu, Duisburg, Germany). The 
mobile phase consisted to 95 % of 30 mM ammonium-formiate, 40 mM ammonium-
nitrate buffer (adjusted to pH 3.65 with formic acid) and to 5 % of acetonitrile. The 
column effluent was monitored by fluorescence detection with an excitation 
wavelength of 385 nm and an emission of wavelength of 515 nm. 
 
Cellular Cys and GSH levels were measured in extra- and intracellular fractions of 
γGCS knockout cells. Cells were incubated in FCS-free cell culture medium for 90 
min. Subsequently, medium was recovered for extracellular and cells for intracellular 
Cys and GSH measurements. Cells were harvested from cell culture dishes by 
  Methods 
 - 47 - 
vigorous pipetting, washed twice in PBS, resuspended in 500 µl Borate Buffer 1 and 
homogenized by sonication. 
 
For GSH and Cys/(Cys)2 measurement, samples (200 µl) were treated on ice with 20 
µl 100 ml/l tri-n-butylphosphine in dimethylformamide for 30 min in order to reduce 
thiols and liberate them from proteins. This reducing step was omitted for free Cys 
detection, to avoid (Cys)2 reduction. 200 µl perchloric acid was added to the samples, 
mixed and incubated on ice for 10 min. Proteins were removed by centrifugation at 
10,000 x g for 10 min at 0°C. 100 µl supernatant, 250 µl Borate Buffer 2 and 100 µl 
SBDF were mixed and incubated at 60°C for 60 min. To terminate the SBDF 
derivatization step, the solutions were snap-cooled on ice and transferred to a cooled 
autosampler vial. Aliquots of 50 µl were injected into the column. Standard samples 
of L-cysteine (3 to 250 µM) and GSH (1 to 50 µM) were prepared by serial dilution in 
Borate Buffer 1.  
 
Borate Buffer 1: 0.2 M boric acid, containing 2 mM Na2EDTA, pH 9.5 
Borate Buffer 2: 0.2 M boric acid, containing 5 mM Na2EDTA, pH 10.5 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
Perchloric acid: 0.5 M perchloric acid, containing 1 mM Na2EDTA 
SBDF: 1.0 g/l 7-fluoro- benzo-2-oxa-1.3-diazole-4- sulphonate in 0.1 M Borate Buffer 1 
 
 
3.10.2 Determination of cellular L-cystine uptake capacity 
The uptake capacity for L-cystine was determined by measuring the time-dependent 
increase of radioactive labelled L-[14C(U)] cystine in the cell. 1x106 cells were seeded 
per 6 cm cell culture dish in DMEM, containing 5 mM NAC, and incubated for 24 h. 
The cellular monolayer was washed with prewarmed PBS(+) (3x), following the 
addition of 500 µl Uptake Solution and incubation in a water bath at 37°C for 90 sec. 
To control the specificity of antiporter xc--mediated cystine uptake, 2.5 mM glutamate 
was added to the Uptake Solution. The Uptake Solution was aspirated, cells were 
washed with ice cold PBS and lysed in 500 µl 0.5 M NaOH over night. The protein 
concentration of the recovered samples was determined by DC Protein Assay (Bio 
Rad). 200 µl cell lysate, 3 ml scintillation cocktail and 100 µl 0.2 M Tris-HCl were 
mixed in a scintillation tube. Radioactivity was determined by a LS 500 TA 
Scintillation Counter. To correlate cystine concentration and radioactivity, 5 µl Uptake 
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Solution (50 µM cystine) was mixed with 500 µl 0.5 M NaOH and the “specific 
activity” was measured. The cellular cystine uptake activity is stated as nmol cystine 
min-1 mg-1. 
 
Uptake Solution: 50 µM L-cystine, 0.2 µCi/ml L-[14C(U)] cystine, 10 % glucose, 1 % CaCl2, 1 % MgCl2 
in PBS. 5 mM L-cystine stock solution was dissolved in 0.05 M HCL with stirring for several hours at 
room temperature. 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
PBS(+): PBS, 10 % glucose, 1 % CaCl2, 1 % MgCl2 
 
 
3.10.3 Determination of extracellular mercaptans 
Levels of extracellular mercaptans were measured with DTNB, also called Ellman’s 
reagent. This aromatic disulfide reacts with aliphatic thiol groups to form a mixed 
disulfide. DTNB has little absorbance, but upon reaction with free sulfhydryl groups it 
gives an intense yellow colour, which can be detected with a photometer at 412 nm. 
γ-GCS knockout cells were incubated in FCS-free DMEM and medium was 
recovered at different time points. 50 µl DTNB solution was added to 500 µl medium, 
mixed and incubated for 2 min. Absorbance was measured with a DU-64 
Spectrophotometer at 412 nm. Control cells were incubated in DMEM*, lacking 
component cystine. Fresh DMEM was used as blank control. Standard samples of 
reduced GSH (10 to 40 µM) were prepared by serial dilution in DMEM.  
 
DTNB Solution: 10 mM DTNB in K-Phosphate Buffer 
K-Phosphate Buffer: 0.2 M K-Phosphate, 10 mM EDTA, pH 7.2 
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4. Results 
 
4.1 Inducible inactivation of PHGPx in primary MEFs 
 
To bypass early embryonic lethality of PHGPx null mice, the Cre/loxP system was 
employed to create mice with targeted conditional disruption of gene PHGPx (Conrad 
Marcus, PhD thesis, 2001) (figure 12-A). These transgenic mice were used in this 
work to generate individual cell lines of primary MEFs. To achieve inducible 
inactivation of PHGPx, cells with one or two loxP flanked (floxed) PHGPx alleles were 
stably transfected with the tamoxifen-inducible Cre fusion protein MerCreMer. 
MerCreMer was used instead of constitutively active Cre, since it was unknown 
whether loss of PHGPx in MEFs might affect cell proliferation or even cause cell 
death. Cells were transfected with the bicistronic expression vector pCAG-3SIP-
MerCreMer (figure 12-D). 
 
The CAG promoter of pCAG-3SIP is a strong promoter consisting of the chicken β-
actin promoter and elements of the CMV enhancer. The bicistronic expression 
cassette, containing MerCreMer and puromycin N-acetyltransferase, ensures stable 
expression of MerCreMer (a kind gift from T. Schroeder, GSF, Munich) (Verrou et al., 
1999), due to the possibility to select for transfected cells by puromycin. A point 
mutation in the oestrogen receptors of MerCreMer prevents binding of endogenous 
17β-oestradiol in the mouse but retains binding capacity for tamoxifen. In the 
absence of tamoxifen, MerCreMer is retained in the cytosol by forming a complex 
with heat shock protein 90 (Hsp90) via its two mutated oestrogen receptor domains. 
The knockout of PHGPx can be induced by the addition of 4-hydroxytamoxifen to the 
cell culture medium. 4-hydroxytamoxifen binds to the mutated oestrogen receptors of 
fusion protein MerCreMer, whereupon MerCreMer is released from Hsp90 and 
translocates to the nucleus where Cre-mediated recombination between two adjacent 
loxP sites takes place. Since Cre activation causes the deletion of exon five to seven 
of the PHGPx gene, including the crucial SECIS element, PHGPx activity is 
abolished. 
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The following nomenclature for mice and cell lines was adopted from Marcus 
Conrad’s work (Conrad Marcus, PhD thesis, 2001). Transgenic PHGPx mice are 
designated with the abbreviation PF (PHGPx, flipped) and isolated fibroblasts with 
the abbreviation PFa. To isolate primary MEFs, male PF (wt/flox or flox/flox) mice 
were mated with PF (wt/flox or flox/flox) females. At 12.5 days post coitum, females 
were sacrificed, and embryos were dissected. In total, 56 primary MEF cell lines were 
isolated from E12.5 embryos and the respective genotypes were determined from 40 
outgrowing cell lines by PCR. The isolated MEF cell lines contain either one or two 
floxed PHGPx alleles. Embryos obtained from matings of heterozygous PF (wt/flox) 
male and PF (wt/flox) female mice gave rise to 7 PFa(wt/wt) (21 %), 16 PFa(wt/flox) (49 
%), and 10 PFa(flox/flox) (30%) cell lines, whereas breeding of homozygous PF(flox/flox) 
parents gave rise to 7 homozygous PFa(flox/flox) cell lines. Four independent PFa cell 
lines were used for further studies. These include the homozygous cell lines 
PFa1(flox/flox) and PFa24(flox/flox), which contain two floxed PHGPx alleles, and the 
hemizygous cell lines PFa37(wt/flox) and PFa43(wt/flox), each harbouring one floxed and 
one wild type allele (figure 12-B). 
 
Plasmid pCAG-3SIP-eGFP (figure 12-D) was included in these studies to monitor 
transfection efficiency and puromycin selection of stably transfected MEFs by 
fluorescence microscopy and flow cytometry analysis. Primary MEFs with early 
passage number grew slowly and transfection efficiency by electroporation did not 
exceed 5 %. At least 6 weeks were necessary to accomplish puromycin selection 
with low passage number MEFs, transfected with pCAG-3SIP-eGFP (figure 12-C). 
Primary MEFs that overcame replicative senescence after 20-30 passages grew 
faster and transfection efficiency increased notably to more than 50 %. These cells 
were clearly reduced in size, which correlated with a significantly faster cell division 
rate. When immortalized cell lines were used, the selection of stably transfected 
clones by puromycin was already accomplished after 2 weeks. Thus, immortalized 
cells were used for all subsequent transfections. After optimisation of the transfection 
and selection procedure with plasmid pCAG-3SIP-eGFP, PFa(wt/flox) and PFa(flox/flox) 
cell lines were stably transfected with pCAG-3SIP-MerCreMer by electroporation and 
subsequent puromycin selection, yielding PFa-MerCreMer cell lines. PFa-MerCreMer 
cells were maintained under selection pressure (2 µg/ml puromycin) to assure stable 
expression of MerCreMer. 
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Figure 12: The inducible Cre/loxP system for PHGPx deletion in MEFs. (A) Depicted is the genomic 
structure of a transgenic PHGPx allele in PFa cells. Exons 5 to 7 were flanked by loxP sites (for further 
details see figure 6). (B) The genotyping of isolated MEFs by PCR shows wild type PHGPx (170 bp) 
and floxed PHGPx (240 bp) alleles. PFa1(flox/flox) and PFa24(flox/flox) were identified as homozygous cell 
lines, whereas PFa37(wt/flox) and PFa42(wt/flox) cells contain one wild type and one floxed PHGPx allele. 
(C) Fluorescence microscopy of pCAG-3SIP-eGFP-transfected MEFs, after selection with puromycin. 
(D) Schematic representation of the bicistronic expression vectors, used for stable expression of 
MerCreMer or eGFP. 
 
The Cre-mediated disruption of PHGPx was assessed by quantitative RT-PCR and 
Western blot in PFa(flox/flox)-MerCreMer cells (figure 13). The antioxidant α-tocopherol 
had to be included in the cell culture medium during the course of the experiments, 
for reasons as outlined below (refer to chapter 4.4). RT-PCR was performed with 
primers specifically binding to the exon 3 to 4 boundary and exon 6. cDNA was 
synthesized from total cellular mRNA, isolated from PFa1(flox/flox)-MerCreMer cells. 24 
hours after the addition of 4-hydroxytamoxifen to the cell culture medium, PHGPx 
mRNA levels decreased to approximately 4 % compared to total PHGPx mRNA in 
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non-treated cells. The mRNA levels remained below 10 %, at least during the 96 
hours after addition of 4-hydroxytamoxifen (figure 13-A). PHGPx protein levels were 
assessed by immunoblotting, using antibody α-PHGPx (mGPx4 1B4) (figure 13-B). 
The PHGPx protein levels drastically decreased 48 hours after the induction of the 
PHGPx knockout. 
 
 
 
Figure 13: Inducible disruption of PHGPx in primary MEFs. (A) Endogenous PHGPx mRNA levels in 
PFa1(flox/flox)-MerCreMer cells were determined by quantitative RT-PCR before and after 4-
hydroxytamoxifen (Tam)-induced activation of MerCreMer. (B) PHGPx protein levels were determined 
by western blot, using α-PHGPx antibody mGPx4-1B4, before and after the induction of the PHGPx 
knockout. 
 
 
4.2 PHGPx depletion causes rapid cell death 
 
To study the effects of PHGPx abolition, PFa(flox/flox)-MerCreMer cells and the 
hemizygous control cell lines PFa37(wt/flox)-MerCreMer and PFa43(wt/flox)-MerCreMer 
were treated with 4-hydroxytamoxifen (figure 14). The deletion of PHGPx in 
PFa1(flox/flox)-MerCreMer and PFa24(flox/flox)-MerCreMer cells caused massive cell 
death, already 48 hours after the addition of 4-hydroxytamoxifen to the cell culture 
medium. By contrast, no obvious phenotype could be observed in 4-
hydroxytamoxifen-treated PFa43(wt/flox)-MerCreMer cells (figure 14-A). PFa37(wt/flox)-
MerCreMer cells showed only a transient retardation in cell growth, but eventually 
recovered from 4-hydroxytamoxifen-treatment (data not shown). 
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Figure 14: PHGPx disruption causes massive cell death in MEFs. (A/B) Cell growth after Cre-
mediated PHGPx depletion in PFa1(flox/flox)-MerCreMer and PFa43(wt/flox)-MerCreMer cells. (B) 4-
hydroxytamoxifen (Tam) treated PFa1(flox/flox)-MerCreMer cells underwent rapid cell death. The 
lipophilic antioxidant α-tocopherol (Toc) fully rescued PHGPx depletion. 
 
 
Of note, 4-hydroxytamoxifen-treated PFa(flox/flox)-MerCreMer cells, seeded at high cell 
density, grew until confluence and did not undergo cell death. Subsequent passaging 
at low cell density, however, caused rapid cell death within 24 hours, indicating that 
only proliferating cells depend on functional PHGPx (data not shown). The 
morphological features of cell death progression in PHGPx-deficient cells were 
observed by time-lapse videos (see supplementary data on CD). PHGPx-deficient 
cells shrunk, showed deformation, and lost contact to the cell culture dish and 
adjacent cells, morphological features reminiscent to those observed in apoptotic 
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cells. Heterozygous control cells with one functional PHGPx allele could be cultivated 
indefinitely in cell culture after 4-hydroxytamoxifen-treatment, without showing any 
signs of increased cell death. 
 
 
4.3 The reconstitution of PHGPx expression with a lentiviral add-back system 
rescues PHGPx knockout cells 
 
The activation of MerCreMer by 4-hydroxytamoxifen caused massive cell death 
within 48 hours in PFa(flox/flox)-MerCreMer cells. To rule out any unspecific detrimental 
side effects, e.g. by Cre activation or by 4-hydroxytamoxifen, PHGPx was ectopically 
expressed in these cells. The coding region of the PHGPx gene was amplified from 
murine testis cDNA and cloned into the pDrive vector. The coding sequences for an 
HA-tag or a Flag-Strep-HA-tag (FSH-tag) were cloned in frame in the 5’-end of 
PHGPx cDNA. The tagged PHGPx constructs were transferred into the lentiviral 
vector p442-PL1, yielding expression vectors p442-HA-PHGPx (figure 15-A) and 
p442-FSH-PHGPx, respectively. The lentiviral infection system, including vector 
p442-PL1, was chosen for several reasons. First, lentiviruses comprise high infection 
efficiency rates due to their ability to infect also non-proliferating cells. Second, 
lentiviruses are retroviruses that stably integrate into the hosts’ genome, and thus 
replicate non-episomally. Moreover, p442-PL1 comprises a strong SFFV promoter 
and a bicistronic IRES-VENUSnucmem element for monitoring simultaneous 
expression of the gene of interest and VENUSnucmem in infected cells. 
 
Ecotropic lentivirus particles were produced in HEK293 T packaging cells. The CaCl2 
transfection efficiency of HEK293 T cells was observed by fluorescence microscopy 
24 hours after transfection (figure 15-B). The virus particles were harvested from 
HEK293 T cell culture medium and used for subsequent infection of PFa1(flox/flox)-
MerCreMer cells. PFa1(flox/flox)-MerCreMer cells, infected with p442-HA-PHGPx and 
p442-FSH-PHGPx, could be detected by fluorescence microscopy and FACS 
analysis due to VENUSnucmem expression. The lentiviral infection efficiency was 
quantified by FACS analysis and ranged between 75-99 % of positive cells (figure 15-
C). 
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Figure 15: Strategy for add-back of exogenous HA-tagged wild type PHGPx with a lentiviral 
transduction system. (A) Schematic illustration of the lentiviral expression vector, including HA-tagged 
PHGPx and VENUSnucmem expression cassette. (B) Fluorescence microscopy of lentiviral 
VENUSnucmem expression. Depicted are HEK293 T packaging cells (left) and PFa1(flox/flox)-
MerCreMer MEFs, after the infection with lentiviral supernatants (right). (C) Quantification of 
VENUSnucmem-expressing PFa1(flox/flox)-MerCreMer cells, infected with vector p442-PL1 or p442-HA-
PHGPx, by FACS analysis. 
 
The expression levels of PHGPx in PFa1(flox/flox)-MerCreMer cells, infected with p442-
HA-PHGPx or p442-FSH-PHGPx, were quantified by RT-PCR and by 
immunoblotting. Cellular localization was visualized by immunocytochemistry. Total 
mRNA was isolated from wild type and p442-HA-PHGPx infected PFa1(flox/flox)-
MerCreMer cells. PHGPx transcripts increased 5-fold in p442-HA-PHGPx infected 
cells compared to non-infected wild type cells (figure 16-A). The protein levels of 
tagged PHGPx (~20 kDa) were analyzed by immunoblotting with α-HA-tag antibody 
3F10 in p442-HA-PHGPx and p442-FSH-PHGPx-infected cells (figure 16-B). A 
distinct band was detected with both variants of tagged PHGPx, whereas the FSH-
tagged PHGPx expression appeared to be much more prominent.  
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Figure 16: Reconstitution of PHGPx expression in PHGPx null cells. HA-tagged or FSH-tagged wild 
type PHGPx were introduced into PFa1(flox/flox)-MerCreMer cells by a lentiviral infection system. (A) 
PHGPx mRNA levels were analyzed by quantitative RT-PCR. PHGPx mRNA levels increased 
approximately 5-fold in p442-HA-PHGPx-infected cells. PHGPx mRNA levels were normalized to 
aldolase transcription levels. (B) Western blot with an α-HA-tag antibody revealed HA-PHGPx and 
FSH-PHGPx expression in PFa1(flox/flox)-MerCreMer cells. (C) Immunocytochemistry with a primary α-
HA antibody and a Cy3-labeled secondary antibody, showing FSH-PHGPx expression in PFa1(flox/flox)-
MerCreMer cells. Cy3 staining was visualized by confocal microscopy. 
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The α-HA-tag antibody 3F10 was also used to visualize FSH-tagged PHGPx 
expression by immunocytochemistry in paraffin-fixed PFa1(flox/flox)-MerCreMer cells. 
Mock-infected PFa1(flox/flox)-MerCreMer cells and control cells, only stained with the 
secondary antibody (α-rat-Cy3), revealed a faint Cy3 background. In contrast, p442-
FSH-PHGPx infected PFa1(flox/flox)-MerCreMer cells yielded a strong Cy3 signal 
(figure 16-C). The exact localization of PHGPx inside the cell could not be 
determined by theses studies, requiring further co-localization experiments with 
organelle specific dyes. A very similar, but significantly weaker Cy3 signal was 
obtained with p442-HA-PHGPx-infected PFa1(flox/flox)-MerCreMer cells (data not 
shown), which is most probably due to weaker expression of the HA-tagged fusion 
protein, as already observed by immunoblotting.  
 
To examine, whether cell death of PHGPx knockout cells could be rescued by 
expression of HA-PHGPx in PFa1(flox/flox)-MerCreMer cells, proliferation assays were 
performed after the deletion of endogenous PHGPx expression (figure 17). The 
number of viable cells was assessed over a period of 96 hours after 4-
hydroxytamoxifen treatment.  
 
 
Figure 17: The reconstitution of PHGPx expression in PHGPx knockout cells rescued MEFs from cell 
death. (A) Growth curve after deletion of endogenous PHGPx in non-infected PFa1(flox/flox)-MerCreMer 
cells, p442-PL1 mock-infected cells, and p442-HA-PHGPx-infected cells. (B) FACS analysis of 
VENUSnucmem-positive PFa1(flox/flox)-MerCreMer cells after p442-HA-PHGPx infection. Quantification 
was performed before (blue, black) and 72 hours after 4-hydroxytamoxifen (Tam) treatment (red). 
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As shown in figure 17-A, the reconstitution of PHGPx expression by lentiviral 
infection with vector p442-HA-PHGPx fully rescued PFa1(flox/flox)-MerCreMer cells 
from cell death. The lentiviral infection itself had no effect on proliferation in the 
absence of 4-hydroxytamoxifen. When treated with 4-hydroxytamoxifen, p442-PL1-
infected control cells died within 48 hours, like non-infected parental PFa1(flox/flox)-
MerCreMer cells. 
 
Since HA-PHGPx and VENUSnucmem expression is coordinated by a bicistronic 
expression cassette, VENUSnucmem expression could be used to track cell survival 
of infected and non-infected cells. The quantification of VENUSnucmem expressing 
cells was performed by FACS analysis. 66 % of PFa1(flox/flox)-MerCreMer cells were 
positive for VENUSnucmem expression immediately after lentiviral infection with 
p442-HA-PHGPx. The treatment with 4-hydroxytamoxifen caused an increase from 
66 % to 97 % of VENUSnucmem-positive cells after 72 hours (figure 17-B), indicating 
that non-infected cells died during this period, while exogenous HA-PHGPx 
expression rescued the deletion of endogenous PHGPx expression. 
 
 
4.4 Vitamin E, but not water-soluble antioxidants rescue PHGPx-deficient cells 
from cell death 
 
PHGPx has been initially identified as an enzyme, efficiently protecting liposomes 
and biomembranes from peroxidative degradation (Ursini et al., 1982). Hence 
antioxidant supplements were considered to protect MEFs from cell death, induced 
by PHGPx disruption. Various concentrations of lipophilic and hydrophilic 
antioxidants were added to the cell culture medium 12 hours after the addition of 4-
hydroxytamoxifen. The number of viable cells was determined 48 hours later by 
trypan blue exclusion (figure 18).  
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Figure 18: The lipophilic antioxidant α-tocopherol (Toc) rescued PHGPx deficiency in vitro. (A/B) The 
addition of 1 µM α-tocopherol fully rescued cells from cell death, (C) whereas NAC, (D) 2-ME, (E) α-
lipoic acid, (F) and GSH-EE did not protect PHGPx knockout cells. Cell numbers are depicted in per 
cent, related to the cell number of non-treated wild type cells. 
 
None of the hydrophilic antioxidants [NAC (0.5-10 mM), 2-ME (5-500 µM), and GSH-
EE (0.25-2.5 mM)] protected PHGPx knockout cells from cell death over a wide 
range of different concentrations. Only 2-ME, at a concentration of 50 µM, showed a 
weak protective effect but higher concentrations were toxic as shown with control 
cells. While α-lipoic acid (1-100 µM) proved to be ineffective, the lipophilic antioxidant 
α-tocopherol (0.01-1 µM) efficiently protected cells from cell death at concentrations 
of 1 µM and higher (figure 14 and 18). Of note, 4-hydroxytamoxifen-treated cells 
could be indefinitely cultivated in cell culture, when supplemented with α-tocopherol. 
A subsequent passaging in the absence of α-tocopherol, however, caused massive 
cell death within 24 hours (data not shown). 
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4.5 Deletion of PHGPx causes cell death, resulting from massive lipid 
peroxidation 
 
To address whether PHGPx deficiency may lead to the accumulation of detrimental 
oxygen radicals, cells were stained with different redox-sensitive dyes. This allowed 
the quantification and discrimination of cytosolic (CM-H2DCFDA) and lipid-associated 
(BODIPY 581/591 C11) ROS.  
 
The lipophilic compound BODIPY 581/591 C11 is a specific indicator for lipid 
peroxidation that intercalates in lipid bilayers and shifts its fluorescence from red to 
green upon oxidation. CM-H2DCFDA has been frequently used for the detection of 
cytosolic ROS, emitting green fluorescence upon oxidation inside the cell. Viable and 
dead cells were discriminated by PI staining. Cells were subjected to FACS analysis, 
2, 24 and 48 hours after 4-hydroxytamoxifen treatment as shown in figure 19. 
 
An increase of lipid peroxidation was detected in more than 70 % of PFa1(flox/flox)-
MerCreMer cells, already 24 hours after the addition of 4-hydroxytamoxifen. Lipid 
peroxidation clearly preceded the onset of cell death and arose when cells still 
maintained cell integrity, as shown by PI exclusion (figure 19-A/C). Cytosolic ROS 
levels were only slightly increased 24 hours after 4-hydroxytamoxifen treatment, but 
were more pronounced at 48 hours (figure 19-B). Likewise, PI staining revealed 
substantial cell death only 48 hours after the induction of the PHGPx knockout (figure 
19-C). The addition of α-tocopherol fully prevented lipid peroxidation, the 
accumulation of cytosolic ROS, and cell death. 
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Figure 19: Lipid peroxidation is an early event in PHGPx knockout cells, preceding the accumulation 
of soluble ROS and cell death. (A) Lipid peroxidation was assessed by BODIPY 581/591 C11 staining. 
(B) Soluble ROS were detected by CM-H2DCFDA staining. (C) Viable and dead cells were 
discriminated by PI staining. The deletion of PHGPx was induced by 4-hydroxytamoxifen (Tam) and 
cells were stained with respective fluorophores at indicated time points. Lipid peroxidation, increase of 
cytosolic ROS, and cell death could be entirely prevented by α-tocopherol (Toc). 
 
 
4.6 The crosstalk between PHGPx and arachidonic acid metabolism 
 
PHGPx, along with other GPxs, has been considered to control the activities of LOXs 
and COXs. In the first catalytic step, LOXs and COXs oxygenate arachidonic acid to 
the hydroperoxyl-intermediates HPETE and PGG2, respectively. (Chen et al., 2003; 
Imai et al., 1998; Jakobsson et al., 1992). Both types of enzymes require a certain 
peroxide tone for initial activation and full activity, mediated by oxidation of the 
catalytically essential ferrous iron to ferric iron (Ivanov et al., 2005). Since PHGPx 
controls the cellular peroxide tone and efficiently reduces alkylhydroperoxides to its 
corresponding alcohols, PHGPx has been regarded as a key regulator antagonizing 
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LOX and COX activities. Since lipid peroxidation was identified as very early event 
triggering cell death in PHGPx-deficient cells, it was conceivable that PHGPx 
depletion in PFa1(flox/flox)-MerCreMer cells may cause an increase in COX and LOX 
activities. The accumulation of LOX- and COX-derived hydroperoxyl-intermediates 
may thus lead to unspecific detrimental lipid peroxidation and eventually cell death in 
PHGPX-deficient cells. 
 
RT-PCR analysis was used to examine, whether LOXs and COXs are in fact 
expressed in MEFs. It was shown that COX1, COX2, and various isoforms of the 
lipoxygenase family, including 5-LOX, 12-LOX, 15-LOX are expressed in MEFs, 
whereas no expression of 8-LOX and epidermis-type 12-LOX could be detected 
(figure 20-A). 
 
To test the hypothesis of aberrant arachidonic acid metabolism in PHGPx knockout 
cells, PFa1(flox/flox)-MerCreMer cells were treated with various concentrations of 
arachidonic acid and cell viability was observed 36 hours later (figure 20-B). 
Arachidonic acid clearly accelerated cell death in a concentration dependent manner 
in PHGPx-deficient cells, whereas wild type cells were not affected by arachidonic 
acid. 
 
 
 
 
Figure 20: (A) The expression of various LOXs and COXs in PFa1(flox/flox)-MerCreMer cells was 
examined by RT-PCR. (B) Arachidonic acid significantly accelerated cell death in PHGPx knockout 
cells. Depicted are the numbers of viable cells, 36 hours after the treatment with 4-hydroxytamoxifen 
(Tam). The cell number is depicted in per cent, related to the number of non-treated wild type cells. 
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Figure 21: The inhibition of LOXs, but not COXs rescued PHGPx-deficient cells from cell death. 
PHGPx knockout cells were treated with inhibitors of PLA2, COXs, and LOXs. Cell number was 
determined 48 hours after 4-hydroxytamoxifen (Tam) treatment. Only the general LOX inhibitor NDGA 
rescued PHGPx-deficient cells from cell death. Cell number is depicted in per cent, related to the 
number of non-treated wild type cells. 
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If deregulated LOXs and/or COXs activities lead to the detrimental increase of lipid-
associated peroxides, inhibitors of enzymes involved in arachidonic acid metabolism 
were considered to protect PHGPx-deficient cells from cell death. 12 hours after 4-
hydroxytamoxifen treatment, various inhibitors were added to PFa1(flox/flox)-MerCreMer 
cells at different concentrations and cell viability was determined 48 h later (figure 
21). 
 
Arachidonic acid, the major substrate for LOXs and COXs, is mainly released from 
biomembranes by PLA2, hence the inhibition of PLA2 by quinacrine (0.1–5 µM) and 
aristolochic acid (1-100 µM) was considered to cause an indirect inhibition of LOXs 
and COXs. Yet, in this cellular system, no protective effect was observed with any 
PLA2 inhibitor. Indomethacin was used as specific COX inhibitor, but did not rescue 
cell death at any tested concentration (10-500 µM). Two non-specific pan-LOXs 
inhibitors, ETYA and NDGA, were tested on 4-hydroxytamoxifen-treated PFa1(flox/flox)-
MerCreMer cells. ETYA (1-25 µM) did not have any protective effect, whereas NDGA 
(0.1-5 µM) fully rescued PHGPx-deficient cells in a concentration dependent manner. 
 
Since the general LOX inhibitor NDGA proved to be effective in preventing cell death 
upon PHGPx depletion, the contribution of individual LOXs was more thoroughly 
evaluated. A set of specific inhibitors of distinct LOX isoforms was employed to verify 
the role of various LOXs (figure 22). 
 
MK886, AA-861 and caffeic acid were used to inhibit 5-LOX activity. MK886 inhibits 
5-LOX indirectly by inhibiting 5-LOX-activating protein (FLAP). AA-861 has also been 
reported to inhibit mouse epidermis-type 12-LOX (Nakadate et al., 1985) and 15-LOX 
(Yamazaki et al., 1996). Baicalein was used as 12-LOX inhibitor, but it has also been 
reported to block 5-LOX, 15-LOX and COX activity (Butenko et al., 1993; Deschamps 
et al., 2006; Sekiya and Okuda, 1982). PD146176 (Sendobry et al., 1997) and 
RO1079051 (Gillmor et al., 1997) were used as specific 15-LOX inhibitors. 
RO1079051 has been shown to be highly effective against human 15-LOX, but rather 
ineffective against murine 15-LOX. Of note, PD146176 has been shown to be a 
highly specific 15-LOX inhibitor, lacking significant antioxidant activity (Sendobry et 
al., 1997), which does not always account for most other inhibitors. 
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Figure 22: 15-LOX is a major player of lipid peroxidation-induced cell death in PHGPx knockout cells. 
PHGPx-deficient cells were treated with 5-LOX, 12-LOX, and 15-LOX inhibitors. Cell number was 
determined 48 hours after the treatment with 4-hydroxytamoxifen (Tam). 5-LOX inhibitor AA-861 and 
the 15-LOX inhibitor PD146176 fully rescued PHGPx-deficient cells. The number of viable cells is 
depicted in per cent, related to the number of non-treated wild type cells. 
 
The 5-LOX inhibitor AA861 efficiently protected PHGPx knockout cells in a dose 
dependent manner (0.01-1 µM). As little as 1 µM AA861 was sufficient for a full 
rescue of PHGPx-deficient cells. The FLAP inhibitor MK886 (1-100 µM) and 5-LOX 
inhibitor caffeic acid (1-1000) did not have any protective effect over a broad range of 
different concentrations. Higher concentrations of MK886 and caffeic acid (> 10 µM) 
caused toxic effects also in control cells. 0.1–5 µM of the 12-LOX inhibitor baicalein 
rescued 4-hydroxytamoxifen-treated cells to some extent, while higher baicalein 
concentrations proved to be toxic for both wild type and knockout cells. The 15-LOX 
inhibitor RO1079051 (5-50 µM) did not have any effect at any tested concentrations. 
In contrast, the 15-LOX-specific inhibitor PD146176, efficiently protected cells from 
cell death at concentrations of only 0.5-1 µM. These findings point to 15-LOX as a 
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central player for the increased lipid peroxidation and cell death in PHGPx knockout 
cells, whereas 5-LOX, 12-LOX and COX seem to play a negligible role. 
 
To investigate whether uncontrolled 15-LOX may lead to substantial accumulation of 
peroxyl-intermediates, various arachidonic acid metabolites were measured by HPLC 
(figure 23). Purified HETE/HPETE isoforms, 5-HETE/HPETE, 12-HETE/HPETE and 
15-HETE/HPETE, could be detected and distinguished due to distinct retention times. 
In general HETEs elute earlier than their respective HPETEs, whereas 15-
HETE/HPETE elutes before 12-HETE/HPETE and 5-HETE/HPETE. 
 
 
 
Figure 23: HETE/HPETE-HPLC profiles (protocol A) with purified HETE and HPETE isoforms, which 
could be distinguished by specific retention times. 15-HETE (5; 10.0 min), 15-HPETE (6; 11.3 min), 
12-HETE (3; 11.8 min), 12-HPETE (4; 13.0 min), 5-HETE (1; 13.1 min), 5-HPETE (2; 15.5 min). 
 
Throughout the analysis, untreated PFa1(flox/flox)-MerCreMer control cells were 
compared with 4-hydroxytamoxifen-treated knockout cells. 24 and 48 hours after the 
addition of 4-hydroxytamoxifen, cells were harvested and arachidonic acid 
metabolism was stimulated for 10 minutes with arachidonic acid and the ionophore 
A23187. Only low HETE/HPETE levels were detected in PFa1(flox/flox)-MerCreMer 
cells and no significant difference in intracellular HETE/HPETE concentrations was 
observed either at 24 or 48 h after the induction of the knockout (figure 24).  
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Figure 24: HETE/HPETE-HPLC analysis (protocol A) of cellular lipid fractions from 4-
hydroxytamoxifen-treated and wild type PFa1(flox/flox)-MerCreMer cells. No significant difference in 
HETE/HPETE concentrations (1) could be observed 24 and 48 h after the knockout induction, as 
compared to uninduced cells. 17-OH-22:3 (2) was used as internal standard. 
 
Since HPETEs might be reduced to HETEs by other peroxidatic enzymes, e.g. GPx1, 
catalase, peroxiredoxins or glutathione-S-transferases, PHGPx knockout cells were 
incubated with 3 µM 5-HPETE for 5 min at 37°C, and the conversion of 5-HPETE to 
5-HETE was determined by HPLC. No significant accumulation of intracellular 5-
HPETE could be detected in PHGPx knockout versus wild type cells. By contrast, 5-
HPETE was completely converted to 5-HETE in 4-hydroxytamoxifen-treated as well 
as non-treated PFa1(flox/flox)-MerCreMer cells (figure 25). 
 
 
 
Figure 25: HETE/HPETE-HPLC analysis (protocol A) of lipid fractions from PFa1(flox/flox)-MerCreMer 
cells co-incubated with 5-HPETE. (A) Purified 5-HPETE (1; 14.6 min) with auto-reduced 5-HETE (2; 
12.3 min) and internal standard 17-OH-22:3 (3; 16.7 min). (B/C) Wild type and PHGPx knockout cells 
(+ Tam) converted 5-HPETE to 5-HETE in a similar manner. 
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Since no significant difference in HPETE and HETE levels could be detected in 
PHGPx wild type versus knockout cells, an additional approach was performed to 
assess possible changes in arachidonic acid metabolism. Leukotriene B4 (LTB4), an 
end product of 5-LOX metabolism, was measured in PFa1(flox/flox)-MerCreMer cells. 
Human neutrophils express high levels of 5-LOX, and thus have been used as a 
positive control. 
 
48 hours after the addition of 4-hydroxytamoxifen, cells were stimulated with 
arachidonic acid and the ionophore A23187. Prostaglandine B2 (PGB2) was used as 
an internal standard during the entire purification process. Yet, no cellular LTB4 
production could be detected in PHGPx wild type and knockout fibroblasts, whereas 
control cells produced high levels of LTB4 after induction of the arachidonic acid 
metabolism (Figure 26). 
 
 
 
 
Figure 26: LTB4-HPLC analysis (protocol B) with lipid fractions from PFa1(flox/flox)-MerCreMer cells and 
human neutrophils. (A) HPLC-setup with purified PGB2 (4; 4.8 min) and LTB4 (1; 7.3 min). (B) Lipid 
fraction from wild type MEFs. (C) Lipid fraction from wild type MEFs, stimulated with arachidonic acid 
and the ionophore A23187. (D) 4-hydroxytamoxifen-treated, PHGPx knockout cells, stimulated with 
arachidonic acid and the ionophore A23187. (E) Unstimulated human neutrophils. (F) Human 
neutrophils, stimulated with arachidonic acid and the ionophore A23187, produced high levels of LTB4 
(1), which is typically accompanied by the non-enzymatic hydrolysis products of LTB4, compound A (2) 
and compound B (3). 
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4.7 Cell death is mediated by AIF translocation in PHGPx knockout cells 
 
LOX activation and lipid peroxidation were shown to be one of the earliest events 
triggering cell death in PHGPx-deficient cells. Arachidonic acid metabolites such as 
HPETEs and HPODEs, have been linked to apoptosis (Shureiqi et al., 2003; Sordillo 
et al., 2005), and lipid peroxidation is considered a common mediator of programmed 
cell death through the mitochondrial death pathway (Buttke and Sandstrom, 1994; 
Kagan et al., 2005; Sarafian and Bredesen, 1994). In this respect, overexpression of 
the anti-apoptotic molecule Bcl-2 or downregulation of the pro-apoptotic molecule AIF 
were thought to prevent cell death in PHGPx-deficient cells (figure 27 and 28). 
 
 
 
 
Figure 27: Bcl-2 overexpression did not protect PHGPx-deficient cells from cell death. (A) 
Immunoblotting and growth curve of PFa1(flox/flox)-MerCreMer cells, transfected with pIRES-neo3-Bcl2-
ActA. (B) Immunoblotting and growth curve of PFa1(flox/flox)-MerCreMer cells, transfected with p442-
Bcl2. The deletion of PHGPx was induced by 4-hydroxytamoxifen (Tam). 
 
PFa1(flox/flox)-MerCreMer cells were transfected with pIRES-neo3-Bcl-2-ActA and 
p442-Bcl-2, respectively. Bcl2-ActA includes the mitochondrial membrane targeting 
sequence of ActA. pIRES-neo3-Bcl-2-ActA transfected cells were selected for 
neomycin resistance with G418 for 2 weeks. p442-Bcl-2 lentiviral infection was 
quantified by FACS analysis due to VENUSnucmem expression, yielding 
approximately 50 % positive cells (data not shown). 
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The protein levels of Bcl-2 were analyzed by immunoblotting, revealing a strong 
expression in both cell lines when compared to mock-transfected cells (figure 27). 
Yet, the deletion of PHGPx in Bcl-2- and Bcl-2-ActA- overexpressing cells caused 
massive cell death within 24-48 hours. Hence neither ActA-tagged Bcl2 nor wild type 
Bcl-2 protected PHGPx-deficient cells from cell death.  
 
A caspase-independent apoptosis pathway includes the translocation of cleaved 
apoptosis-inducing factor (AIF) (activation) from mitochondria to the nucleus upon 
mitochondrial outer membrane permeabilization (MOMP). Activated AIF induces 
chromatin condensation and DNA fragmentation (Modjtahedi et al., 2006; Yuste et 
al., 2005). To examine, whether AIF depletion in PFa1(flox/flox)-MerCreMer cells might 
prevent cell death, gene silencing of AIF was performed with AIF-specific siRNAs. 
Silencing of gene expression by siRNA is only transient and rapidly recovers after 
siRNA molecules are used up. Thus, the knockout of PHGPx was induced before 
siRNA transfection in the presence of α-tocopherol. Since removal of α-tocopherol 
causes rapid cell death within 24-48 hours, this time window was sufficient to explore 
the effects of siRNA-mediated knockdown of AIF. 
 
AIF expression levels were determined by immunoblotting, revealing a substantial 
reduction in AIF-12 and AIF-22 siRNA-transfected cells, whereas AIF-20 siRNA was 
rather inefficient (figure 28-A). After siRNA-treatment, cells were seeded in the 
presence and absence of α-tocopherol and the number of viable cells was 
determined 30 hours later.  
 
Control cells, supplemented with α-tocopherol, showed a weak retardation in cell 
growth after transfection with AIF siRNA, compared to control siRNA transfected 
cells. This is in line with previous findings by other groups, suggesting that AIF has 
both pro- and anti-apoptotic functions (Modjtahedi et al., 2006). Which and how these 
antagonizing mechanisms prevail under certain conditions is still unclear. Yet, AIF 
knockdown with AIF-12 and AIF-22 siRNA clearly reduced cell death in PHGPx-
deficient cells, 30 hours after the withdrawal of α-tocopherol (figure 28-B). AIF-20 
siRNA only marginally protected cells from cell death, which is in line with no 
detectable reduction of the AIF protein level. These findings demonstrate that cell 
death caused by PHGPx inactivation involves the AIF death pathway. 
  Results (PHGPx) 
 - 72 - 
 
 
 
Figure 28: AIF gene-silencing prevented cell death in PHGPx knockout cells. (A) Immunoblotting of 
PFa1(flox/flox)-MerCreMer cells, 48 hours after the transfection of AIF siRNA. (B) AIF knockdown 
significantly reduced cell death in PHGPx knockout cells. Number of viable cells was determined 30 
hours after the removal of α-tocopherol and is depicted in per cent, related to control cells. 
 
 
4.8 The physiological role of catalytically important amino acids of PHGPx 
 
In the past, some of the catalytically important amino acids of PHGPx as well as its 
biochemistry have been studied in great detail. The physiological relevance of 
specific amino acids, such as the catalytic triad (Sec46, Gln81, Trp136), the nine Cys 
residues, and some highly conserved amino acids, has remained unclear (figure 29). 
 
The amino acid sequence of PHGPx is highly conserved within mammals (>90%), 
shares significant identity with vertebrates, and homologues are even found in 
insects, plants, and yeast (figure 30-A). Of note, only PHGPx from vertebrates 
contains Sec, whereas insects, plants, and yeast express a Cys-containing 
homologue. 
 
To investigate the biological significance of Sec in the catalytic centre, two PHGPx 
mutants were generated by PCR mutagenesis in plasmid pDrive-HA-PHGPx. The 
Sec codon (UGA) at position 46 of the cytosolic protein sequence was mutated to 
Cys (UGC) and Ser (AGC), respectively. Both HA-PHGPx mutant sequences were 
cloned into the lentiviral vector p442-PL1, yielding plasmids p442-HA-PHGPx-UC 
and p442-HA-PHGPx-US. Like the reconstitution experiment with HA-tagged wild 
type PHGPx (see chapter 4.3), both mutants were introduced into PFa1(flox/flox)-
MerCreMer cells by lentiviral infection. The infection efficiency was determined by 
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FACS analysis, ranging from 79-99% (figure 31-A). No alterations in morphology or 
proliferation rates was observed in PFa1(flox/flox)-MerCreMer cells, overexpressing any 
of the HA-PHGPx mutants. 
 
 
Species:   Sequence: 
 
                            C2      C10               C28 Y32  C37      U46 
Mus_musculus               MCASRDDWRCARSMHEFSAKDIDGHMVCLDKYRGFVCIVTNVASQUGKTD 50 
Rattus_norvegicus          MCASRDDWRCARSMHEFAAKDIDGHMVCLDKYRGCVCIVTNVASQUGKTD 50 
Sus_scrofa                 MCASRDDWRCARSMHEFSAKDIDGHMVNLDKYRGYVCIVTNVASQUGKTE 50 
Bos_taurus                 MCASRDDWRCARSMHEFSAKDIDGRMVNLDKYRGHVCIVTNVASQUGKTD 50 
Homo_sapiens               MCASRDDWRCARSMHEFSAKDIDGHMVNLDKYRGFVCIVTNVASQUGKTE 50 
Gallus_gallus              MCAQADEWRSATSIYDFHARDIDGRDVSLEQYRGFVCIITNVASKUGKTA 50 
Drosophila_melanogaster    MSAN-GDYKNAASIYEFTVKDTHGNDVSLEKYKGKVVLVVNIASKCGLTK 49 
Saccharomyces_cerevisiae   ----------MSEFYKLAPVDKKGQPFPFDQLKGKVVLIVNVASKCGFTP 40 
 
                             Y53       Y63C66      C75   Q81               Y96 
Mus_musculus               VNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSN--QEIKEFAAG-YN 97 
Rattus_norvegicus          VNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSN--QEIKEFAAG-YN 97 
Sus_scrofa                 VNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSD--AEIKEFAAG-YN 97 
Bos_taurus                 VNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSN--AEIKEFAAG-YN 97 
Homo_sapiens               VNYTQLVDLHARYAECGLRILAFPCNQFGKQEPGSN--EEIKEFAAG-YN 97 
Gallus_gallus              VNYTQLVDLHARYAEKGLRILAFPCNQFGKQEPGDD--AQIKAFAEG-YG 97 
Drosophila_melanogaster    NNYEKLTDLKEKYGERGLVILNFPCNQFGSQMPEADGEAMVCHLRDS-KA 98 
Saccharomyces_cerevisiae   -QYKELEALYKRYKDEGFTIIGFPCNQFGHQEPGSD--EEIAQFCQLNYG 87 
 
                                    C107                          W136 
Mus_musculus               VKFDMYSKICVNGDDAHPLWKWMKVQPKGRGMLGN-AIKWNFTKFLIDKN 146 
Rattus_norvegicus          VRFDMYSKICVNGDDAHPLWKWMKVQPKGRGMLGN-AIKWNFTKFLIDKN 146 
Sus_scrofa                 VKFDMFSKICVNGDDAHPLWKWMKVQPKGRGMLGN-AIKWNFTKFLIDKN 146 
Bos_taurus                 VKFDLFSKICVNGDDAHPLWKWMKVQPKGRGMLGN-AIKWNFTKFLIDKN 146 
Homo_sapiens               VKFDMFSKICVNGDDAHPLWKWMKIQPKGKGILGN-AIKWNFTKFLIDKN 146 
Gallus_gallus              VKFDMFSKIEVNGDGAHPLWKWLKEQPKGRGTLGN-AIKWNFTKFLINRE 146 
Drosophila_melanogaster    DIGEVFAKVDVNGDNAAPLYKYLKAKQTG--TLGS-GIKWNFTKFLVNKE 145 
Saccharomyces_cerevisiae   VTFPIMKKIDVNGGNEDPVYKFLKSQKSG--MLGLRGIKWNFEKFLVDKK 135 
 
                            C148 Y153           C168/Y169 
Mus_musculus               GCVVKRYGPMEEPQVIEKDLPCYL---- 170 
Rattus_norvegicus          GCVVKRYGPMEEPQVIEKDLPCYL---- 170 
Sus_scrofa                 GCVVKRYGPMEEPQVIEKDLPCYL---- 170 
Bos_taurus                 GCVVKRYGPMEEPLVIEKDLPCYL---- 170 
Homo_sapiens               GCVVKRYGPMEEPLVIEKDLPHYF---- 170 
Gallus_gallus              GQVVKRYSPMEDPYVIEKDLPAYL---- 170 
Drosophila_melanogaster    GVPINRYAPTTDPMDIAKDIEKLL---- 169 
Saccharomyces_cerevisiae   GKVYERYSSLTKPSSLSETIEELLKEVE 163 
 
 
Figure 29: Sequence alignment of murine PHGPx and its homologues from other species, using 
ClustalW V1.82. Highlighted are the catalytic triad (red), consisting of Sec (U), Gln (Q), and Trp (W), 
all Cys residues (green), and particularly conserved Tyr residues (blue). The positions of all 
highlighted amino acids within the PHGPx sequence of mus musculus are indicated in detail. 
 
 
 
  Results (PHGPx) 
 - 74 - 
The expression levels of wild type PHGPx and both mutant forms were evaluated by 
immunoblotting, using the antibody α-HA-tag 3F10 (figure 30-B). While, the 
expression level of HA-tagged wild type PHGPx was similar as described in chapter 
4.3, the expression of both PHGPx mutants (Sec/Cys and Sec/Ser) was dramatically 
higher than that of wild type PHGPx (figure 30-B). 
 
 
 
 
Figure 30: (A) PHGPx protein sequence alignment (ClustalW 1.83). The PHGPx amino acid 
sequence from various species was compared with mus musculus PHGPx. (B) Western blot of 
PFa1(flox/flox)-MerCreMer cells, overexpressing wild type and mutant forms of HA-tagged PHGPx. Due 
to the strong expression of the PHGPx mutants, only 5 % of the respective protein extract was applied. 
 
 
To determine whether Cys or Ser in the catalytic site of PHGPx are able to maintain 
PHGPx function, cell viability assays were performed in cells devoid of endogenous 
PHGPx (figure 31-B). The number of viable cells was recorded until 96 hours after 
the addition of 4-hydroxytamoxifen. As described in chapter 4.3, HA-PHGPx fully 
rescued genomic PHGPx depletion. Surprisingly, the Sec to Cys mutant (HA-PHGPx-
UC) equally rescued 4-hydroxytamoxifen-treated PFa1(flox/flox)-MerCreMer cells from 
cell death. In contrast, the HA-PHGPx-US mutant was functionally inactive and did 
not compensate the loss of wild type PHGPx. These cells died at a similar rate like 
non-infected or mock-infected control cells. 
 
 
 
 
 
  Results (PHGPx) 
 - 75 - 
 
 
 
 
Figure 31: Mutational analysis of PHGPx (A) Quantification of lentiviral infection efficiency by flow 
cytometry. Cells were screened for VENUSnucmem expression on channel FL1 at 530 nm. (M1 = 
non-infected cells; M2 = infected cells). (B) Growth curves of PHGPx knockout cells, expressing 
different HA-PHGPx mutants. PHGPx deletion was induced by addition of 4-hydroxytamoxifen (Tam). 
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The substitution of Sec by Cys has been reported to decrease enzymatic activity in 
purified recombinant PHGPx protein, at least by three orders of magnitude (Maiorino 
et al., 1995). To address, whether the Sec to Cys mutant is fully functional, cells 
lacking endogenous PHGPx but expressing HA-PHGPx-UC, were exposed to pro-
oxidants (figure 32). Mock, p442-HA-PHGPx, and p442-HA-PHGPx-UC transfected 
cells were used in these experiments. The knockout of PHGPx was only induced in 
cells, expressing HA-PHGPx or HA-PHGPx-UC, since mock cells die within 48 hours. 
Hence, mock-transfected control cells still express endogenous PHGPx, whereas the 
two other cell lines express either HA-tagged wild type PHGPx or the HA-tagged 
Sec/Cys mutant. Cells were treated with increasing concentrations of H2O2 (0.1 – 1.0 
mM) and BOOH (10 – 50 µM) and the number of viable cells was assessed after 72 
hours. All three cell lines showed a dose dependent increase in cell death after 
addition of H2O2 or butylhydroperoxide (BOOH). Concentrations above 100 µM H2O2 
and 10 µM BOOH caused retarded cell growth and eventually cell death in all cell 
lines. Of note, no differences was observed between cells, overexpressing HA-
tagged wild type PHGPx and the Sec/Cys mutant, suggesting that both cell lines are 
equally resistant towards oxidative stress, at least in this system. 
 
 
 
 
Figure 32: PHGPx knockout cells, overexpressing HA-PHGPx or HA-PHGPx-UC, were equally 
resistant to oxidative stress. Infected PFa1(flox/flox)-MerCreMer cells were stressed with different 
concentrations of H2O2 and BOOH. The number of viable cells is given in per cent, related to non-
stressed cells, 72 h after the addition of stressors. PHGPx disruption was induced in indicated cell 
lines by the addition of 4-hydroxytamoxifen (Tam). 
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4.9 xCT overexpression rescues γ-GCS-deficient cells from GSH depletion 
 
GSH is the major endogenous scavenger of ROS in the cell by acting as a reducing 
equivalent for GPxs, but also constitutes a major substrate for other GSH dependent 
systems, such as glutaredoxins and glutathione-S-transferases. GSH is present in 
millimolar concentrations in the cell and has long been considered indispensable for 
cell survival. Shi et al. showed that mice with targeted deletion of the γ-GCS heavy 
subunit fail to gastrulate and die at embryonic day 7.5. Isolated ES cell like cells from 
γ-GCS-deficient blastocysts, however, grew indefinitely in GSH-free medium, when 
supplemented with NAC (Shi et al., 2000). γ-GCS knockout cells were used in this 
work, to investigate the importance of GSH for cell survival and proliferation, and to 
address the functional relationship between the (Cys)2/Cys redox cycle and the GSH-
dependent system. 
 
γ-GCS-deficient ES cell like cells were obtained from Michel W. Lieberman, Houston, 
Texas (Shi et al., 2000) and were adapted to DMEM standard cell culture medium, 
supplemented with NAC (chapter 3.1.2). Cells proliferated rapidly but proved to be 
highly sensitive towards seeding at low cell density and trypsinization. Hence, cells 
were detached by pipetting up and down and passaging was performed every 48-72 
hours at a ratio of only 1:3. 
 
To verify previously described features of γ-GCS knockout cells in our cell culture 
system, cells were supplemented with various antioxidants. As described by Shi et 
al., NAC (5 mM) and GSH (2.5 mM) efficiently protected cells from cell death, 
whereas the lipophilic antioxidant α-tocopherol did not have any protective effect 
(figure 33-A). Also glutathione ethyl ester (GSH-EE) (2.5 mM) efficiently rescued γ-
GCS-deficient cells from cell death. 
 
Since NAC supplementation efficiently protects γ-GCS-deficient cells from cell death, 
overexpression of xCT, the substrate specific subunit of (Cys)2/Glu antiporter system 
xc-, was envisaged a genetic mechanism that may rescue γ-GCS knockout cells from 
cell death. System xc- was supposed to increase cellular (Cys)2-uptake capacity, 
causing increased cellular Cys levels after reduction of (Cys)2 within the cell. To test 
this hypothesis, cells were transfected with pCAG-3SIP, pCAG-3SIP-eGFP, and 
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pCAG-3SIP-xCT, respectively (figure 33-B). pCAG-3SIP based vectors comprise a 
strong CMV-chicken β-actin promoter and an IRES-puromycin N-acetyltransferase 
cassette for coordinated gene expression. This enables a strong and stable 
expression of the gene of interest by puromycin selection. 
 
Antibiotic selection with 1 µM puromycin led to outgrowth of single cell clones, which 
were individually isolated and expanded gradually. Puromycin selection was highly 
efficient, as observed in pCAG-3SIP-eGFP transfected cells by fluorescence 
microscopy (figure 33-C) and FACS analysis (figure 33-D). Less than 1 % of pCAG-
3SIP-eGFP transfected cells stained negative on channel FL1 after puromycin 
selection. For further studies, one mock-transfected clone (mock), one eGFP-
transfected (eGFP) clone, and two independently outgrowing xCT-transfected clones 
(xCT-5 and xCT-7) were used. 
 
Due to the lack of functional antibodies against xCT, transfected cells were assayed 
for xCT-transcription by Northern blot and quantitative RT-PCR. Northern blot 
hybridisation signals were obtained in both xCT-transfected clones, corresponding to 
the bicistronic xCT-IRES-puromycin mRNA sequence of 2.7 kb (figure 33-E). By 
contrast, no hybridisation signals were detectable in mock- and eGFP-transfected 
control cells. 
 
Quantitative RT-PCR was performed with primers xCT for1/rev1 and aldolase A/B for 
the normalisation of xCT expression levels. xCT cDNA was detected in clones xCT-5 
and xCT-7 with crossing points at 21.54 and 23.02 cycles, respectively (data not 
shown). When normalized to aldolase, clone xCT-5 had approximately 8-fold higher 
xCT cDNA levels than clone xCT-7 (compare Northern blot). No xCT amplification 
signals were detected until cycle 50 in both control-transfected cell lines, indicating 
that xCT expression is virtually absent in the parental and the control cell lines. 
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Figure 33: xCT overexpression in γ-GCS-deficient cells. (A) Growth curves of γ-GCS-deficient cells, 
supplemented with various antioxidants (5 mM NAC, 2.5 mM GSH, 250 µM α-tocopherol (Toc)). (B) 
Schematic representation of the bicistronic expression vectors, used for stable expression of xCT or 
eGFP. (C) Fluorescence microscopy of pCAG-3SIP-eGFP transfected  cells after three weeks of 
puromycin selection. (D) FACS analysis of eGFP-expressing cells after puromycin selection. (E) 
Northern blot with isolated mRNA from transfected γ-GCS knockout cells. 
 
 
All γ-GCS-deficient cell lines were routinely maintained in medium supplemented with 
5 mM NAC. To test xCT-transfected cells for their capability to survive in the absence 
of antioxidant supplements, cells were seeded in Standard DMEM without antioxidant 
supplements and cell growth was monitored for 48 hours. Mock and eGFP 
transfected cells died rapidly in the absence of NAC within 24 to 48 hours after 
seeding. Of note, a significant amount of control cells did not even adhere to the cell 
culture dish. xCT-transfected γ-GCS-deficient cells, however, grew until confluence 
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without showing any impairment in morphology or proliferation. xCT-overexpressing 
cells could be cultivated indefinitely in cell culture medium, lacking NAC or other 
antioxidant supplements (figure 34 and 37-A). 
 
 
 
 
Figure 34: Phase contrast microscopy of transfected γ-GCS-deficient cells, in the absence of 
antioxidants. pCAG-3SIP- and pCAG-3-SIP-eGFP-transfected cells died within 24-48 hours. xCT 
overexpressing γ-GCS knockout cells survive in the absence of antioxidant supplements. 
 
 
Cell death was assessed by PI staining and FACS analysis in control- and xCT-
transfected γ-GCS knockout cells (figure 35). No increase of PI-positive cells was 
detected in xCT-overexpressing cells, whereas a vast majority of control cells stained 
PI-positive, already 24 hours after NAC depletion. Moreover, cell death was 
accompanied by an increase of intracellular ROS, as demonstrated by DCF staining. 
Whether increased levels of intracellular ROS trigger or just coincide with cell death 
could not be determined, due to the extremely fast kinetic of cell death after NAC 
withdrawal. 
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Figure 35: CM-H2DCFDA and PI staining of transfected γ-GCS-deficient cells, depleted from NAC for 
24 hours. 
 
GSH has long been considered as an indispensable player for many cellular 
processes. It was thus barely conceivable that minute amounts of GSH, synthesized 
in  γ-GCS-deficient cells, may functionally cooperate with xCT overexpression to 
allow cell survival and proliferation. Since γ-GCS-deficient cells derive from 
transgenic mice that were designed such that a PGK-hrpt cassette of the targeting 
vector replaced only exon 1 of γ-GCS in AB2.1 embryonic stem cells, it could not be 
ruled out that a residual  γ-GCS activity may cause the synthesis of small amounts of 
intracellular GSH. To exclude residual γ-GCS activity that may contribute to cell 
survival, γ-GCS(-/-) cells were treated with high concentrations of BSO, a highly 
specific and potent γ-GCS inhibitor. Cells could be treated with up to 1 mM BSO, 
which did not impact survival or proliferation (figure 36-A). Of note, cells could be 
cultivated in the presence of BSO (1 mM) for more than 10 passages, without 
showing any impairment of proliferation (figure 36-B). Of note, MEFs and other cell 
lines used in our lab, die at BSO concentrations as low as 10-50 µM. These findings 
provide evidence that γ-GCS knockout cells do not have residual γ-GCS activity, 
which might have contributed to cell survival under non-permissive conditions. 
 
An alternative source of GSH is the γ-glutamyl transpeptidase (GGT) pathway. GGT 
cleaves extracellular GSH to γ-Glu-Cys/(Cys)2, which may theoretically lead to a γ-
GCS-independent recycling of GSH within the cell. To examine whether this GGT-
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mediated salvage pathway may contribute to GSH synthesis, xCT-overexpressing γ-
GCS knockout cells were treated with increasing concentrations of acivicin (figure 36-
C). Acivicin is a general inhibitor of amidotransferases, frequently used to inhibit 
GGT. xCT-overexpressing cells were used in this experiment, since they could be 
cultivated in the absence of NAC, GSH, GSH-EE or any other antioxidant. GSH-EE 
supplemented control cells were used to discriminate between effects possibly 
arising from acivicin-mediated GSH depletion and unspecific toxic side effects. Cells 
supplemented with GSH-EE grew significantly faster than non-supplemented cells, 
but the addition of acivicin affected both cell lines in a an equal manner. Acivicin 
concentrations above 0.5 µM reduced cell viability in both cell lines, independently of 
GSH-EE. Lower acivicin concentrations, however, did not have any effect on γ-GCS-
deficient cells, supplemented with or without GSH-EE. Since no increased 
susceptibility to acivicin was observed, it must be concluded that the GGT salvage 
pathway does not significantly contribute to cell survival in γ-GCS knockout cells. 
 
 
 
Figure 36: Evaluation of a putative residual GSH biosynthesis in γ-GCS knockout cells. (A) Cell 
survival of γ-GCS-deficient cells after BSO treatment. The number of viable cells was determined 72 
hours after the addition of BSO. (B) Phase contrast microscopy of BSO-treated (1 mM) γ-GCS 
knockout cells after 10 passages. (C) Relative number of viable cells (clone xCT-5), 48 hours after 
acivicin treatment. 
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Intracellular GSH levels were measured by HPLC in xCT- and control-transfected 
cells and in the embryonic stem cell line E14 as a positive control. No significant 
levels of intracellular GSH were detected in all γ-GCS knockout cell lines. E14 control 
cells, however, had significantly higher levels of GSH (~ 2 nmol/mg) (figure 37-B). 
 
 
 
Figure 37: (A) Growth curves of mock- and xCT-transfected γ-GCS-deficient cells, in the absence of 
thiol-containing supplements, such as NAC and GSH. (B) Determination of intracellular GSH levels in 
transfected γ-GCS knockout and murine wild type ES cells (E14) by HPLC. No significant levels of 
GSH were detectable in γ-GCS knockout cells. (C) (Cys)2 uptake activity of mock- and xCT-transfected 
cells. (D) Measurement of intracellular Cys levels in transfected γ-GCS knockout cells by HPLC. 
 
The (Cys)2 uptake capacity was measured in mock-transfected cells and clone xCT-5 
with radioactively labelled L-[14C(U)] (Cys)2. 2.5 mM glutamate was used as specific 
inhibitor of system xc--mediated (Cys)2 uptake. xCT-overexpressing cells had a (Cys)2 
uptake capacity of 0.8 nmol/min/mg, which could be entirely inhibited by the addition 
of glutamate. Mock-transfected cells had a significantly lower (Cys)2 uptake capacity 
of approximately 0.1 nmol/min/mg, which was unaffected by the addition of glutamate 
(figure 37-C). Hence, the (Cys)2 uptake capacity increased approximately 8-fold upon 
overexpression of xCT in γ-GCS knockout cells (clone xCT-5). 
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Intracellular Cys levels were measured by HPLC in control- and xCT-transfected 
cells. Yet, despite an 8-fold increase of (Cys)2-uptake capacity, only a marginal 
increase of intracellular Cys was detected in xCT-overexpressing cells (figure 37-D). 
 
This alleged discrepancy was resolved by the determination of extracellular total 
mercaptans and Cys in particular. Extracellular total mercaptans were quantified in 
control and xCT-transfected cells by DTNB staining (figure 38). Cells were incubated 
in DMEM without FCS. Medium was recovered at different time points and subjected 
to DTNB staining. The levels of extracellular total mercaptans increased dramatically 
(up to 250 µM) in xCT-overexpressing cells. Extracellular total mercaptans in control 
cells were unaltered after 100 min of incubation, resembling the status of fresh 
DMEM (figure 38-A). Incubation of cells in (Cys)2-free DMEM* was performed to 
address if the increase in extracellular mercaptans was indeed caused by augmented 
(Cys)2 uptake and subsequent secretion of reduced Cys (figure 38-B). Even after 90 
min of incubation, no increase of extracellular total mercaptans could be detected in 
any cell line incubated in (Cys)2-free DMEM*. These findings highlight (Cys)2 as the 
major, if not the only, source of free SH-groups in the cell culture medium of xCT-
overexpressing γ-GCS knockout cells. 
 
 
Figure 38: Determination of extracellular total mercaptans in xCT-overexpressing cells. (A) 
Extracellular total mercaptans (free SH-groups) in transfected γ-GCS-deficient cells. (B) Extracellular 
total mercaptans after 90 min of incubation in DMEM and (Cys)2-deficient DMEM*, respectively.  
 
To prove whether Cys is the major mercaptan secreted into the extracellular space, 
Cys levels were measured directly by HPLC in control- and xCT-transfected γ-GCS 
knockout cells after 90 min of incubation in FCS-free DMEM. High extracellular levels 
of approximately 200 µM Cys were detected in both xCT-overexpressing clones, 
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whereas only marginal amounts were found in control cells (figure 39-A/B). These 
findings perfectly fit to the results obtained by the quantification of total mercaptan. Of 
note, intra- and extracellular Cys levels can be directly compared despite different 
units, since cell extracts contained approximately 1 mg protein per ml. Thus, 
intracellular Cys levels of xCT-overexpressing cells are stable and remain rather low 
(~ 5 nmol/mg) in contrast to the strong increase of extracellular Cys that reaches at 
least 200 nmol/ml (figure 39-B/C). DMEM contains 200 µM (Cys)2, which equals 400 
µM Cys in a fully reduced state, hence, xCT-overexpressing cells reduce within 90 
min at least half of the extracellular (Cys)2-pool to Cys. 
 
 
Figure 39: Intra- and extracellular Cys levels of control and xCT-transfected γ-GCS knockout cells. 
(A/B) HPLC analysis of extracellular Cys levels (C) HPLC analysis of intracellular Cys levels. 
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Since the overexpression of xCT caused a drastic elevation of extracellular but not 
intracellular Cys levels, xCT-overexpressing cells were hypothesized to protect 
control cells from cell death in the absence of any antioxidant supplement, if 
cultivated in coculture. To this end, clone xCT-7 and eGFP-transfected γ-GCS 
knockout cells were seeded in equal amounts, supplemented with or without GSH, 
and the survival rate of eGFP-control cells was monitored by FACS analysis. After 72 
hours, the ratio of xCT- and eGFP-overexpressing cells was unaltered even in the 
absence of GSH. The heterogeneous coculture maintained a stable ratio of 50 % 
xCT and 50 % eGFP-expressing cells (figure 40), demonstrating that xCT-
overexpressing cells act in a feeder-like manner and provide Cys to eGFP-
transfected cells. Of note, eGFP-transfected cell cultures died in the absence of 
GSH, and thus could not be assayed by FACS analysis. 
 
 
 
Figure 40: Coculture of eGFP- and xCT-overexpressing γ-GCS knockout cells. (A) FACS analysis of 
cells, 72 hours after GSH depletion. (B) Fluorescence microscopy of cocultured cells, 72 hours after 
GSH depletion. 
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5 Discussion 
 
5.1 PHGPx regulates cell death via a cascade of events, including 15-LOX 
activation, lipid peroxidation, and AIF translocation. 
 
The accumulation of detrimental amounts of oxygen derived free radicals in cells and 
tissues have been frequently linked with acute and chronic degenerative disorders, 
such as atherosclerosis, myocardial infarction, stroke, and neuronal disorders, such 
as Alzheimer’s and Parkinson’s disease. This work describes a comprehensive 
model of cellular degeneration, triggered by the deregulation of the cellular redox 
balance. It has been shown that PHGPx abolition triggers a cascade of events, 
including the deregulation of 15-LOX activity, the lipid peroxidation of biological 
membranes, and AIF-mediated apoptosis. While individual events of this cascade 
have been studied in the past, strong evidence for a functional relationship between 
sensing and transducing oxidative stress in a distinctive cell death inducing pathway 
can now be provided by the results obtained during these studies. 
 
A variety of enzymatic and non-enzymatic scavenger systems exist in cells that 
maintain the cellular redox balance. PHGPx is regarded as one of the key redox 
enzymes within the cell, efficiently protecting biomembranes from lipid peroxidation 
(Ursini et al., 1982). While its biochemical traits have been analysed to some extent, 
its physiological role in cells and tissues has remained widely enigmatic. This is 
largely due to the early embryonic death of PHGPx null embryos, the expression of 
three distinct forms of PHGPx, and to the lack of suitable in vivo as well as ex vivo 
systems. 
 
PHGPx null mice die already at gestational day E7.5 (Imai et al., 2003; Yant et al., 
2003). So far, no knockout data are available linking a distinct selenoprotein other 
than PHGPx to such an early embryonic lethal phenotype. Only mice lacking any of 
the 24 selenoproteins, achieved by targeted removal of the gene encoding the 
selenocysteine-specific tRNA, fail to develop beyond E6.5 (Bosl et al., 1997). This 
strongly argues for PHGPx being indeed one of the most important selenoenzymes, 
which is also reflected by its high position in the hierarchy of selenoproteins. 
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To assess the physiological significance of PHGPx in life and death decisions, tissue 
development and tissue homeostasis, mice with a non-functional PHGPx were 
generated by Marcus Conrad (Conrad Marcus, PhD thesis, 2001). To bypass the 
early embryonic lethality of PHGPx deficient mice, the Cre/loxP system was used to 
create mice with conditional abolition of PHGPx expression.  
 
Since early embryonic lethality impedes further in-depth studies on the molecular and 
cellular functions of PHGPx, the conditional PHGPx knockout mice were used to 
create a tamoxifen-inducible ex vivo system, including transgenic PHGPx(flox/flox) and 
PHGPx(wt/flox) MEF cell lines. In this system, 4-hydroxytamoxifen-mediated activation 
of MerCreMer (Verrou et al., 1999) caused a rapid decrease of endogenous PHGPx 
transcripts within 24 hours, followed by efficient depletion of cellular PHGPx protein 
levels. PHGPx inactivation caused massive cell death, 48 hours after tamoxifen 
administration. Thus, PHGPx is not only required for early murine development (Imai 
et al., 2003; Yant et al., 2003) but also for cell survival in ex vivo cultured MEFs. The 
heterozygous cell line PFa37(wt/flox) showed a short period of retarded cell growth just 
after Cre-mediated disruption of the floxed PHGPx allele, but eventually recovered 
and could be cultivated indefinitely in cell culture. Hence, the loss of one PHGPx 
allele appears to be compensated by either the upregulation of PHGPx expression 
from the remaining PHGPx wild type allele or by the upregulation of enzymes with 
related activity, such as other GPxs, in this cellular system. Yant et al., however, 
reported that heterozygous knockout cells derived from PHGPx(wt/-) mice express 
reduced PHGPx levels and are more sensitive to oxidative stress (Yant et al., 2003), 
indicating that the lack of one PHGPx allele can not be fully compensated. This 
alleged discrepancy may be resolved by applying more provocative stress conditions 
to the heterozygous cell lines. 
 
To confirm that the specific loss of PHGPx is causally linked to cell death and not due 
to potential toxic side effects of Cre activity or 4-hydroxytamoxifen itself, a highly 
efficient lentiviral system for PHGPx reconstitution was established. The add-back of 
exogenous wild type PHGPx fully rescued the effects caused by the depletion of 
endogenous PHGPx expression, corroborating that cell death can be unequivocally 
attributed to PHGPx abolition and not to unspecific toxic side effects.  
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Previous studies on PHGPx mainly involved heterozygous PHGPx knockout cells 
(PHGPx(wt/-)) (Yant et al., 2003), overexpression of PHGPx (Imai et al., 1996; Nomura 
et al., 1999; Shidoji et al., 2006), and indirect inactivation of PHGPx by either Se 
depletion (Weitzel and Wendel, 1993) or inhibition of GSH biosynthesis (Jakobsson 
et al., 1992). This cellular system yields for the first time an inducible ex vivo 
knockout model for PHGPx, allowing efficient abolition of PHGPx expression in cell 
culture. Hence, this unique in vitro system proved to be most advantageous for the 
investigation of the molecular and cellular mechanisms of PHGPx in cell fate 
decisions. 
 
After PHGPx inactivation, lipid peroxidation was observed as the first event of a 
cascade, eventually leading to cell death. Lipid peroxidation clearly preceded the 
accumulation of soluble ROS and the onset of cell death. This finding supports earlier 
reports in which PHGPx was characterized as an enzyme, efficiently protecting 
membranous compartments from detrimental peroxidation (Thomas et al., 1990; 
Ursini et al., 1982). Interestingly, very low concentrations of the lipophilic antioxidant 
α-tocopherol fully prevented the increase of intracellular peroxides and cell death in 
PHGPx knockout MEFs, whereas all other tested antioxidant supplements had only 
marginal or no effects. This finding underpins the enzymatic function of PHGPx in the 
protection of biological membranes from lipid peroxidation, yet the fact that α-
tocopherol efficiently substituted PHGPx expression is surprising. Previous studies 
indicated that the protection against microsomal lipid peroxidation requires a 
functional cooperation between vitamin E and PHGPx (Maiorino et al., 1989), and 
that dietary vitamin E impacts PHGPx expression (Bourre et al., 2000; Lei et al., 
1997). Our data, however, show that even minor amounts of vitamin E by themselves 
are sufficient to replace PHGPx activity in vitro. This finding may turn out to be of 
major importance, in particular for in vivo experiments using PHGPx knockout mice. 
Since laboratory animals are generally maintained on a vitamin E fortified diet, some 
phenotypes of tissue-specific PHGPx knockout mice might be hidden by supra-
nutritional amounts of vitamin E. 
 
Vitamin E, the generic term for tocopherol, is an essential antioxidant of which 
different isomers exist. α-tocopherol has been shown to be the most reactive isoform 
in humans. Tocopherols consist of a chromanol ring that provides a hydrogen atom 
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for the reduction of free radicals. The lipophilic side chain of vitamin E enables the 
intercalation into biological membranes, enabling an efficient protection from lipid 
peroxidation in membranes. Vitamin E is discussed to delay the development of 
coronary heart diseases, cancer, and neurodegenerative disorders, such as 
Alzheimer’s disease (Grundman, 2000) and Parkinson’s disease (Bier, 2006), by its 
antioxidant properties. Nevertheless, results obtained from increased dietary vitamin 
E intake in humans provided a controversial picture and need further investigation 
with the focus on long-term clinical trials. Very recently, a meta-analysis on mortality 
of antioxidant supplements for primary and secondary prevention suggests that 
vitamin E may even increase mortality (Bjelakovic et al., 2007). Yet, vitamin E has 
been demonstrated to protect cortical and hippocampal neurons in vitro from cerebral 
ischemia and reperfusion induced detriment (Tagami et al., 1999; Tagami et al., 
1998). Moreover, Pratico et al. showed that the oral administration of vitamin E 
diminished aortic lesions in apolipoprotein E-deficient mice, an in vivo model for 
atherosclerosis, probably by preventing the oxidation of low density lipoprotein (LDL) 
(Pratico et al., 1998). Of note, 15-LOX is expressed in atherosclerotic lesions and 
has been implicated in the oxidation of LDL during atherogenesis. Interestingly, 
apolipoprotein E and 15-LOX compound knockout mice display strongly reduced lipid 
peroxidation and atherogenesis compared to apolipoprotein E null mice, indicating a 
functional linkage between the administration of vitamin E and 15-LOX-deficiency 
(Cyrus et al., 2001; Zhao et al., 2005). 
 
Since lipid peroxidation emerged as the major cell death-inducing event that could be 
efficiently prevented by α-tocopherol supplementation, it was hypothesized that lipid 
peroxidation may be provoked by altered lipoxygenase and/or cyclooxygenase 
activities. Interestingly, when grown to confluency, PHGPx knockout cells did not 
require functional PHGPx, suggesting that the lipid peroxidation is caused by 
endogenous sources that are only active in proliferating cells. Moreover, PHGPx has 
been previously reported to antagonize LOX and COX activities (Huang et al., 1999). 
Thus, intermediate hydroperoxyl-metabolites of LOXs and/or COXs, such as PGG2, 
HPETE, and HPODE, were considered as a major source of lipid-associated ROS 
production in PHGPx-deficient cells. 
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Incubation of PHGPx knockout cells with arachidonic acid, the common and main 
substrate of LOXs and COXs, clearly accelerated cell death, indicating a direct link 
between PHGPx and arachidonic acid metabolism in this system. To investigate the 
individual contribution of oxygenases to cell death upon PHGPx abolition, knockout 
cells were treated with a variety of LOX and COX inhibitors. In fact, various LOX 
inhibitors rescued PHGPx-deficient cells. Yet, it must be taken into account that 
many LOX inhibitors have been reported to harbour antioxidant properties, such as 
NDGA (Shappell et al., 1990), ETYA (Takami et al., 2000), baicalein, and caffeic acid 
(Dailey and Imming, 1999). The antioxidant activity of these inhibitors may protect 
PHGPx-deficient cells by directly scavenging peroxides rather than by a specific 
inhibition of LOX activity. PD146176, however, is a specific 15-LOX inhibitor without 
showing any significant antioxidant activity (Sendobry et al., 1997). Thus, the highly 
efficient rescue of PHGPx knockout cells by PD146176 implies a major contribution 
of 15-LOX to this cell death-inducing pathway. Besides PD146176, some 15-LOX 
inhibitors protected PHGPx-deficient cells from cell death, whereas most other 
inhibitors were rather ineffective, despite the expression of 5-LOX, 12-LOX, 15-LOX, 
COX1, and COX2 in this cellular system. These findings strongly argue for a 
deregulated activity of 15-LOX, rather than of other LOXs or COXs, triggering a lipid 
peroxidation cascade, which finally leads to cell death in PHGPx-deficient MEFs. 
This is in line with findings, implicating 15-LOX in the pathophysiology of various 
degenerative diseases, such as atherosclerosis (Cyrus et al., 2001; Pratico et al., 
1998) and many neuronal disorders (Grundman, 2000; Khanna et al., 2003; Tagami 
et al., 1999). Initially, Li et al. showed that inhibition of the arachidonic acid 
metabolism by various LOX inhibitors protects cortical neurons from GSH depletion 
(Li et al., 1997). Neurons isolated from 15-LOX-deficient mice are resistant to Glu-
induced cell death, indicating a critical impact of 15-LOX on oxidative stress-induced 
neuronal death (Khanna et al., 2003). The inhibition of (Cys)2-uptake by high 
concentrations of extracellular Glu is an established model for the investigation of 
oxidative stress (Murphy et al., 1990; Tan et al., 1998). Besides this non-receptor-
mediated Glu toxicity, however, also a receptor-mediated excitotoxicity of Glu is 
discussed (Choi, 1990). Moreover, the 15-LOX inhibitor baicalein has been shown to 
protect neurons from ischemia/reperfusion injury, to an extent which is similar to that 
observed after transient experimental stroke in the brain of 15-LOX knockout mice 
(van Leyen et al., 2006). Interestingly, a cellular model system for oxidative stress, 
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including Se-deficient bovine aortic endothelial cells, showed apoptosis via a strong 
increase of 15-LOX activity and 15-HPETE production (Sordillo et al., 2005), which 
may be attributed to reduced PHGPx expression. 
 
Still, it can not be concluded from these results that the abolition of PHGPx does not 
affect the activity of other oxygenases, in particular in other cells and tissues. The 
severe consequences of an aberrant 15-LOX activity may mask less dramatic effects 
of PHGPx inactivation towards other LOXs and COXs, at least in this cellular system. 
This would be in agreement with previous studies, where a rather general role for 
PHGPx in controlling LOX and COX activities has been documented Chen et al., 
2002, 2003; Imai et al., 1998; Sakamoto et al., 2000). 
 
To underpin the importance of 15-LOX for this cellular system, arachidonic acid 
metabolites were quantified by HPLC. However, only low levels of HETE/HPETE and 
no substantial accumulation of these intermediate metabolites in PHGPx null cells 
could be detected. Likewise, virtually no LTB4 was released from these cells. The 
lack of LTB4 after the activation of the arachidonic acid metabolism in MEFs suggests 
that despite its expression, only a minor amount of 5-LOX is active in this cell system. 
This finding also elucidates why 5-LOX inhibitors did not protect PHGPx-deficient 
cells from cell death, although 5-LOX activity has been frequently linked to the 
generation of oxidative stress, e.g. during ischemia/reperfusion in the brain of 5-LOX 
knockout mice (Patel et al., 2004). The detection of only marginal amounts of 
HPETEs may reflect a short half life of the generated HPETE isoforms, which are 
rapidly metabolized to leukotrienes, hepoxilins, and lipoxins. However, 15-LOX also 
accepts linoleic acid as a substrate, catalyzing the production of 13-HODE via a 13-
HPODE intermediate. Hence, the biosynthesis of HODE/HPODE from linoleic acid is 
an alternative peroxide source, which may account for lipid peroxidation. Of note, 13-
HODE has been demonstrated to induce apoptosis by decreasing the activation of 
the transcription factor peroxisome proliferator-activated receptor (PPAR)-delta in 
colorectal cancer cells (Shureiqi et al., 2003; Zuo et al., 2006), indicating a functional 
link between the LOX metabolism and programmed cell death. 
 
The increase of lipid peroxidation, which is mediated by the deregulation of 15-LOX 
in PHGPx deficient MEFs, is generally considered as a potent mediator of apoptosis 
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via the mitochondrial death pathway (Buttke and Sandstrom, 1994; Kagan et al., 
2005; Sarafian and Bredesen, 1994). Moreover, the generation of 15-HPETE has 
been previously reported to induce apoptosis in bovine aortic endothelial cells 
(Sordillo et al., 2005). Hence, apoptosis rather then necrosis was considered as the 
mechanism of cell death in PHGPx-deficient cells. Most apoptotic processes involve 
the disruption of the mitochondrial inner transmembrane potential (Δψ) and an 
increase of the inner mitochondrial membrane permeability, the so called 
permeability transition (Bernardi et al., 1999; Loeffler and Kroemer, 2000), causing 
the release of proteins required for the execution of cell death, such as cytochrome c 
and AIF (Susin et al., 1999). The classical model of the mitochondrial death pathway 
involves several pro- and anti-apoptotic Bcl-2 family members, which mediate the 
mitochondrial permeability transition upon a stress signal. Released cytochrome c 
forms apoptosomes by aggregating with the apoptotic protease activating factor-1 
(APAF-1). The apoptosomes cleave procaspase-9 to release activated caspase-9, 
triggering a proteolytic cascade that involves caspase-3 activation and further 
downstream effects. First indications that PHGPx-deficient cells undergo a form of 
apoptosis were obtained from time-lapse videos, showing stereotypical 
morphological changes, such as shrinking, deformation, loss of intercellular contacts, 
and detachment from the cell culture dish. 
 
Oxidative stress induced apoptosis has been previously reported to be prevented in 
cells overexpressing Bcl-2 (Hockenbery et al., 1993; Kane et al., 1993; Reed, 1998), 
by blocking cytochrome c release from the mitochondria, possibly through the 
inhibition of the pro-apoptotic Bcl-2 family members Bax and Bak. In this respect, the 
anti-apoptotic molecule Bcl-2 was overexpressed in PHGPx knockout cells. In the 
present system, the overexpression of Bcl-2 or Bcl-2-ActA, including a mitochondrial 
insertion sequence, did not protect PHGPx-deficient cells from cell death. These 
findings indicate that Bcl-2 is not involved in the cell death process, triggered by 
PHGPx depletion, at least in this system. This correlates with previous reports 
showing that Bcl-2 did not protect Burkitt’s lymphoma cells from oxidative stress (Lee 
and Shacter, 1997) as well as A3.01 human T cells from 15-HPETE and 13-HPODE 
induced apoptosis (Sandstrom et al., 1995). The discrepancy between studies, 
reporting that Bcl-2 did or did not protect from oxidative stress, may be due to the fact 
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that different forms of ROS induce apoptosis via diverse apoptosis inducing 
pathways, which may also differ between various cell types. 
 
A caspase-independent model of mitochondrial apoptosis involves the flavoprotein 
AIF. In healthy cells, AIF is located in the mitochondrial intermembranous space or at 
the inner membrane of mitochondria, where it exerts vital functions as a redox-active 
enzyme with putative antioxidant activity (Klein and Ackerman, 2003; Lipton and 
Bossy-Wetzel, 2002). Upon activation, AIF is released from mitochondria and 
translocates to the nucleus, where it induces chromatin condensation and DNA 
degradation (Daugas et al., 2000). Thus, AIF comprises a dual role, either as an anti-
apoptotic redox-active enzyme or as a pro-apoptotic mediator of DNA fragmentation. 
Interestingly, AIF-mediated apoptosis has been implicated in ischemia/reperfusion 
injury (Cao et al., 2003; van Wijk and Hageman, 2005), indicating a direct link 
between oxidative stress and AIF release. Due to the described pro-apoptotic 
properties upon oxidative stress, AIF downregulation was considered to prevent cell 
death in PHGPx-deficient cells. It could be shown that the siRNA-knockdown of AIF 
efficiently protected MEFs from cell death, induced by PHGPx depletion. This is in 
line with a previous study, showing that increased lipid peroxidation indeed induces 
the disruption of Δψ and permeability transition (Marchetti et al., 1997), causing 
intrinsic apoptosis via the mitochondrial death pathway. Nevertheless, the findings by 
Marchetti et al. left open how lipid peroxidation is triggered and what are the 
upstream components, sensing and transducing oxidative stress in a cellular 
response. 
 
Inducible PHGPx disruption allowed the dissection of a distinctive pathway, including 
deregulation of 15-LOX activity, lipid peroxidation, and eventually AIF-mediated 
apoptosis. In the presented in vitro system, the process of lipid peroxidation seems to 
bypass the Bcl-2-dependent activation of the mitochondrial death pathway by directly 
releasing AIF. This finding is in agreement with studies by Arnoult et al., 
demonstrating that the pro-apoptotic Bcl-2 family member Bax triggers the release of 
cytochrom c, but not of AIF (Arnoult et al., 2002), indicating an independent 
regulation of the two death pathways. Yet, it is still not understood how apoptosis is 
mediated via AIF activation. Yu et al. demonstrated that the activation of poly(ADP-
ribose) polymerase-1 (PARP-1) is required for AIF translocation in a caspase-
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independent manner (Yu et al., 2002). PARP-1 is involved in the DNA repair 
mechanism of the cell, but also acts as a mediator of cell death after 
ischemia/reperfusion injury, glutamate toxicity, and various inflammatory processes 
(van Wijk and Hageman, 2005). Recently, it has been shown that only severe 
oxidative stress activates the pro-apoptotic function of PARP-1 (Diaz-Hernandez et 
al., 2007). Thus, PARP-1 mediated AIF translocation may be a common signature of 
degenerative disorders that are induced by the accumulation of ROS. Interestingly, 
heat shock protein 70 has been reported to inhibit apoptosis not only by preventing 
the apoptosome assembly, but also by binding to AIF (Lui and Kong, 2007; 
Ravagnan et al., 2001). Final proof of an exclusively AIF-mediated apoptosis of 
PHGPx-deficient cells is still lacking. Further studies are required to address the role 
of other pro- and anti-apoptotic members in PHGPx knockout cells. In this respect, 
cytochrome c release, breakdown of Δψ, and caspase activation are important 
hallmarks that need further investigation. The impact of various caspases will be 
addressed by using a set of caspase inhibitors with different specificity for various 
caspase family members. 
 
Taken together, this work elucidates a cascade of events causing cell death upon 
PHGPx depletion in primary MEFs (figure 41). PHGPx abolition leads to the 
activation of 15-LOX, which causes a detrimental increase of lipid-associated 
hydroperoxides inside the cell. The increase of cellular hydroperoxides causes an 
autocatalytic chain reaction of lipid peroxidation which severely damages 
biomembranes, most likely including the mitochondrial membrane. The disruption of 
the mitochondrial membrane probably initiates the breakdown of the mitochondrial 
membrane potential Δψ, followed by permeability transition and AIF release. The 
process of caspase-independent apoptosis is characterized by the translocation of 
AIF to the nucleus, where it mediates chromatin condensation and DNA degradation. 
Whether the release of AIF is supported or even induced by PARP activation due to 
DNA damage is still unclear. Eventually, the PHGPx knockout in MEFs causes 
massive cell death.  
 
This cascade of events may be a common signature of various degenerative 
disorders that include a severe insult by oxidative stress, which inevitably leads to 
GSH depletion. A detrimental increase of ROS levels is a general characteristic of 
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acute and chronic inflammation processes, observed in atherosclerosis, arthritis, 
diabetes, Alzheimer’s and Parkinson’s disease, but also myocardial infarction and 
stroke coincides with massive oxidative stress during reperfusion. Therefore, this 
inducible PHGPx knockout model may prove extremely useful to gain deeper insights 
into the molecular mechanisms of uncontrolled cell death in the etiology of complex 
human disorders. 
 
 
Figure 41: Proposed mechanism of cell death, initiated by PHGPx depletion in MEFs. PHGPx controls 
the 15-LOX activity by regulating the cellular peroxide tone. After the depletion of PHGPx, augmented 
15-LOX activity most likely causes an accumulation of cellular HPETE and HPODE levels, which lead 
to rapid non-specific lipid peroxidation, followed by AIF release and massive cell death. At various 
steps, this cell death inducing cascade can be disrupted, including inhibitors against 15-LOX, lipophilic 
antioxidants, or AIF silencing. 
 
 
5.2 Mutational analysis of PHGPx revealed functional interchangeability of Sec 
with Cys: a model to study a putative redox sensor function of PHGPx 
 
In mammals, the overall homology of PHGPx compared with the other Sec-
containing GPxs is less than 40 %, yet they share conserved motifs that include the 
catalytic triad of Sec, Gln and Trp. This conserved triad forms a catalytic centre in 
which the selenol group of Sec is stabilized and activated by hydrogen bonds 
provided by the Gln and Trp residues (Maiorino et al., 1995). An initial mutational and 
biochemical approach by Maiorino et al. revealed that the conversion of Sec to Cys 
causes a marked decrease of PHGPx activity by about three orders of magnitude in 
the recombinant protein (Maiorino et al., 1995). Also mutations of Gln and Trp of the 
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catalytic triad reduced PHGPx enzyme activity, highlighting the importance of the 
proposed catalytic centre. 
 
The lentiviral add-back system for wild type and various mutant forms of PHGPx in 
the PHGPx null background proved to be an ideal tool for mutagenesis studies on a 
cellular level, with main focus on the active site Sec. MEFs were reconstituted with 
PHGPx mutants, containing Ser and Cys substitutions for Sec. The Ser-containing 
mutant of PHGPx did not protect PHGPx-deficient cells from cell death, 
demonstrating that Sec or Cys at this position is absolutely essential for PHGPx 
function. Surprisingly, the Cys-containing PHGPx mutant fully rescued MEFs from 
cell death after Cre-mediated disruption of the endogenous PHGPx alleles and no 
difference in susceptibility towards peroxides was detected. Of note, the translational 
insertion of Sec is a complex process with a rather low efficiency, ranging around 4 
% compared to the incorporation of other amino acids (Suppmann et al., 1999). 
Consequently, the expression levels of Sec/Ser and Sec/Cys mutants were 
significantly higher compared to wild type PHGPx. These findings demonstrate that 
despite its dramatically reduced enzyme activity (Maiorino et al., 1995), the Sec/Cys 
PHGPx mutant can fully substitute wild type PHGPx in vitro. 
 
This surprising finding raises the question why mammalian cells express 
selenoproteins at all, when Cys-containing variants are apparently capable to replace 
Sec-containing wild type counterparts, at least for normal cell function. Certainly, 
findings obtained from in vitro cell culture studies can not be entirely translated to the 
far more complex system of a whole organism. At present, it can only be speculated 
that the Sec-containing wild type PHGPx exerts cellular functions beyond its activity 
as antioxidant enzyme, e.g. during embryonic and tissue development, stress 
conditions, and sperm development. This hypothesis will be addressed in our 
laboratory by the production of knockin mice, harbouring the Cys-containing mutant 
of PHGPx. Moreover, the impact of PHGPx on cellular processes may vary 
significantly between different cell types. To address this question, ongoing studies in 
my laboratory will unravel, whether the Cys-containing variant is also able to replace 
wild type PHGPx in other in vitro PHGPx knockout systems, such as ES cells, 
epithelium precursor cells, and neurons. 
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Since H2O2 and other hydroperoxides are now considered as not mere toxic 
compounds, but have drawn great attention as important second messengers, it has 
been speculated that PHGPx regulates various cellular processes by sensing and 
transducing the redox tone of the cell. Further mutational studies, using the inducible 
knockout system, may gain novel insights into these enzymatic mechanisms of 
PHGPx. In this respect, the nine Cys residues in the PHGPx gene are of major 
interest, since certain Cys residues may form a redox couple or also in cooperation 
with the Sec. 
 
One putative mechanism involves redox sensor and transducer reactions, as initially 
described for the yeast PHGPx homologue, GPx3 (Delaunay et al., 2002). Upon 
increasing H2O2 levels, yeast GPx3 senses and transduces the stress signal to the 
transcription factor Yap1. The peroxidase function of yeast GPx3 was shown to 
involve the oxidation of Cys36 and Cys82 to form a transient intra-molecular Cys36-SS-
Cys82 bridge. Subsequently, Yap1 is activated by yeast GPx3, involving a transient 
disulfide bond between GPx3 Cys36 (Sec46 homologue in mus musculus) and Cys598 
of Yap1. So far, no equal mechanism has been reported for mammalian PHGPx. But 
this cellular PHGPx knockout/knockin tool will prove most suitable to investigate this 
putative H2O2 sensing and transducing mechanism of mammalian PHGPx. 
 
In the cell, ROS are not only generated as detrimental side products of the 
mitochondrial respiration, but are also produced for essential physiological functions. 
H2O2 production is catalysed by NADPH oxidases such as NOXs (NADPH oxidase) 
and DUOXs (dual oxidase), (Rueckschloss et al., 2003) mainly for the regulation of 
detoxification processes and inflammatory responses. Upon cellular infection, 
neutrophils and phagocytic cells produce large amounts of ROS in order to kill 
invading bacteria. Yet, NOX isoforms were also found in a number of non-phagocytic 
cells and tissue, indicating that the generation of ROS is a rather general feature of 
all somatic cells than being restricted to phagocytic cells (Lambeth, 2004). In this 
regard, H2O2 seems to be the major component of receptor mediated ROS 
production, which can be stimulated by cytokines or growth factors, such as 
transforming growth factor-β1 (TGF-β1) (Thannickal and Fanburg, 1995), interleukin-
1 (Meier et al., 1989), tumor necrosis factor α (TNFα) (Lo et al., 1996), platelet-
derived growth factor (PDGF) (Krieger-Brauer and Kather, 1995; Sundaresan et al., 
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1995), epidermal growth factor (EGF) (Bae et al., 1997) and basic fibroblast growth 
factor (bFGF) (Krieger-Brauer and Kather, 1995; Lo et al., 1996). ROS have been 
shown to activate mitogen-activated protein kinases (MAPK) (Sundaresan et al., 
1995) and protein kinase C (Konishi et al., 1997), most likely by the specific 
inactivation of phosphatases (Lee et al., 1998). This has been nicely demonstrated 
by Kamata et al., showing that JNK-inactivating phosphatases are inhibited by ROS, 
by converting the catalytically active Cys to sulfenic acid (Kamata et al., 2005). 
Initially, Meng et al. demonstrated a reversible inactivation of multiple protein tyrosine 
phosphatases by H2O2 in vivo (Meng et al., 2002). Only recently, the established 
cellular PHGPx knockout system was used in our laboratory, to address a putative 
impact of PHGPx on PDGFβ receptor signalling. By using this system, it has been 
shown that PHGPx antagonizes PDGFβ receptor signalling in MEFs, most likely by 
regulating lipid-associated ROS levels. Thereby, lipid-associated ROS transiently 
oxidize and thus inactivate counteracting protein tyrosine phosphatases (Conrad et 
al., in preparation). 
 
ROS have also been reported to act as physiological mediators of transcriptional 
control by activating transcription factors, such as activation protein-1 (AP-1) (Meyer 
et al., 1993) and NF-κB (Schreck et al., 1991). Interestingly, PHGPx overexpression 
has been shown to inhibit the expression of NF-κB target genes, such as IL-1 
mediated induction of VCAM-1 in smooth muscle cells (Banning et al., 2004) and 
TNF-induced COX2 expression in L929 cells (Heirman et al., 2006), by dampening 
intracellular ROS levels. 
 
In conclusion, PHGPx may be involved in various cellular processes which have 
been masked by the lethal effects, caused by to the complete removal of PHGPx. 
The presented in vitro system, including the efficient reconstitution of PHGPx 
mutants, provides an ideal tool for further investigations on PHGPx functions. This 
may provide additional knowledge to the herein identified function of PHGPx, as a 
regulator of a distinct cell death-inducing pathway by sensing and transducing 
oxidative stress inside the cell. 
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5.3 The Cys/(Cys)2-cycle rescues GSH deficiency in γ-GCS knockout cells 
 
GSH is the major endogenous scavenger of ROS in the cell by acting as a reducing 
equivalent for GPxs and other detoxifying enzymes. Inside the cell, GSH is present 
up to millimolar concentrations and has long been considered indispensable for cell 
survival. This work highlights the significance of the Cys/(Cys)2-cycle as an 
independent redox-cycle, capable to compensate GSH deficiency in γ-GCS knockout 
cells. The overexpression of the Glu/(Cys)2 antiporter system xc- boosted the 
Cys/(Cys)2-cycle, rendering GSH dispensable for cell survival and proliferation. The 
investigation of the Cys/(Cys)2-cycle and its implication in cell survival and cell death 
required a cellular system, free of GSH. Shi et al. generated γ-GCS-deficient ES cell 
like cells, lacking detectable levels of GSH after the removal of GSH from the cell 
culture medium (Shi et al., 2000). These γ-GCS-deficient ES cell like cells proved to 
be an ideal tool to dissect the relevance of the Cys/(Cys)2-cycle for cell survival in the 
absence of endogenous GSH biosynthesis. 
 
Shi et al. showed that no significant levels of intracellular GSH are detectable by 
HPLC in γ-GCS-deficient cells (Shi et al., 2000). Yet, it is a long-lasting paradigm that 
GSH is absolutely essential for cell survival, thus the presence of minor amounts of 
GSH had to be considered in this experimental system. Due to the limited sensitivity 
of the HPLC method, however, it could not be ruled out that marginal amounts of 
GSH are still present. In this respect, two possibilities were regarded as a putative 
source of remaining GSH biosynthesis, a residual γ-GCS enzyme activity and the 
GGT salvage pathway. γ-GCS-deficient cells derive from transgenic mice that were 
designed such that a PGK-hrpt cassette replaced only exon 1 of gene γ-GCS (Shi et 
al., 2000). Although no alternative splicing variants of γ-GCS have been reported so 
far, some remaining enzyme activity could not be entirely excluded. On the other 
hand, GGT may mediate the salvage of residual GSH, independently from γ-GCS 
(Anderson and Meister, 1983; Griffith et al., 1981). GGT cleaves secreted GSH to γ-
Glu-Cys/(Cys)2, which is incorporated into the cell by the γ-Glu-AA transporter. In the 
cell, γ-Glu-Cys acts as the precursor for GSH, bypassing the rate limiting step of γ-
Glu-Cys biosynthesis. GGT is considered to have a significant influence on GSH 
metabolism and the protection against oxidative stress (Karp et al., 2001; Lieberman 
  Discussion (xCT) 
 - 101 - 
et al., 1995). To address these two possible mechanisms of GSH biosynthesis, 
proliferation assays were carried out in the presence and absence of specific 
inhibitors for γ-GCS and GGT, respectively. In case one of these pathways would 
sustain cell survival, the cells should be particularly susceptible to the inhibition of the 
respective enzyme. 
 
The proliferation rate of NAC-supplemented γ-GCS-deficient cells was not impaired, 
even at exceedingly high concentrations of BSO. This remarkable resistance of γ-
GCS-deficient cells to BSO strongly suggests the absence of a residual γ-GCS 
enzyme activity, and against a putative contribution of γ-GCS to cell survival. Of note, 
BSO proved to be a highly specific γ-GCS inhibitor, since no toxic side effects were 
observed. In addition, the putative GSH biosynthesis by the GGT-mediated salvage 
pathway was assessed by treating γ-GCS-deficient cells with the potent GGT inhibitor 
acivicin. The proliferation assay did not reveal any increased susceptibility to acivicin 
of γ-GCS-deficient cells as compared to GSH-EE-supplemented cells, indicating that 
a GGT-mediated GSH biosynthesis does not significantly contribute to cell survival. 
This finding is conceivable, since the initial presence of GSH is a prerequisite for its 
recycling by the GGT salvage pathway (Rajpert-De Meyts et al., 1992). Taken 
together, these findings indicate that no residual GSH biosynthesis is present in γ-
GCS-deficient cells, neither by remaining enzymatic γ-GCS activity nor by the GGT 
salvage pathway. Hence, the γ-GCS knockout cells state an ideal system to 
investigate the impact of the Cys/(Cys)2-cycle, independently from GSH biosynthesis.  
 
Jones et al. reported that the steady-state redox potential of Cys/(Cys)2 is 
considerably more oxidized than GSH/GSSG, indicating that both redox couples 
must be regulated independently (Jones et al., 2004). This finding also supports the 
notion that the Cys(Cys)2-cycle does not act as a mere supplier for GSH 
biosynthesis. The first indication that GSH may be dispensable for cell survival was 
obtained by Shi et al., showing that γ-GCS-deficient cells proliferate when 
supplemented with NAC (Shi et al., 2000). The present work, however, highlights the 
importance of the physiological Cys/(Cys)2-cycle, driven by the Glu/(Cys)2 antiporter, 
system xc-. The antiporter system xc- consists of two protein components, xCT light 
chain and 4F2 heavy chain, whereas xCT mediates substrate specificity for (Cys)2 
(Sato et al., 1999). Since 4F2 heavy chain is constitutively expressed, it was 
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sufficient to overexpress xCT in order to achieve an increased (Cys)2 uptake capacity 
by system xc- (Banjac Ana, PhD thesis, 2005).Two single cell clones were 
established from γ-GCS-deficient cells, stably overexpressing the xCT subunit. 
Murine xCT light chain was cloned into a eukaryotic expression vector and used for 
stable transfection of γ-GCS-deficient ES cell like cells. The xCT-overexpressing cells 
showed an approximately 8-fold increase in (Cys)2 uptake capacity, yet intracellular 
Cys levels were only slightly increased compared to mock-transfected control cells. 
Determination of secreted mercaptans, however, revealed a dramatic increase of 
extracellular free thiols in xCT-overexpressing cells. HPLC analysis confirmed that 
the extracellular mercaptans was virtually exclusively Cys. These findings 
demonstrate that the overexpression of xCT facilitates the production of a highly 
reducing environment, by mediating a rapid turnover of (Cys)2 to Cys inside the cell 
(figure 42). This is in line with findings by Ana Banjac, demonstrating that xCT 
overexpression increased extra and intracellular Cys levels in HH514 Burkitt’s 
lymphoma cells (Banjac Ana, PhD thesis, 2005). Obviously, system xc- drives the 
Cys/(Cys)2-cycle, which transports large amounts of oxidized (Cys)2 into the cell. 
Intracellular (Cys)2 is readily reduced to Cys and the surplus is secreted into the 
medium by the neutral amino acid transport system. The secreted Cys accumulates 
in the extracellular space, constituting the major part of a highly reducing 
environment. Eventually Cys is oxidized to (Cys)2 by oxygen in the medium. 
 
Consequently the question arises, which molecules are responsible for the reduction 
of (Cys)2 to Cys inside the cell, especially in the absence of GSH. Under normal 
conditions, the prime candidate would be glutaredoxin, which usually reduces 
disulfide bonds in proteins at the expense of 2 molecules GSH. In the absence of 
GSH, however, GSH reductase with its reducing equivalent NADPH may also accept 
(Cys)2 instead of GSSG as an additional substrate. A further possibility is the Trx 
system, which may take over the function of (Cys)2 reduction. The Trx system, 
consisting of Trx, TrxR, and NADPH, represents another major system for cellular 
protein disulfide reduction (Arner and Holmgren, 2000). Recently it has been shown 
by our group that wild type but not TrxR2 knockout MEFs survive BSO-mediated 
GSH depletion (Conrad et al., 2004). This finding indicates that the GSH-dependent 
system can be at least partially compensated by the Trx system, which may be 
attributed to the recycling of oxidized (Cys)2 to Cys inside the cell. 
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Figure 42: The Cys/(Cys)2- and the GSH/GSSG-cycle are two individual redox-systems. The 
Cys/(Cys)2-cycle includes the incorporation of (Cys)2 by system xc-. Intracellular (Cys)2 is reduced to 
Cys by a yet unknown mechanism. A large part of Cys is secreted into the extracellular space by 
neutral amino acid transport systems. Extracellular Cys is readily oxidized to (Cys)2 by oxygen in the 
medium. The GSH/GSSG-cycle includes the oxidation of GSH to a GSSG, usually by GSH-dependent 
enzymes, such as GPxs and glutaredoxins. GSH is reconstituted by GSH reductase at the expense of 
NADPH. Both redox-cycles are linked via the biosynthesis of GSH, which is catalysed by the rate-
limiting enzyme γ-GCS from Cys, Glu, and Gly. 
 
To test whether the increased (Cys)2 uptake capacity may compensate for GSH 
deficiency, cells were cultivated in the absence of thiol-containing supplements, such 
as NAC or GSH. Antiporter system xc- has been reported to protect various cell types 
from oxidative stress, such as human fibroblasts (Bannai et al., 1989), mouse 
peritoneal macrophages (Sato et al., 1995), and human peripheral neutrophils 
(Sakakura et al., 2007), yet this was mainly attributed to increased GSH biosynthesis 
inside the cell. Since γ-GCS-deficient cells lack the capability to synthesize GSH, the 
impact of the Cys/(Cys)2-cycle on cell fate decisions could be investigated 
independently from GSH biosynthesis. After withdrawal of glutathione or NAC, mock-
transfected γ-GCS knockout cells rapidly died, coinciding with a dramatic increase of 
soluble ROS. This is in line with findings by Shi et al., showing that γ-GCS knockout 
cells only grow in medium, supplemented with thiol-containing compounds, such as 
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NAC or GSH (Shi et al., 2000). In contrast xCT-overexpressing γ-GCS-deficient cells 
survived and proliferated independently of GSH and NAC, demonstrating that GSH 
can be replaced at least in vitro. This finding adds an important contribution to the 
work of Ana Banjac, showing that an increased (Cys)2 uptake capacity by xCT 
overexpression rendered HH514 Burkitt’s lymphoma cells resistant to BSO-induced 
cell death (Banjac Ana, PhD thesis, 2005). In her work, the GSH levels of BSO-
treated HH514 cells were reduced by 80-90 %. Thus, it could not be ruled out that 
remaining amounts of GSH still played an important role for cell survival, which can 
now be excluded by the findings presented herein. Reduced availability of Cys has 
long been regarded to cause the lack of GSH biosynthesis, which eventually 
becomes limiting for cell survival (Hanigan, 1995). Our work, however, suggests that 
GSH may not be of exceptional importance for cell survival but can be substituted by 
other thiol-containing compounds, at least in this cellular system.  
 
Since xCT overexpression caused a dramatic increase of extracellular Cys levels, a 
putative feeder effect of xCT-overexpressing to mock-transfected cells was explored 
by coculture experiments. Indeed, xCT-overexpressing cells efficiently protected 
mock-transfected control cells from cell death. This finding demonstrates that xCT-
overexpressing cells secrete sufficient Cys to maintain cell survival of mock-
transfected control cells, which can carry Cys via the amino acid transport system 
ASC. This mechanism resembles a previously described feeder effect of irradiated 
fibroblasts, which provide reduced Cys to Burkitt’s lymphoma cells (Falk et al., 1993). 
In vitro cultivated B cells and Burkitt’s lymphoma cells are highly sensitive to 
suboptimal growth conditions and readily undergo apoptosis when seeded at low cell 
density. Previous work showed that B cells comprise a very limited (Cys)2 uptake 
capacity, causing low levels of intracellular Cys and reduced GSH biosynthesis (Falk 
et al., 1998; Ishii et al., 1981). Small GSH levels, however, render B cells particularly 
sensitive to apoptotic stimuli, such as oxidative stress. 
 
How and to what extent intracellular and extracellular Cys contribute to the protection 
of GSH-deficient cells is still unknown and requires further investigation. Still, it is 
rather conceivable that high Cys levels directly protect cells from oxidative stress by 
representing a pool of reduced substrates for the scavenging of ROS. Sato et al. 
showed that in the brain, system xc- is predominantly expressed in regions facing the 
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cerebrospinal fluid, implying that relatively high levels of ROS in the brain are 
counteracted by the supply of reduced Cys (Sato et al., 2002). Yet, beyond its 
essential role for protein synthesis, Cys comprises a wide range of known functions 
in the cell, such as mixed disulfide formation, metal binding, hydrolysis, electron 
donation and redox-catalysis (Giles et al., 2003). Most importantly, the redox state of 
Cys/(Cys)2 inside the cell significantly contributes to the maintenance of the cellular 
redox balance, influencing other redox couples, such as GSSG/GSH, the Trx system, 
protein disulfide isomerases, and glutaredoxins. Jonas et al. showed that the redox 
state of Cys/(Cys)2 strongly affects proliferation rates as well as the response to 
growth factors in a colon carcinoma cell line (Jonas et al., 2002). In general, changes 
in the cellular redox state are now believed to be a common regulator of cell 
signalling pathways, influencing cell survival, proliferation, and death decisions. Since 
the present cellular system is devoid of GSH, it may prove useful for future studies, 
aiming at the investigation of Cys-mediated redox regulations as well as the impact of 
the Cys/(Cys)2 redox state on diverse cellular processes. In this respect, the 
maturation of iron-sulfur proteins may turn out to be of major importance. Sipos et al. 
reported that the maturation of cytosolic iron-sulfur proteins requires GSH (Sipos et 
al., 2002). They propose a model, in which iron-sulfur clusters are assembled in 
mitochondria, followed by a GSH-dependent export mechanism into the cytosol (Lill 
et al., 2006). Recently, the iron-sulfur protein Rli1p was shown to be essential for 
ribosome biogenesis, whereas the loss of the iron-sulfur cluster in Rli1p caused the 
loss of cell viability (Kispal et al., 2005). Since at least one cytosolic iron-sulfur protein 
proved to be indispensable for cell survival, it must be concluded from this work that 
Cys mediates the maturation of cytosolic iron-sulfur cluster proteins, at least when 
GSH levels are low or even absent.  
 
As described above, PHGPx was shown to be absolutely necessary for cell survival 
and proliferation (chapter 4.2). Hence, it must be concluded that PHGPx is still 
functional in γ-GCS knockout cells, despite the lack of its major substrate GSH. This 
finding strongly suggests that PHGPx also uses Cys as alternative reducing 
equivalent, at least under conditions of low GSH availability. That PHGPx accepts 
other reducing equivalents besides GSH is conceivable, since PHGPx was described 
as the least substrate specific GPxs for its reducing as well its oxidising substrate. 
GPx1-3 contain two arginine residues that guide GSH to the catalytic centre, whereas 
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PHGPx comprises two lysines substitutions, considered to be less specific for GSH 
(Mauri et al., 2003; Roveri et al., 2001; Ursini et al., 1999; Ursini et al., 1997). PHGPx 
has been reported to exhibit low specificity towards both the oxidizing and reducing 
substrate, indeed accepting complex hydroperoxides, such as phospholipid and 
cholesterol hydroperoxide. Moreover, PHGPx is reduced faster by synthetic dithiols, 
such as dithiothreitol (DTT) and dithioerythreitol (DTE), than by GSH (Roveri et al., 
1994; Thomas et al., 1990). Nevertheless, the finding that α-tocopherol did not 
rescue γ-GCS deficient cells but fully protected PHGPx knockout cells, indicates that 
the effects provoked by GSH depletion are not in total reflected by impaired PHGPx 
activity. Hence, it must be concluded that further GSH-dependent systems exist that 
are essential for maintaining cell survival and proliferation. 
 
Interestingly γ-GCS-deficient mice fail to develop beyond embryonic day 7.5 (Shi et 
al., 2000). This severe phenotype strongly resembles the phenotype of PHGPx 
deficient mice, both causing early embryonic lethality at E7.5 in mice (Imai et al., 
2003; Imai and Nakagawa, 2003; Yant et al., 2003). These findings imply that early 
embryonic lethality of γ-GCS-deficient mice reflects to a major extent the impairment 
of PHGPx enzyme activity, lacking its substrate GSH. This hypothesis seems 
reasonable, since PHGPx is the only reported GSH-dependent enzyme that proved 
to be essential for this early embryonic stage, unlike other GPx family members (Ho 
et al., 1997), glutathione-S-transferases (Hayes et al., 2005), or GGT (Lieberman et 
al., 1996).  
 
Taken together, it has become evident from this work that an increased activity of the 
Cys/(Cys)2-cycle, driven by antiporter system xc-, renders cells independent from 
GSH biosynthesis. The antiporter system xc- mediates a strong increase of cellular 
Cys levels, mainly in the extracellular space, efficiently protecting cells from oxidative 
stress. So far, the Cys/(Cys)2-cycle was mainly regarded as a supplier of Cys for the 
biosynthesis of GSH and proteins. This work provides for the first time genetic proof 
for the concept that the Cys/(Cys)2-cycle involves an additional redox couple of major 
importance (Jonas et al., 2002; Jones et al., 2004). In conclusion, the maintenance of 
the cellular redox balance, rather than the GSH level itself, seems to be of major 
importance for cell survival. The physiological significance of the Cys/(Cys)2-cycle 
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under normal and pathophysiological conditions will be addressed by using mice 
lacking the xCT gene (Sato et al., 2005). 
 
Oxidative stress and concomitant GSH depletion has been implicated in various 
degenerative disorders, yet the impact of the Cys/(Cys)2-cycle has been so far 
neglected. Concluding from this work, the Cys/(Cys)2-cycle should be viewed as an 
individual redox-metabolism of major importance, which may be capable to 
compensate GSH-deficiency under pathophysiological conditions, such as 
atherosclerosis, Parkinson’s disease, myocardial infarction, and stroke. Altogether, 
the present work depicts a comprehensive picture of the molecular mechanisms 
occurring under conditions of oxidative stress, mainly caused by GSH depletion and 
the associated inhibition of essential antioxidant enzymes, such as PHGPx. 
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7 Summary 
 
Acute or chronic oxidative stress, accompanied by GSH depletion, has been 
frequently linked with many degenerative human diseases, such as atherosclerosis, 
myocardial infarction, stroke, and Parkinson’s disease. While the accumulation of 
reactive oxygen species is known being detrimental to cells and tissues, it has 
remained enigmatic if this is just a pleiotropic effect or whether a distinct signalling 
pathway is involved in oxidative stress-mediated cell death. Phospholipid 
hydroperoxide glutathione peroxidase (PHGPx) has emerged as an essential 
antioxidant enzyme in cells, efficiently detoxifying phospholipid hydroperoxides within 
biological membranes at the expense of GSH. To study PHGPx functions on life and 
death decisions in a cellular context, an inducible knockout model for PHGPx was 
established in mouse embryonic fibroblasts (MEFs), by using the 4-
hydroxytamoxifen-inducible MerCreMer/loxP system. Targeted PHGPx abolition 
enabled to pinpoint a specific cell death inducing pathway, including activation of 15-
lipoxygenase (15-LOX), lipid peroxidation, translocation of apoptosis inducing factor 
(AIF), and eventually cell death. The onset and execution of cell death could be 
efficiently prevented at each single step, either by the administration of the 
antioxidant α-tocopherol, by the highly specific 15-LOX inhibitor PD146176, or by 
siRNA-mediated knockdown of AIF. Since PHGPx is considered as the major GSH-
dependent enzyme, this cell death-inducing pathway may be a common signature in 
the etiology of many degenerative disorders, involving a detrimental accumulation of 
reactive oxygen species (ROS). To gain further insights into the role of GSH for 
cellular life and death decisions, a GSH-deficient in vitro model of γ-glutamylcysteine 
synthetase (γ-GCS) knockout cells was used. The glutamate/cystine (Cys)2 
antiporter, system xc-, consists of two protein components, xCT light chain and 4F2 
heavy chain, whereas xCT mediates transport specificity. The overexpression of xCT 
in γ-GCS knockout cells increased intra- and extracellular cysteine (Cys)-levels, 
rendering cell survival and proliferation independent from GSH. The elevated Cys 
levels are generated by the increased uptake of (Cys)2, intracellular reduction to Cys, 
and subsequent secretion to the extracellular space. These findings also imply that in 
the absence of GSH PHGPx accepts cysteine (Cys) as an alternative reducing 
equivalent when present in sufficient amounts. Since the maintenance of the cellular 
redox balance rather than GSH itself appeared to be essential for the maintenance of 
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cell integrity, the Cys/(Cys)2-cycle has to be regarded as a distinct redox cycle of 
major importance. In conclusion, we propose that acute or chronic oxidative stress in 
cells and tissues triggers the herein described cell death pathway, including GSH 
depletion, impaired PHGPx enzyme activity, 15-LOX activation, lipid peroxidation, 
and AIF release. Whether up-regulation of xCT expression may represent a back-up 
system for low GSH levels, as observed under various pathophysiological conditions, 
certainly deserves further investigations.  
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